Short Name,Full Name,Faculty,Category,Instructors,TAs,Assessment title,Assessment type,Format,weight,Cumulative,due date,Specific objectives,Course Outcomes: all,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,Midterm,Exam,Multiple choice,50,,16-01-21,,"By the end of this course, students will be able to know and understand nutritional terminology, what a healthy diet is, macro/micro nutrient requirements, and the role of nutrients in health and disease states (obesity, diabetes, cardiovascular, osteoporosis, gut diseases, cancer, autoimmune-inflammatory diseases, and metabolic syndrome).","By the time students finish the course, they should be able to explain their learning and knowledge in the area of nutrition to others. This will be tested by multiple choices and short-answer exam questions.","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 327 (Winter 2016 LEC B1 B2 SEM J1),PHARM 327 Wi16 - NUTRITION Combined LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,, Therapeutics,",Hoon Sunwoo,,FInal,Exam,Multiple choice,50,,16-02-12,,"By the end of this course, students will be able to know and understand nutritional terminology, what a healthy diet is, macro/micro nutrient requirements, and the role of nutrients in health and disease states (obesity, diabetes, cardiovascular, osteoporosis, gut diseases, cancer, autoimmune-inflammatory diseases, and metabolic syndrome).","By the time students finish the course, they should be able to explain their learning and knowledge in the area of nutrition to others. This will be tested by multiple choices and short-answer exam questions.","By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Pre-Seminar Quiz 1,Quiz,Written and multiple choice,5,,16-01-20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Pre-Seminar Quiz 2,Quiz,Written and multiple choice,5,,16-02-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Midterm,Exam,Written and multiple choice,40,,16-02-09,,Identify the main anatomy components of the endocrine system.,"Describe the physiological effects of the following: adrenal, thyroid, parathyroid, neurohypophyseal and pancreatic hormones.","Describe the epidemiology, etiology, and risk factors of endocrine disorders.","Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Recognize the main structural features of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used in the management of endocrine disorders.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of endocrine disorders.,Describe the specific laboratory tests used in the diagnosis and monitoring of endocrine disorders.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments to the prevention, treatment and management of endocrine disorders, including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).","Recognize and understand the appropriate acute management strategies for patients with diabetes, including travel, exercise and acute illness.",Describe the toxicity of medications used in the management of endocrine disorders.,Identify ethical and cultural issues surrounding endocrine disorders.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).","Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Pre-Seminar Quiz 3,Quiz,Written and multiple choice,5,,16-03-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 497 (LEC B1 Wi16),PHARM 497 ENDOCRINE (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Candace Necyk,,Final,Exam,Written and multiple choice,45,,16-04-11,,Identify the main anatomy components of the endocrine system.,"Describe the physiological effects of the following: adrenal, thyroid, parathyroid, neurohypophyseal and pancreatic hormones.","Describe the epidemiology, etiology, and risk factors of endocrine disorders.","Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Recognize the main structural features of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used in the management of endocrine disorders.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of endocrine disorders.,Describe actions and adverse effects of common natural health products used for management of endocrine disorders.,Describe the specific laboratory tests used in the diagnosis and monitoring of endocrine disorders.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments to the prevention, treatment and management of endocrine disorders, including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).","Recognize and understand the appropriate acute management strategies for patients with diabetes, including travel, exercise and acute illness.",Describe the toxicity of medications used in the management of endocrine disorders.,Identify ethical and cultural issues surrounding endocrine disorders.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).","Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,Learning Opportunities (On-going),Participation,N/A,10,,16-09-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,Lab Reflection,Assignment,N/A,10,,16-12-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,Lab Exam,Exam,Multiple choice,50,,16-03-07,,Explain the importance of stress management in professional life,Understand purpose for talking with a patient about new medication vs ongoing therapy,Describe the elements of a medication history,"Compare and contrast concordance, compliance, and adherence frameworks ",Identify supportive communication techniques to assess patients medication to assess med taking behaviours and detect barriers,Compare and contrast intentional and unintentional medication taking behaviours ,Appreciate patient perspective in living with vision loss.,Appreciate patient perspective in living with hearing loss.,Differentiate strategies to communicate with patients with hearing and hearing loss. ,Identify communication challenges associated with providing care to a patient whose first language is not English. ,Understand effective patient education skills,Describe the appropriate process for working with an interpreter in a healthcare setting. ,Understand the complexity of communicating risk to patients,Identify several strategies for effectively communicating risk,Describe the SBAR technique for communicating with other healthcare professionals,Identify a process to manage emotional consults,Identify core principles and key skills of motivational interviewing,Practice self-care activities to manage stress in professional life,Detect barriers to patients medication taking behaviors using supportive probing techniques ,Develop strategies to help patients overcome barriers to taking their medications,"Recognize verbal and nonverbal cues signaling anger, conflict, and lack of trust ","Demonstrate appropriate techniques for dealing with anger, conflict, and lack of trust ",Communicate effectively with people with vision or hearing loss,Communicate effectively using a translator ,Select and integrate communication techniques to effectively communicate risk to patients,Select and integrate communication techniques to effectively communicate with other healthcare professionals.,Engage in effective partnerships with their patients to support positive behaviour changes,Perform rapid assessments of their patients readiness for change,Help patients to increase motivation and overcome barriers to change,Recognize prior encounters with the patient (if applicable),Provide tailored information (verbal and written),Provide clear patient information in manageable chunks,Relate explanation to patients experiences and understandings,Check for patient understanding of medication information ,"Invite follow-up includes who, how, and when",Establish organization and flow while taking a full medication history,Listen and adapt to patient cues in differing patient scenarios,Reflect on your communication skills,Accept responsibility for communicating professionally through both student and professional career ,Accept responsibility for providing patient care ,Foster curiosity to understand and appreciate your patients unique life experience,Advocate for pharmacists role in monitoring medication therapy at the medication refill,,,,,PHARM 334 (Winter 2016 LEC B1 SEM J1 J2),PHARM 334 Wi16 - HLTH PROF COMM PART 2 Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences",Lisa Guirguis,,Written Final,Exam,Multiple choice,30,,16-03-11,,Explain the importance of stress management in professional life,Understand purpose for talking with a patient about new medication vs ongoing therapy,Describe the elements of a medication history,"Compare and contrast concordance, compliance, and adherence frameworks ",Identify supportive communication techniques to assess patients medication to assess med taking behaviours and detect barriers,Compare and contrast intentional and unintentional medication taking behaviours ,Appreciate patient perspective in living with vision loss.,Appreciate patient perspective in living with hearing loss.,Differentiate strategies to communicate with patients with hearing and hearing loss. ,Identify communication challenges associated with providing care to a patient whose first language is not English. ,Understand effective patient education skills,Describe the appropriate process for working with an interpreter in a healthcare setting. ,Understand the complexity of communicating risk to patients,Identify several strategies for effectively communicating risk,Describe the SBAR technique for communicating with other healthcare professionals,Identify a process to manage emotional consults,Identify core principles and key skills of motivational interviewing,Practice self-care activities to manage stress in professional life,Detect barriers to patients medication taking behaviors using supportive probing techniques ,Develop strategies to help patients overcome barriers to taking their medications,"Recognize verbal and nonverbal cues signaling anger, conflict, and lack of trust ","Demonstrate appropriate techniques for dealing with anger, conflict, and lack of trust ",Communicate effectively with people with vision or hearing loss,Communicate effectively using a translator ,Select and integrate communication techniques to effectively communicate risk to patients,Select and integrate communication techniques to effectively communicate with other healthcare professionals.,Engage in effective partnerships with their patients to support positive behaviour changes,Perform rapid assessments of their patients readiness for change,Help patients to increase motivation and overcome barriers to change,Recognize prior encounters with the patient (if applicable),Provide tailored information (verbal and written),Provide clear patient information in manageable chunks,Relate explanation to patients experiences and understandings,Check for patient understanding of medication information ,"Invite follow-up includes who, how, and when",Establish organization and flow while taking a full medication history,Listen and adapt to patient cues in differing patient scenarios,Reflect on your communication skills,Accept responsibility for communicating professionally through both student and professional career ,Accept responsibility for providing patient care ,Foster curiosity to understand and appreciate your patients unique life experience,Advocate for pharmacists role in monitoring medication therapy at the medication refill,,,,,PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Lab #2 evaluation,Other,N/A,5,,16-02-08,,Identify the basic process requirements in utilizing the Patient Care Process: a. Construct a patient care database b. Identify the drug related problem c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products ,Identify legal requirements when accepting/receiving written & verbal prescriptions.,"Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Identify and document potential medication prescribing errors in written and verbal prescriptions.,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Lab #3 evaluation,Other,N/A,5,,16-02-22,,Identify the basic process requirements in utilizing the Patient Care Process: a. Construct a patient care database b. Identify the drug related problem c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products ,Identify legal requirements when accepting/receiving written & verbal prescriptions.,"Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Identify and document potential medication prescribing errors in written and verbal prescriptions.,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Midterm,Exam,Written and multiple choice,25,,16-01-29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Lab #4 evaluation,Other,N/A,5,,16-02-29,,Identify the basic process requirements in utilizing the Patient Care Process: a. Construct a patient care database b. Identify the drug related problem c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products ,Identify legal requirements when accepting/receiving written & verbal prescriptions.,"For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.","Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Identify and document potential medication prescribing errors in written and verbal prescriptions.,Apply concepts of third party billing and prescription pricing in the drug use process.,Recognize issues surrounding drug diversion and security.,Demonstrate an introductory level of adverse drug reporting and management.,Relate the concepts of the culture of patient safety to the drug use process.,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Document search process for drug information questions, citing references used.",Communicate effectively when having a dialogue with a simulated patient and other health care practitioners,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Final exam,Exam,Written and multiple choice,45,,16-03-14,,Identify the basic process requirements in utilizing the Patient Care Process: a. Construct a patient care database b. Identify the drug related problem c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products ,Identify legal requirements when accepting/receiving written & verbal prescriptions.,"For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.","Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Identify and document potential medication prescribing errors in written and verbal prescriptions.,Apply concepts of third party billing and prescription pricing in the drug use process.,Recognize issues surrounding drug diversion and security.,Demonstrate an introductory level of adverse drug reporting and management.,Relate the concepts of the culture of patient safety to the drug use process.,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Document search process for drug information questions, citing references used.",Communicate effectively when having a dialogue with a simulated patient and other health care practitioners,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Lab #1 evaluation,Other,N/A,5,,16-02-01,,Identify the basic process requirements in utilizing the Patient Care Process: a. Construct a patient care database b. Identify the drug related problem c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products ,Identify legal requirements when accepting/receiving written & verbal prescriptions.,"Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Identify and document potential medication prescribing errors in written and verbal prescriptions.,Apply concepts of third party billing and prescription pricing in the drug use process.,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 342 (Winter 2016 LAB LEC SEM),PHARM 342 Wi16 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Ravina Sanghera-Grewal,,Self-reflection (Community pharmacy visit(,Assignment,N/A,10,,16-12-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa16),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Jody Shkrobot,,Midterm,Exam,Written and multiple choice,25,,16-10-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa16),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Jody Shkrobot,,Business Plan Presentation â€“ Peer Evaluation (Group),Assignment,N/A,5,,16-11-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa16),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Jody Shkrobot,,Peer Performance Evaluation (Final) â€“ Peer Evaluation (Individual),Other,N/A,5,,16-12-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa16),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Jody Shkrobot,,Case Presentation â€“ Instructor Evaluation (Group),Other,N/A,2,,17-05-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa16),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Jody Shkrobot,,"Business Plan Written Report â€“ Instructor Evaluation (Group) Note: Sample business plans, prepared in prior years, will be available for student viewing, on request.",Assignment,N/A,10,,16-11-25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa16),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Jody Shkrobot,,Case Presentation â€“ Peer Evaluation (Group),Other,N/A,2,,17-05-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa16),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Jody Shkrobot,,Final,Exam,Written and multiple choice,35,,16-12-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa16),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Jody Shkrobot,,Peer Performance Evaluation (Midpoint) â€“ Peer Evaluation (Individual),Other,N/A,5,,16-10-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa16),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Jody Shkrobot,,Business Plan Presentation â€“ Instructor / Guest Panel Evaluation (Group),Other,N/A,10,,16-11-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 311 (LEC A1 Fa16),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,In Class Quiz #1,Quiz,Multiple choice,10,,16-09-08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 311 (LEC A1 Fa16),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Final Exam ,Exam,Multiple choice,50,,16-10-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 311 (LEC A1 Fa16),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Midterm Exam ,Exam,Multiple choice,40,,16-09-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 311 (LEC A1 Fa16),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,In Class Quiz #2,Quiz,Multiple choice,10,,16-09-23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Final,Exam,Multiple choice,45,,17-04-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Medical Terminology Quiz #5,Exam,Multiple choice,2,,16-11-28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Medical Terminology Quiz #1,Quiz,Multiple choice,2,,16-11-26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Medical Terminology Quiz #2,Quiz,Multiple choice,2,,16-11-26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Medical Terminology Quiz #3,Quiz,Multiple choice,2,,16-11-26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,OTC Submission,Assignment,N/A,10,,17-04-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Medical Terminology Quiz #4,Exam,Multiple choice,2,,16-11-26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Midterm,Exam,Multiple choice,25,,17-03-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,"Lab # 1 Patient Care Process (Eye, Ear and Lice)",Other,N/A,5,,17-03-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 307 (Winter 2016 LAB LEC SEM),"PHARM 307 Wi16 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi16",Cross Listed Courses,"Therapeutics,",Ravina Sanghera-Grewal,,Lab # 2: Patient Care Process (Dermatologic Conditions),Other,N/A,5,,17-04-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 377 (LEC B1 Wi16),PHARM 377 IMMUNOTHERAPEUTIC & TRANSPLANT (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Dr. Sharon Mitchell,,Midterm,Exam,Multiple choice,40,,16-03-10,,Understand the mechanisms of action and effects and adverse effects of anti-Â_â€êrejection medication.,Understand and apply pharmacokinetic principles in the management of anti-Â_â€êrejection medications.,Understand the rationale for combination anti-Â_â€êrejection therapy following organ transplantation.,Understand issues related to organ donation,Understand the pathophysiology of transplanted organ rejection.,"Understand problems associated with opportunistic infections, malignancy, metabolic effects and adverse drug effects associated with immunosuppression.",Recognize and manage immunosuppression and toxicity induced by anti-Â_â€êrejection therapy.,Recognize and be able to manage drug interactions with anti-Â_â€êrejection therapy.,Adjust dosages of anti-Â_â€êrejection therapy based on drug levels and therapeutic targets.,To develop an understanding of the patient perspective of receiving a transplant.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 377 (LEC B1 Wi16),PHARM 377 IMMUNOTHERAPEUTIC & TRANSPLANT (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Dr. Sharon Mitchell,,Final,Exam,Multiple choice,60,,16-04-17,,Understand the mechanisms of action and effects and adverse effects of anti-Â_â€êrejection medication.,Understand and apply pharmacokinetic principles in the management of anti-Â_â€êrejection medications.,Understand the rationale for combination anti-Â_â€êrejection therapy following organ transplantation.,Understand issues related to organ donation,Understand the pathophysiology of transplanted organ rejection.,"Understand problems associated with opportunistic infections, malignancy, metabolic effects and adverse drug effects associated with immunosuppression.",Recognize and manage immunosuppression and toxicity induced by anti-Â_â€êrejection therapy.,Recognize and be able to manage drug interactions with anti-Â_â€êrejection therapy.,Adjust dosages of anti-Â_â€êrejection therapy based on drug levels and therapeutic targets.,To develop an understanding of the patient perspective of receiving a transplant.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Midterm,Exam,Written and multiple choice,35,,16-02-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,BP Clinic and E-Journal,Assignment,N/A,5,,16-02-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Seminar 1,Quiz,Multiple choice,3,,16-03-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Seminar 2,Quiz,Multiple choice,3,,16-03-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Seminar 3,Quiz,Multiple choice,3,,16-03-23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Seminar 4,Quiz,Multiple choice,3,,16-03-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 367 (Winter 2016 LEC B1 B2),PHARM 367 Wi16 - CARDIOLOGY Combined LEC Wi16,Cross Listed Courses,"Therapeutics,",John Seubert,,Final,Exam,Written and multiple choice,45,,16-04-21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,Assignment - Part III,Assignment,N/A,10,,16-01-28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,Pediatrics,Exam,Multiple choice,37,,16-02-03,,"Describe the pharmacoepidemiology, including prescription, non-prescription medication, and natural health products.","Describe risks for adverse drug events in pediatric and geriatric patients, and explain why they are more susceptible to adverse events.",Identify and describe age-appropriate communication strategies.,"Describe the role that culture, religion, and ethnicity may play in health and decision making.",Identify controversial health issues involving pediatric and geriatric populations,"Identify and discuss some of the challenges involved in treating the pediatric population; including communication strategies, presentation of illness and the management and administration of medications to infants and children.",Discuss the importance of medication safety and identify measures used to ensure safe medication practices,Review pediatric toxicology and discuss preventative interventions that pharmacists can promote to patients or utilize in their practice to minimize pediatric toxicological poisonings or incidences.,Discuss basic neonatal care and challenges including premature birth.,Explain how pharmacokinetic parameters are different in infants and children versus adults.,"Explain the significant differences in physiologic parameters between adolescents, children, toddlers and infants; including premature babies, and neonates",Identify and discuss appropriate management plans for common pediatric illnesses such as teething and fevers.,"Identify and discuss appropriate management plans for common pediatric gastrointestinal illnesses (e.g. vomiting, diarrhea, dehydration, colic, and constipation).",Discuss presentation and treatment for common pulmonary pediatric illnesses; Croup and Bronchiolitis.,"Describe the various forms of pediatric abuse and discuss the Child, Youth and Family Enhancement Act and the responsibilities that are associated with the Act",Discuss the management and implications involved with a diagnosis of autism.,Be able to triage patients in a community setting and refer them to medical attention as appropriate.,Apply applicable pharmacokinetic parameters to monitor patients and assess appropriate use of medications.,Apply knowledge and skills to establish safe and effective drug use.,Utilize when available an evidence based approach to therapeutic management of pediatric and geriatric patients.,Identify sources of information needed to solve drug related problems specific to the populations being studied.,Identify and be able to recommend aids to assist in medication management and administration.,"Empathize with children, older adults, and caregivers regarding challenging decision-making.",Take and defend a position on a controversy related to pediatrics and geriatrics using evidence-based arguments.,Collaborate with peers to prepare and present an argument.,Communicate position through oral presentation and debate.,"Develop a caring, empathic attitude for and response to pediatric and geriatric patients","Develop an appreciation of the comprehensive, interdisciplinary nature of patient care for children and older adults",Appreciate the challenges related to decision making and advocacy in grey areas of clinical practice and health.,,,,,,,,,,,,,,,,,,PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,Geriatrics,Exam,Multiple choice,37,,16-01-18,,"Define and be able to use the following terms in a clinical context: geriatrics, gerontology, elderly, aging, frailty.",Describe common stereotypes and biases toward aging in our western society.,"Explain the demographics of aging, and how that may impact society and the healthcare system.",Briefly describe the psychosocial aspects of aging and be able to explain the role of the pharmacist in dealing with these aspects.,Describe the physiologic alterations associated with normal aging that modify drug response in the elderly patient.,"Describe the pharmacokinetic and pharmacodynamic changes associated with aging, and apply the principles to medications commonly used in geriatrics.",List the most common chronic diseases and causes of death in seniors.,Contrast disease presentation between the young adult and the elderly adult.,Identify medications that are considered inappropriate or high risk in older adults and explain why they are inappropriate or high risk.,Describe how criteria were developed to classify medications as appropriate or inappropriate in seniors.,Define polypharmacy and underutilization in terms of medications in seniors.,Contrast the presentation of adverse events in the elderly compared to the young adult.,Describe the impact of falls on the senior population.,Identify risk factors for falls in older individuals.,Describe appropriate interventions for falls.,Contrast how a geriatric syndrome is different than a disease state.,List the common geriatric syndromes.,Discuss the role of the pharmacist in medication management of seniors.,Identify methods of appropriately communicating with older adults who are hard of hearing.,Describe the role of the pharmacist in working with home care.,Identify appropriate home care supports for a given patient.,Categorize the types of abuse commonly suffered by seniors.,Describe the role of the pharmacist in reducing elder abuse.,"Explain the demographics of the pediatric population in society, and explain how that may impact our role as pharmacists. (e.g. improvement of childhood illnesses, trend towards chronic disease management)","Identify and discuss some of the challenges involved in treating the pediatric population; including communication strategies, presentation of illness and the management and administration of medications to infants and children.",Discuss the importance of medication safety and identify measures used to ensure safe medication practices,Apply knowledge and skills to establish safe and effective drug use.,Utilize when available an evidence based approach to therapeutic management of pediatric and geriatric patients.,Identify sources of information needed to solve drug related problems specific to the populations being studied.,Identify and be able to recommend aids to assist in medication management and administration.,"Empathize with children, older adults, and caregivers regarding challenging decision-making.",Take and defend a position on a controversy related to pediatrics and geriatrics using evidence-based arguments.,Collaborate with peers to prepare and present an argument.,Communicate position through oral presentation and debate.,"Develop a caring, empathic attitude for and response to pediatric and geriatric patients","Develop an appreciation of the comprehensive, interdisciplinary nature of patient care for children and older adults",Appreciate the challenges related to decision making and advocacy in grey areas of clinical practice and health.,,,,,,,,,,PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,Assignment - Part I,Assignment,N/A,5,,16-01-21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 387 (LEC B1 Wi16),PHARM 387 PEDIATRICS / GERIATRICS (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,Cheryl Sadowski,,Assignment - Part II,Assignment,N/A,10,,16-01-21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Midterm,Exam,Multiple choice,40,,16-03-22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Final,Exam,Multiple choice,50,,16-04-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Seminar 1 Quiz,Quiz,Multiple choice,5,,16-03-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 499 (LEC B1 Wi16),PHARM 499 WOMEN'S & MEN'S HEALTH (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,NesÃ© Yuksel,,Seminar 3 Quiz,Quiz,Multiple choice,5,,16-03-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Midterm,Exam,Multiple choice,34,,16-10-24,,"Comprehend one and two compartmental models, including the underlying reasons for the appearance of more than one compartment in a plasma concentration vs. time profile.","Identify the relationships between different pharmacokinetic parameters and blood fluid concentrations after drug administration by the intravenous, oral and injectable routes.",Grasp the concept of steady state and its dependency on half-life in relation to constant intravenous infusion and repeated dose administration.,"Understand the relationship between organ clearance and total body clearance, and detail the mechanisms involved in renal and hepatic drug clearance of a particular drug.","Use the knowledge obtained from determination of pharmacokinetic parameters to devise an individualized dosing regimen for a patient, tailored to achieve a therapeutic goal of concentration and/or effect.",Comprehend concepts related to nonlinear elimination of drug.,Recognize factors that can influence the relationship between plasma concentrations and pharmacodynamics potency of drugs,"Determine CL, Vd, and other dependent pharmacokinetic parameters (half-life, maximum concentration after dosing, area under the concentration vs. time curve) from plasma concentration vs. time data.",Become proactive in including and considering concepts of therapeutic drug monitoring in practice skills.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Final,Exam,Multiple choice,44,,16-12-21,,"Explain the following pharmacokinetic concepts:a. First and zero order rate processes. b. Rates, rate constants, and intercepts. c. Total body clearance (CL). d. Volume of distribution (Vd).",Recognize the relationship between pharmacokinetics and therapeutic relevance in: a. Extremes of age b. Genetic differences in drug metabolism (polymorphism) c. Diminished renal function d. Concomitant administration of interacting drugs e. Drug disposition in maternal and infants (pregnancy and breastmilk,"Use knowledge related to measures of organ clearance to predict changes in blood levels when physiological 3 factors or clinical conditions are present that may affect blood flows, intrinsic clearance and transporter function.",Become proactive in including and considering concepts of therapeutic drug monitoring in practice skills.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture Participation Bonus,Participation,N/A,2,,16-12-14,,"Explain the following pharmacokinetic concepts:a. First and zero order rate processes. b. Rates, rate constants, and intercepts. c. Total body clearance (CL). d. Volume of distribution (Vd).","Comprehend one and two compartmental models, including the underlying reasons for the appearance of more than one compartment in a plasma concentration vs. time profile.","Identify the relationships between different pharmacokinetic parameters and blood fluid concentrations after drug administration by the intravenous, oral and injectable routes.",Grasp the concept of steady state and its dependency on half-life in relation to constant intravenous infusion and repeated dose administration.,"Understand the relationship between organ clearance and total body clearance, and detail the mechanisms involved in renal and hepatic drug clearance of a particular drug.","Use the knowledge obtained from determination of pharmacokinetic parameters to devise an individualized dosing regimen for a patient, tailored to achieve a therapeutic goal of concentration and/or effect.",Comprehend concepts related to nonlinear elimination of drug.,Recognize factors that can influence the relationship between plasma concentrations and pharmacodynamics potency of drugs,Recognize the relationship between pharmacokinetics and therapeutic relevance in: a. Extremes of age b. Genetic differences in drug metabolism (polymorphism) c. Diminished renal function d. Concomitant administration of interacting drugs e. Drug disposition in maternal and infants (pregnancy and breastmilk,"Determine CL, Vd, and other dependent pharmacokinetic parameters (half-life, maximum concentration after dosing, area under the concentration vs. time curve) from plasma concentration vs. time data.","Use knowledge related to measures of organ clearance to predict changes in blood levels when physiological 3 factors or clinical conditions are present that may affect blood flows, intrinsic clearance and transporter function.",Become proactive in including and considering concepts of therapeutic drug monitoring in practice skills.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 351 (LEC A1 Fa16),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Dion Brocks,,Pharmacokinetic web-based problem assignments (15 in total),Assignment,N/A,20,,16-12-14,,"Explain the following pharmacokinetic concepts:a. First and zero order rate processes. b. Rates, rate constants, and intercepts. c. Total body clearance (CL). d. Volume of distribution (Vd).","Comprehend one and two compartmental models, including the underlying reasons for the appearance of more than one compartment in a plasma concentration vs. time profile.","Identify the relationships between different pharmacokinetic parameters and blood fluid concentrations after drug administration by the intravenous, oral and injectable routes.",Grasp the concept of steady state and its dependency on half-life in relation to constant intravenous infusion and repeated dose administration.,"Understand the relationship between organ clearance and total body clearance, and detail the mechanisms involved in renal and hepatic drug clearance of a particular drug.","Use the knowledge obtained from determination of pharmacokinetic parameters to devise an individualized dosing regimen for a patient, tailored to achieve a therapeutic goal of concentration and/or effect.",Comprehend concepts related to nonlinear elimination of drug.,Recognize factors that can influence the relationship between plasma concentrations and pharmacodynamics potency of drugs,Recognize the relationship between pharmacokinetics and therapeutic relevance in: a. Extremes of age b. Genetic differences in drug metabolism (polymorphism) c. Diminished renal function d. Concomitant administration of interacting drugs e. Drug disposition in maternal and infants (pregnancy and breastmilk,"Determine CL, Vd, and other dependent pharmacokinetic parameters (half-life, maximum concentration after dosing, area under the concentration vs. time curve) from plasma concentration vs. time data.","Use knowledge related to measures of organ clearance to predict changes in blood levels when physiological 3 factors or clinical conditions are present that may affect blood flows, intrinsic clearance and transporter function.",Become proactive in including and considering concepts of therapeutic drug monitoring in practice skills.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Lab #1,Other,N/A,0,,16-01-11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Lab #2,Other,N/A,0,,16-01-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Lab #3,Other,N/A,0,,16-01-25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Midterm,Exam,Written and multiple choice,30,,16-01-25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Lab #4,Other,N/A,0,,16-02-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Lab #5,Other,N/A,0,,16-02-08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Lab #7,Other,N/A,0,,16-02-29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Final,Exam,Multiple choice,40,,16-03-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Lab Exam,Exam,Multiple choice,10,,16-03-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 331 (Winter 2016 LAB LEC SEM),PHARM 331 Wi16 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi16,Cross Listed Courses,"Pharmaceutical Sciences,",Raimar LÃ¶benberg,,Lab #6,Other,N/A,0,,17-02-22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (Winter 2016 LEC B1 B2),PHARM 382 Wi16 - PROV/CDN HEALTHCARE Combined LEC Wi16,Cross Listed Courses,"Pharmacy Practice,",Jody Shkrobot,,Midterm,Exam,Written and multiple choice,30,,16-02-22,,"The student will be able to describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically,Alberta.","The student will be able to list the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to thedelivery of health care in Canada with particular emphasis on organizations that impact theprofession of pharmacy.",The student will be able to describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,"The student will develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Alberta health systems.",The student will develop an appreciation of the different pharmacy service delivery models in different provincial and relevant international jurisdictions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (Winter 2016 LEC B1 B2),PHARM 382 Wi16 - PROV/CDN HEALTHCARE Combined LEC Wi16,Cross Listed Courses,"Pharmacy Practice,",Jody Shkrobot,,Team Debate (Group) â€“ Instructor evaluation,Assignment,N/A,10,,16-03-14,,The student will be able to identify and debate key issues and challenges facing the Canadian healthcare system.,The student will be able to develop and debate solutions to some of the challenges facing the Canadian healthcare system with emphasis on how pharmacists and pharmacies can be a part ofthose solutions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (Winter 2016 LEC B1 B2),PHARM 382 Wi16 - PROV/CDN HEALTHCARE Combined LEC Wi16,Cross Listed Courses,"Pharmacy Practice,",Jody Shkrobot,,Team Debate (Group) â€“ Peer evaluation,Assignment,N/A,5,,16-03-31,,The student will be able to identify and debate key issues and challenges facing the Canadian healthcare system.,The student will be able to develop and debate solutions to some of the challenges facing the Canadian healthcare system with emphasis on how pharmacists and pharmacies can be a part ofthose solutions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (Winter 2016 LEC B1 B2),PHARM 382 Wi16 - PROV/CDN HEALTHCARE Combined LEC Wi16,Cross Listed Courses,"Pharmacy Practice,",Jody Shkrobot,,Peer Assessment,Other,N/A,5,,16-03-31,,The student will be able to identify and debate key issues and challenges facing the Canadian healthcare system.,The student will be able to develop and debate solutions to some of the challenges facing the Canadian healthcare system with emphasis on how pharmacists and pharmacies can be a part ofthose solutions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (Winter 2016 LEC B1 B2),PHARM 382 Wi16 - PROV/CDN HEALTHCARE Combined LEC Wi16,Cross Listed Courses,"Pharmacy Practice,",Jody Shkrobot,,Final,Exam,Written and multiple choice,50,,16-04-13,,"The student will be able to describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically,Alberta.","The student will be able to list the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to thedelivery of health care in Canada with particular emphasis on organizations that impact theprofession of pharmacy.",The student will be able to describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,"The student will develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Alberta health systems.",The student will develop an appreciation of the different pharmacy service delivery models in different provincial and relevant international jurisdictions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 427 (LEC B1 Wi16),PHARM 427 PAIN (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,John Ussher,,Class participation,Participation,N/A,5,,16-12-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 427 (LEC B1 Wi16),PHARM 427 PAIN (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,John Ussher,,Midterm,Exam,Written and multiple choice,40,,16-02-25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 427 (LEC B1 Wi16),PHARM 427 PAIN (LEC B1 Wi16),Faculty of Pharmacy and Pharmaceutical Sciences,,John Ussher,,Final,Exam,Multiple choice,55,,16-04-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 362 (LEC A1 Fa16),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Ubaka Ogbogu,,Midterm,Exam,Multiple choice,30,,16-11-21,,"Define and explain the following ethical concepts: beneficence, nonmaleficence, autonomy, and informed consent.",Outline the pharmacists ethical obligations.,Describe the court system in the Province of Alberta.,Explain the process of disciplinary action by the Alberta College of Pharmacists.,Describe the course of action taken by the Alberta College of Pharmacists on the issue of substance abuse by pharmacists.,Apply legal and ethical principles to issues that may occur in practice.,"Argue both sides of an ethical or legal issue using ethical and legal principles derived from statutes, case law, bioethics literature and the Alberta College of Pharmacists Code of Ethics","Analyze an ethical or legal issue by determining principles involved, clarifying facts, prioritizing principles, assessing alternatives, determining duty and justifying decisions.","Apply actions that a pharmacist can take in order to avoid legal liability (e.g. avoiding medication errors, proper documentation, etc.).","Utilize the problem-solving method (e.g. identify the problem, identify possible alternatives, evaluate the alternatives, choose the best course of action, and defend the action) to integrate ethical and legal principles, and professionalism into pharmacy practice.",Apply actions that a pharmacist can take to avoid ethical breaches and professional discipline,"Demonstrate ability to distinguish an ethical problem from a legal one, and to identify points of intersection, divergence or confrontation.",Participate in debating a legal/ethical issue with oneâ€™s peers,"Demonstrate awareness of the demands of professional, ethical and legal responsibility.",Accept the professional responsibility to act for the benefit of the patient.,Demonstrate caring and respect for others.,"Accept possible differences between personal values, morals and rights versus professional obligations and ethics.",Be sensitive to ethical/legal issues that arise in contemporary pharmacy practice.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 362 (LEC A1 Fa16),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Ubaka Ogbogu,,Final,Exam,Multiple choice,40,,16-12-09,,Explain the elements of negligence.,Define and explain the meaning and relevance of law and legal institutions.,"Describe the types of legal actions: Criminal prosecution, civil actions and professional discipline",Explain the process of disciplinary action by the Alberta College of Pharmacists.,Describe notable events in the history of medical ethics as relates to the pharmacy profession.,Describe ways that a pharmacist can avoid being sued for negligence.,Explain the legal requirements for privacy and confidentiality of health information under the Alberta Health Information Act.,Explain the legal implications of a personal directives and enduring powers of attorney.,Describe the unique health care issues faced by the Aboriginal Peoples of Canada.,Describe the legal and professional rules governing medical aid in dying.,Describe the defenses to a negligence or malpractice lawsuit.,Explain how compensation for a negligence lawsuit is determined.,Describe the course of action taken by the Alberta College of Pharmacists on the issue of substance abuse by pharmacists.,Apply legal and ethical principles to issues that may occur in practice.,"Argue both sides of an ethical or legal issue using ethical and legal principles derived from statutes, case law, bioethics literature and the Alberta College of Pharmacists Code of Ethics","Analyze an ethical or legal issue by determining principles involved, clarifying facts, prioritizing principles, assessing alternatives, determining duty and justifying decisions.","Apply actions that a pharmacist can take in order to avoid legal liability (e.g. avoiding medication errors, proper documentation, etc.).","Utilize the problem-solving method (e.g. identify the problem, identify possible alternatives, evaluate the alternatives, choose the best course of action, and defend the action) to integrate ethical and legal principles, and professionalism into pharmacy practice.",Apply actions that a pharmacist can take to avoid ethical breaches and professional discipline,"Demonstrate ability to distinguish an ethical problem from a legal one, and to identify points of intersection, divergence or confrontation.",Participate in debating a legal/ethical issue with oneâ€™s peers,"Demonstrate awareness of the demands of professional, ethical and legal responsibility.",Accept the professional responsibility to act for the benefit of the patient.,Demonstrate caring and respect for others.,"Accept possible differences between personal values, morals and rights versus professional obligations and ethics.",Be sensitive to ethical/legal issues that arise in contemporary pharmacy practice.,,,,,,,,,,,,,,,,,,,,,PHARM 362 (LEC A1 Fa16),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Ubaka Ogbogu,,Group Writing Assignment,Assignment,N/A,30,,16-12-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Final,Exam,Written and multiple choice,50,,16-12-14,,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments for electrolyte disorders, acid-base disorders, acute kidney injury, chronic kidney disease, nephrolithiasis, and LUTS including use of specific target drugs for the condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).","Identify medications which can cause renal toxicity, and describe the appropriate management.","Describe the epidemiology, etiology, and risk factors of the following: renal disorders including acute kidney injury, nephrolithiasis, Chronic Kidney Disease, and LUTS.","Describe the anatomy of the kidney, ureters, bladder, and urethra.","Describe the physiology of the ureters, bladder and urethra including a general outline of bladder function and micturition.","Describe the physiology of the kidney including regulation of glomerular filtration, sodium/water balance, fluid balance, acid-base balance as well as other electrolytes, tubular reabsorption and secretion.","Explain the major functions and consequences of disturbances of: sodium, potassium, magnesium, calcium, and phosphate.","Describe the etiology, pathophysiology, clinical presentation, and compensatory mechanism of the four acid-base disorders.",Describe the societal and economic impact of LUTS,"Describe the pathophysiology of renal disorders including acute kidney injury, chronic kidney disease, nephrolithiasis, and incontinence including clinical presentation and symptomatology and long term health consequences","Describe the principles of the various Renal Replacement Therapies (Hemodialysis, Peritoneal Dialysis, and Continuous Renal Replacement Therapy). ","Explain the effects of drugs used in the management of electrolyte disorders, acute kidney injury, chronic kidney disease, nephrolithiasis, and LUTS.","Explain and interpret pertinent serum chemistry laboratory values, as well as specific laboratory tests used in the diagnosis and monitoring of acute kidney injury, chronic kidney disease, nephrolithiasis, and lower urinary tract symptoms (LUTS).",Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,For each of the conditions described the student should:,"Identify the presenting signs and symptoms of electrolyte disorders, acid-base disorders, acute kidney injury, chronic kidney disease, nephrolithiasis, and LUTS and describe criteria used to make the diagnosis.","Discuss the therapeutic options, including risks and benefits, and medication and alternative therapy choices.",Identify appropriate monitoring parameters.,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters.,"Apply concepts and knowledge of pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of electrolyte disorders (hyper/hyponatremia, hyper/hypokalemia), acid-base disorders, acute kidney injury, chronic kidney disease nephrolithiasis, and LUTS.",Assess lab data in order to manage medical condition and medication regimen.  ,Describe how to triage a given patient in a community setting and identify when to refer them to medical attention as appropriate.,"Design pharmaceutical care plans including alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with electrolyte disorders, acute kidney injury, nephrolithiasis, and LUTS","Assess fluid balance based on medical history as well as presenting signs and symptoms, and recommend appropriate management of the patient.",Calculate creatinine clearance and adjust doses for medications that are renally eliminated.,Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus. ",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs,,,,,,,,,,,,,,,,,PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Midterm,Exam,Written and multiple choice,40,,16-10-11,,"Describe the anatomy of the kidney, ureters, bladder, and urethra.","Describe the physiology of the ureters, bladder and urethra including a general outline of bladder function and micturition.","Describe the physiology of the kidney including regulation of glomerular filtration, sodium/water balance, fluid balance, acid-base balance as well as other electrolytes, tubular reabsorption and secretion.","Explain the major functions and consequences of disturbances of: sodium, potassium, magnesium, calcium, and phosphate.","Describe the etiology, pathophysiology, clinical presentation, and compensatory mechanism of the four acid-base disorders.","Identify the presenting signs and symptoms of electrolyte disorders, acid-base disorders, acute kidney injury, chronic kidney disease, nephrolithiasis, and LUTS and describe criteria used to make the diagnosis.","Assess fluid balance based on medical history as well as presenting signs and symptoms, and recommend appropriate management of the patient.",Calculate creatinine clearance and adjust doses for medications that are renally eliminated.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus. ",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Online Quiz #2,Quiz,Multiple choice,3,,16-11-03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Online Quiz #1,Quiz,Multiple choice,3,,16-10-02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 397 (Fall 2016 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa16 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa16",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Online Quiz #3,Quiz,Multiple choice,3,,16-12-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Midterm,Exam,Written and multiple choice,38,,16-09-28,,Apply knowledge of sterility requirements,Explain how to maintain a clean work environment,Explain importance of quality of ingredients including bioburden,Identify risks of cross contamination in a laminar flow work bench,Explain importance of monitoring programs and training of personnel,Explain how Health Canada Guidelines (GMP and GLP) are related to the pharmacistâ€™s role in compounding.,"Gain and apply knowledge on the formulation needs and process involved for the manufacturing of solid dosage forms, controlled release products, transdermal delivery systems and aerosols in pharmaceutical industry",Perform compounding and packaging of drug products in small quantities according to legal and professional standards,"Develop skills and techniques that are important for the handling of drugs, excipients and pharmaceutical equipment and instruments.",Apply modern pharmacopeia standards and methods to assess the quality of dosage forms,"Interpret official compendia standards and specifications for pharmaceutical preparations including USP standards, International pharmacopoeias, and Professional standards.",Perform aseptic compounding techniques,Evaluate various sterilization methods,Develop standard operation procedures,Apply knowledge of a quality assurance program for sterile compounding,Evaluate risk levels,Set up an aseptic work environment and maintain the quality of the work environment,Conduct quality control of the final product,Apply appropriate parenteral technique in clinical situations.,Evaluate the stability and the shelf life of drugs under different storage conditions,Evaluate and interpret literature with respect to existing and new dosage forms as related to Pharmaceutics and Compounding procedures. ,Identify and locate sources of information needed to solve a problem related to Pharmaceutics,Critically evaluate the appropriateness and reliability of information from literature resources related to Pharmaceutics.,Synthesize information gained from various literature resources to solve problems or make recommendations related to Pharmaceutics,Demonstrate appropriate documentation practices in compounding.,,,,,,,,,,,,,,,,,,,,,,PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Final,Exam,Written and multiple choice,48,,16-11-04,,Apply knowledge of sterility requirements,Explain how to maintain a clean work environment,Explain importance of quality of ingredients including bioburden,Identify risks of cross contamination in a laminar flow work bench,Explain importance of monitoring programs and training of personnel,Explain how Health Canada Guidelines (GMP and GLP) are related to the pharmacistâ€™s role in compounding.,"Gain and apply knowledge on the formulation needs and process involved for the manufacturing of solid dosage forms, controlled release products, transdermal delivery systems and aerosols in pharmaceutical industry",Perform compounding and packaging of drug products in small quantities according to legal and professional standards,"Develop skills and techniques that are important for the handling of drugs, excipients and pharmaceutical equipment and instruments.",Apply modern pharmacopeia standards and methods to assess the quality of dosage forms,"Interpret official compendia standards and specifications for pharmaceutical preparations including USP standards, International pharmacopoeias, and Professional standards.",Perform aseptic compounding techniques,Evaluate various sterilization methods,Develop standard operation procedures,Apply knowledge of a quality assurance program for sterile compounding,Evaluate risk levels,Set up an aseptic work environment and maintain the quality of the work environment,Conduct quality control of the final product,Apply appropriate parenteral technique in clinical situations.,Evaluate the stability and the shelf life of drugs under different storage conditions,Evaluate and interpret literature with respect to existing and new dosage forms as related to Pharmaceutics and Compounding procedures. ,Identify and locate sources of information needed to solve a problem related to Pharmaceutics,Critically evaluate the appropriateness and reliability of information from literature resources related to Pharmaceutics.,Synthesize information gained from various literature resources to solve problems or make recommendations related to Pharmaceutics,Demonstrate appropriate documentation practices in compounding.,Be aware of recent trends in development of new drug delivery systems,,,,,,,,,,,,,,,,,,,,,PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab reports,Assignment,N/A,12,,16-12-07,,Apply knowledge of sterility requirements,Explain how to maintain a clean work environment,Explain importance of quality of ingredients including bioburden,Identify risks of cross contamination in a laminar flow work bench,Explain importance of monitoring programs and training of personnel,Explain how Health Canada Guidelines (GMP and GLP) are related to the pharmacistâ€™s role in compounding.,"Gain and apply knowledge on the formulation needs and process involved for the manufacturing of solid dosage forms, controlled release products, transdermal delivery systems and aerosols in pharmaceutical industry",Perform compounding and packaging of drug products in small quantities according to legal and professional standards,"Develop skills and techniques that are important for the handling of drugs, excipients and pharmaceutical equipment and instruments.",Apply modern pharmacopeia standards and methods to assess the quality of dosage forms,"Interpret official compendia standards and specifications for pharmaceutical preparations including USP standards, International pharmacopoeias, and Professional standards.",Perform aseptic compounding techniques,Evaluate various sterilization methods,Develop standard operation procedures,Apply knowledge of a quality assurance program for sterile compounding,Evaluate risk levels,Set up an aseptic work environment and maintain the quality of the work environment,Conduct quality control of the final product,Apply appropriate parenteral technique in clinical situations.,Evaluate the stability and the shelf life of drugs under different storage conditions,Evaluate and interpret literature with respect to existing and new dosage forms as related to Pharmaceutics and Compounding procedures. ,Identify and locate sources of information needed to solve a problem related to Pharmaceutics,Critically evaluate the appropriateness and reliability of information from literature resources related to Pharmaceutics.,Synthesize information gained from various literature resources to solve problems or make recommendations related to Pharmaceutics,Demonstrate appropriate documentation practices in compounding.,Be aware of recent trends in development of new drug delivery systems,,,,,,,,,,,,,,,,,,,,,PHARM 361 (Fall 2016 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa16 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Hot Topic Assignment,Assignment,N/A,2,,16-10-16,,Be aware of recent trends in development of new drug delivery systems,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 347 (Fall 2016 LEC A1 A2),PHARM 347 Fa16 - HEMATOLOGY Combined LEC Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Seminar Quiz,Quiz,Multiple choice,5,,16-11-22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 347 (Fall 2016 LEC A1 A2),PHARM 347 Fa16 - HEMATOLOGY Combined LEC Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Final ,Exam,Written and multiple choice,65,,16-12-12,,Explain the anatomy of blood supply and the lymphatic system of the human.,Identify applicable health system resources,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Identify ethical issues surrounding treatment of the conditions of primary focus.,"Discuss the physiology of the blood supply and lymphatic system including the composition and properties of blood, blood groups and selected functions of blood.","Describe the pathophysiology of the conditions of primary focus, including clinical presentation and symptomatology and long term health consequences.",Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus.,"Describe the mechanisms, efficacy, side effect profiles and role of each of the following drugs or drug classes: i. Anticoagulants ii. Antiplatelets iii. Fibrinolytics iv. Antifibrinolytics v. Stimulating Factors vi. Iron products","Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Utilize self-directed learning abilities,Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of primary focus.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).","Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring",Utilize an evidence based approach to therapeutic management of the conditions of primary focus.,Apply concepts and knowledge of pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of primary focus.,Critically evaluate the appropriateness and reliability of information from literature resources,Identify and locate sources of information needed to solve drug related problems,"Develop a caring, empathic attitude for patients experiencing anemia and thrombosis.",Accept responsibility for keeping abreast of emerging technologies and drugs,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 347 (Fall 2016 LEC A1 A2),PHARM 347 Fa16 - HEMATOLOGY Combined LEC Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Midterm,Exam,Multiple choice,30,,16-11-03,,Explain the anatomy of blood supply and the lymphatic system of the human.,Identify applicable health system resources,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Identify ethical issues surrounding treatment of the conditions of primary focus.,"Discuss the physiology of the blood supply and lymphatic system including the composition and properties of blood, blood groups and selected functions of blood.","Describe the pathophysiology of the conditions of primary focus, including clinical presentation and symptomatology and long term health consequences.",Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus.,"Describe the mechanisms, efficacy, side effect profiles and role of each of the following drugs or drug classes: i. Anticoagulants ii. Antiplatelets iii. Fibrinolytics iv. Antifibrinolytics v. Stimulating Factors vi. Iron products","Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Utilize self-directed learning abilities,Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of primary focus.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).","Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring",Utilize an evidence based approach to therapeutic management of the conditions of primary focus.,Apply concepts and knowledge of pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of primary focus.,Critically evaluate the appropriateness and reliability of information from literature resources,Identify and locate sources of information needed to solve drug related problems,"Develop a caring, empathic attitude for patients experiencing anemia and thrombosis.",Accept responsibility for keeping abreast of emerging technologies and drugs,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab grades,Participation,N/A,10,,16-09-01,,Describe the impact of communication in health and health care ,Explain the importance of communication in the practice of pharmacy,Explain the link between effective communication skills and patient care ,Understand the importance of listening,Understand the meaning of a patient-centred care,Review techniques to improve communication with low-literacy patients,Identify different types of question asking,Discuss the link between reflection and lifelong learning ,Identify appropriate uses of social media in health care,Understand the impact of empathetic responding in patient-provider interactions ,"Recognize the difference between aggressive, passive, and assertive communication ",Define a medication experience,Describe the importance of a patient'sâ€™ medication experience,Describe the health care experiences of low-literacy patients,Discuss health literacy and medication ,Demonstrate effective public speaking and presentation skills,Write in a clear and concise manner using the rules of grammar and punctuation,Work effectively in groups,Critically reflect on communication in patient care,Introduce self and identify patient,Gather sufficient information to evaluate medication appropriateness,Display confidence in a patient encounter,"Identify and name patient feelings (i.e., empathetic responding) ",Tailor communication to specific contexts and audiences,Use small talk to establish rapport,Offer and receive constructive feedback,Demonstrate professional communication,Demonstrate effective non-verbal communication skills,Write data section of a clinical documentation note after a standardized patient encounter,Solicit the full patient agenda ,Use appropriate question style,Use active listening skills to explore the patient experience and concerns,Establish flow and organization in a patient encounter,Appreciate the patientâ€™s experience and perspective in health care ,Accept responsibility for communicating professionally through both student and professional career ,Value reflection and its role in lifelong learning,,,,,,,,,,,PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Reflection,Assignment,N/A,20,,16-09-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,In-Class Learning Opportunities,Participation,N/A,10,,16-09-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab Final,Exam,Multiple choice,30,,16-10-31,,Describe the impact of communication in health and health care ,Explain the importance of communication in the practice of pharmacy,Explain the link between effective communication skills and patient care ,Understand the importance of listening,Understand the meaning of a patient-centred care,Review techniques to improve communication with low-literacy patients,Identify different types of question asking,Discuss the link between reflection and lifelong learning ,Identify appropriate uses of social media in health care,Understand the impact of empathetic responding in patient-provider interactions ,"Recognize the difference between aggressive, passive, and assertive communication ",Define a medication experience,Describe the importance of a patient'sâ€™ medication experience,Describe the health care experiences of low-literacy patients,Discuss health literacy and medication ,Demonstrate effective public speaking and presentation skills,Write in a clear and concise manner using the rules of grammar and punctuation,Work effectively in groups,Critically reflect on communication in patient care,Introduce self and identify patient,Gather sufficient information to evaluate medication appropriateness,Display confidence in a patient encounter,"Identify and name patient feelings (i.e., empathetic responding) ",Tailor communication to specific contexts and audiences,Use small talk to establish rapport,Offer and receive constructive feedback,Demonstrate professional communication,Demonstrate effective non-verbal communication skills,Write data section of a clinical documentation note after a standardized patient encounter,Solicit the full patient agenda ,Use appropriate question style,Use active listening skills to explore the patient experience and concerns,Establish flow and organization in a patient encounter,,,,,,,,,,,,,,PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Pharmacy Speechcraft by Toastmasters,Participation,N/A,0,,16-09-01,,Demonstrate effective public speaking and presentation skills,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 314 (Fall 2016 LAB LEC SEM),PHARM 314 Fa16 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Written Final,Exam,Multiple choice,0,,16-11-15,,Describe the impact of communication in health and health care ,Explain the importance of communication in the practice of pharmacy,Explain the link between effective communication skills and patient care ,Understand the importance of listening,Understand the meaning of a patient-centred care,Review techniques to improve communication with low-literacy patients,Identify different types of question asking,Discuss the link between reflection and lifelong learning ,Identify appropriate uses of social media in health care,Understand the impact of empathetic responding in patient-provider interactions ,"Recognize the difference between aggressive, passive, and assertive communication ",Define a medication experience,Describe the importance of a patient'sâ€™ medication experience,Describe the health care experiences of low-literacy patients,Discuss health literacy and medication ,Demonstrate effective public speaking and presentation skills,Write in a clear and concise manner using the rules of grammar and punctuation,Work effectively in groups,Critically reflect on communication in patient care,Introduce self and identify patient,Gather sufficient information to evaluate medication appropriateness,Display confidence in a patient encounter,"Identify and name patient feelings (i.e., empathetic responding) ",Tailor communication to specific contexts and audiences,Use small talk to establish rapport,Offer and receive constructive feedback,Demonstrate professional communication,Demonstrate effective non-verbal communication skills,Write data section of a clinical documentation note after a standardized patient encounter,Solicit the full patient agenda ,Use appropriate question style,Use active listening skills to explore the patient experience and concerns,Establish flow and organization in a patient encounter,,,,,,,,,,,,,,PHARM 357 (LEC A1 Fa16),PHARM 357 GASTROINTESTINAL (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. NesÃ© Yuksel,,Midterm,Exam,Multiple choice,40,,16-11-23,,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Describe the specific laboratory tests and other diagnostic tests used in the diagnosis and monitoring of the conditions of primary focus.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the conditions of primary focus.","Describe the mechanisms, efficacy, side effect profiles and role of each of the following drugs or drug classes: i. Antidiarrheals ii. Laxatives iii. Antinauseants iv. Antiemetics v. Antacids vi. Anti-gas vii. Antispasmodics viii. Drugs Stimulating Gastrointestinal Motility (Prokinetic Agents) ix. Proton-Pump Inhibitors x. H2 receptor antagonists xi. Mucosal protective agents Sucralfate, Prostaglandin analogs (ie misoprostil), Colloidal Bismuth Compounds xii. Antibiotics used for PUD xiii. Aminosalicylates xiv. Corticosteroids used in IBD xv. Immunosuppressants used in IBD (including azathioprine, 6-mercaptopurine, cyclosporine, methotrexate) xvi. Tumour necrosis factor â€“ alpha antagonists (infliximab, adalimumab, certolizumab, golimumab) xvii. Pharmacotherapy for complications of cirrhosis (ie diuretics, spironolactone, beta-blockers, octreotide, lactulose, and metronidazole)","Describe the pathophysiology of the conditions of primary focus including clinical presentations, symptomatology, and complications. ",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments to the conditions of primary focus, including use of specific target drugs for condition as well as complementary and alternative therapies",Describe the societal and economic impact of the conditions of primary focus.,Identify ethical issues surrounding treatment of the conditions of primary focus,Discuss drugs that can be toxic to the liver,"Describe the treatment options for oral health such as canker sores, dry mouth, and mouth care.",Discuss the types of ostomy supplies used by patients with ostomies,Discuss the complementary and alternative medicine used in GI diseases.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the disease of focus,"Select appropriate treatment for special groups (pediatrics, elderly, pregnancy)",Utilize self-directed learning abilities.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 357 (LEC A1 Fa16),PHARM 357 GASTROINTESTINAL (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. NesÃ© Yuksel,,Final,Exam,Written and multiple choice,50,,16-12-16,,Explain the anatomy of the gastrointestinal tract; describe the functions of the gastrointestinal tract.  ,Explain the anatomy of the liver; describe the functions of the liver . ,Appreciate the interdisciplinary approach to management of the condition,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the disease of focus,"Select appropriate treatment for special groups (pediatrics, elderly, pregnancy)",Utilize self-directed learning abilities.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 357 (LEC A1 Fa16),PHARM 357 GASTROINTESTINAL (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. NesÃ© Yuksel,,Seminar 1 Quiz,Quiz,Written,5,,17-05-09,,"Describe the pathophysiology of the conditions of primary focus including clinical presentations, symptomatology, and complications. ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 357 (LEC A1 Fa16),PHARM 357 GASTROINTESTINAL (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. NesÃ© Yuksel,,Seminar 2 Quiz,Quiz,Written,5,,16-11-28,,"Describe the pathophysiology of the conditions of primary focus including clinical presentations, symptomatology, and complications. ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Midterm,Exam,Multiple choice,40,,16-11-04,,Understand and demonstrate how recombinant DNA technology is used in the manufacture of biotechnology-based pharmaceuticals,"Describe the four major classes of biotechnology-based pharmaceuticals (peptides, blood products, vaccines, therapeutic proteins [including monoclonal antibodies])",Appreciate the range of drug delivery systems currently employed to administer biotechnology-based pharmaceuticals,"Describe how antisense therapy, gene therapy and stem cell therapy work",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 321 (LEC A1 Fa16),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Michael R. Doschak,,Final,Exam,Multiple choice,60,,16-12-14,,Describe the elements of the human immune system,Distinguish between the Innate and Adaptive arms of the immune system,Distinguish between humoral and cell mediated immune effector mechanisms,Distinguish between active and passive immunity,"Compare and contrast the immune responses witnessed in situations of infection, allergy & hypersensitivity, and autoimmune disease",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 306 (LEC A1 Fa16),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Midterm,Exam,Multiple choice,35,,16-09-28,,"Physiology: Describe body composition, body fluids, and fluid compartments.","Describe lysosomal function, membrane function and membrane transport.",Explain resting potential.,Describe membrane transport.,Describe action potential,Explain how the various sensory mechanisms function.,Describe nerve conduction and neuromuscular and synaptic transmission.,Describe the types and organization of muscles.,"Pharmacology: Describe how and why drugs interact with their targets, and how this affects the functioning of tissues",". Understand how and why drugs work in a concentration-dependent manner, and be familiar with related graphing approaches and core equations.",Understand basic processes governing pharmacokinetic behaviour of drugs.,Be familiar with the autonomic pharmacology of the eye as an example of basic principles governing drug mechanisms.,"Pathophysiology: Explain the events which occur in two major pathways of cell death, and in sublethal cell injury.",Define the types of toxins which create problems in the environment.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 306 (LEC A1 Fa16),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Final,Exam,Multiple choice,65,,16-10-25,,"Anatomy: Describe cell structure, cell function and tissue types","Physiology: Describe body composition, body fluids, and fluid compartments.","Describe lysosomal function, membrane function and membrane transport.",Explain resting potential.,Describe membrane transport.,Describe action potential,Explain how the various sensory mechanisms function.,Describe nerve conduction and neuromuscular and synaptic transmission.,Describe the types and organization of muscles.,"Pharmacology: Describe how and why drugs interact with their targets, and how this affects the functioning of tissues",". Understand how and why drugs work in a concentration-dependent manner, and be familiar with related graphing approaches and core equations.",Understand basic processes governing pharmacokinetic behaviour of drugs.,Be familiar with the autonomic pharmacology of the eye as an example of basic principles governing drug mechanisms.,"Pathophysiology: Explain the events which occur in two major pathways of cell death, and in sublethal cell injury.","List seven basic classes of disease based on disease mechanisms, and give examples.",Discuss the molecular and cellular events underlying the different classes of disease.,Correlate drug therapy with disease mechanisms for representative major diseases.,"Understand and use medical terminology related to disease, to a degree sufficient to understand the pathophysiology content in the subsequent blocks","Toxicology: Understand basic toxicological concepts, and the different areas of toxicology.",Define the types of toxins which create problems in the environment.,Explain the mechanism of toxicity of individual toxins which cause problems in the environment,Describe hazard identification and assessment methods,Determine dose-response assessment,Determine exposure assessment,Examine applicable Canadian and American legislation governing environmental discharge. Understand where forensic toxicology is used ,Understand toxicity and safety assessment of natural health products,,,,,,,,,,,,,,,,,,,,,PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Midterm,Exam,Multiple choice,40,,16-10-18,,Describe the long term health consequences of the conditions of primary focus.,Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of primary focus.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Appreciate the interdisciplinary approach to management of the conditions of primary focus.,Identify ethical issues surrounding treatment of the conditions of primary focus,"Explain the anatomy of the central, peripheral and autonomic nervous system, cranial nerves and sensory and motor system","Describe the physiology of the spinal reflexes, somatosensory system, motor control and higher nervous function.",Describe the pathophysiology of the conditions of primary focus.,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Describe the clinical presentation and symptomatology of the conditions of primary focus.,Describe the laboratory tests used in the diagnosis and monitoring of the conditions of primary focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments for the conditions of primary focus, including use of specific target drugs for condition as well as alternative therapies (including dose, route of administration, duration of therapy, monitoring parameters)","Apply concepts and knowledge of medicinal chemistry, pharmacology/toxicology, and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe the societal and economic impact of the conditions of primary focus.,Synthesize information gained from various literature resources to solve problems or make recommendations,Identify when to inform caregivers and other members of the health care team if there are danger signs apparent in the assessment.,Calculate and apply the applicable pharmacokinetic parameters to monitor patients using these medications.,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug-related problems relating to of the conditions of primary focus in patient case studies.,Identify clinically significant drug interactions with drugs used to treat the conditions of primary focus.,Identify presenting symptoms that would be integrated into a triage approach for patients.,"Select appropriate treatment for special groups (e.g. pediatrics, geriatrics, pregnancy, lactation)",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug-related problems,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",,,,,,,,,,,,,,,,,,,,,,PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Rare Neurologic Disorders Assignment,Assignment,N/A,10,,17-05-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 417 (LEC A1 Fa16),PHARM 417 NEUROLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sherif Mahmoud,,Final,Exam,Written and multiple choice,50,,16-11-03,,Describe the long term health consequences of the conditions of primary focus.,Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of primary focus.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Appreciate the interdisciplinary approach to management of the conditions of primary focus.,Identify ethical issues surrounding treatment of the conditions of primary focus,"Explain the anatomy of the central, peripheral and autonomic nervous system, cranial nerves and sensory and motor system","Describe the physiology of the spinal reflexes, somatosensory system, motor control and higher nervous function.",Describe the pathophysiology of the conditions of primary focus.,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Describe the clinical presentation and symptomatology of the conditions of primary focus.,Describe the laboratory tests used in the diagnosis and monitoring of the conditions of primary focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments for the conditions of primary focus, including use of specific target drugs for condition as well as alternative therapies (including dose, route of administration, duration of therapy, monitoring parameters)","Apply concepts and knowledge of medicinal chemistry, pharmacology/toxicology, and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe the societal and economic impact of the conditions of primary focus.,Synthesize information gained from various literature resources to solve problems or make recommendations,Identify when to inform caregivers and other members of the health care team if there are danger signs apparent in the assessment.,Calculate and apply the applicable pharmacokinetic parameters to monitor patients using these medications.,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug-related problems relating to of the conditions of primary focus in patient case studies.,Identify clinically significant drug interactions with drugs used to treat the conditions of primary focus.,Identify presenting symptoms that would be integrated into a triage approach for patients.,"Select appropriate treatment for special groups (e.g. pediatrics, geriatrics, pregnancy, lactation)",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug-related problems,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",,,,,,,,,,,,,,,,,,,,,,PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Case Submission and Reflection,Assignment,N/A,1,,16-09-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Quiz #1,Quiz,Multiple choice,2,,16-09-08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Quiz #2,Quiz,Multiple choice,2,,16-09-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Quiz #3,Quiz,Multiple choice,2,,16-09-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Quiz #4,Quiz,Multiple choice,2,,16-09-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Quiz #5,Quiz,Multiple choice,5,,16-09-23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Quiz #6,Quiz,Multiple choice,2,,16-09-28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Quiz #7,Quiz,Multiple choice,2,,16-10-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Final,Exam,Multiple choice,45,,16-10-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,10 Specified online exercises,Assignment,N/A,10,,16-12-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 487 (LEC A1 Fa16),PHARM 487 PULMONARY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Renette Bertholet,,Midterm,Exam,Written and multiple choice,25,,16-09-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Pharmacy Organizations Quiz,Quiz,Multiple choice,10,,16-09-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Midterm,Exam,Written and multiple choice,35,,16-10-14,,Describe the role of health behaviour theory in pharmacy practice. ,"Describe, compare and contrast the impact of the social determinants of health",Demonstrate an awareness of the evolving practice environment of pharmacy.,Demonstrate an understanding of the concept of professionalism ,Discuss the payment model within the realm of pharmacy ,Demonstrate an understanding of the concepts and principles of Health and Health Promotion.,Describe the historical development of pharmacy through trends that have led to the current practice philosophy.,Understand the pharmacy regulatory bodies in Canada ,"Identify basic concepts, principles, and components of health care delivery and the health care system in Canada and the province of Alberta. ",Understand the role of Complementary and Alternative Medicine providers in the health care system and how pharmacists can collaborate with them to optimize patient care and safety.,Integrate knowledge from various sources/activities with respect to pharmacy practice.,Appreciate the pharmacist as a member of the health care team ,"Accept that a patient's perspective of health and health behaviour may be different than your own, and may impact (positively or negatively) treatment strategies.","Demonstrate a professional image and positive attitude through behaviour, language, personal presentation and interaction with others.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Final,Exam,Written and multiple choice,40,,16-12-16,,Describe the role of theory in health care,Summarize the patient care process and how it relates to the pharmacistâ€™s role in the health care system. ,Understand the interprofessional learning pathway and roles of students in other health professions ,Apply introductory knowledge of the health care system for solving problems in practice.,Apply the patient care process to solve problems,Demonstrate appropriate writing skills at post-secondary level.,Apply theories of patient behaviours to identify methods of intervention for treatment outcomes.,Analyse your own personal health beliefs and how they impact your clinical decision making process.,Integrate knowledge from various sources/activities with respect to pharmacy practice.,Appreciate the pharmacist as a member of the health care team ,"Accept that a patient's perspective of health and health behaviour may be different than your own, and may impact (positively or negatively) treatment strategies.","Demonstrate a professional image and positive attitude through behaviour, language, personal presentation and interaction with others.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 322 (LEC A1 Fa16),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Ravina Sanghera,,Interprofessional (IP) Launch Self Reflection,Assignment,N/A,15,,16-10-07,,Appreciate the pharmacist as a member of the health care team ,"Accept that a patient's perspective of health and health behaviour may be different than your own, and may impact (positively or negatively) treatment strategies.","Demonstrate a professional image and positive attitude through behaviour, language, personal presentation and interaction with others.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Midterm Exam,Exam,Written and multiple choice,40,,16-10-13,,Identify the structural components of bacteria.,Identify the bacterial physiologic processes.,"Identify the processes in bacterial cellular replication, DNA and RNA replication and protein synthesis ","Identify the taxonomic categories, source, virulence factors, and diseases caused by bacteria","Identify the pharmacodynamic parameters relating to successful antimicrobial therapy. â€¢ Identify factors that influence choice of antimicrobial therapy (i.e. age, pregnancy, renal & hepatic function, site of infection, immune function etc.).",Identify the role of the immune system in response to infection. ,"Identify the mechanism of action, structure-activity relationships of antibacterial agents â€¢ Identify relevant adverse effects and drug interactions, appropriate and inappropriate uses of antibacterial agents ","Identify the pathogenesis, diagnosis, and appropriate treatment options for various bacterial infections.",Identify preventative strategies for infectious diseases in individual populations.,Determine appropriate antibiotic therapy for an individual patient based on current literature and therapeutic guidelines,Evaluate the current literature and therapeutic guidelines associated with selected infectious diseases,"Interpret laboratory & clinical tests used to diagnose and monitor bacterial infections including gram stains, MIC, WBC and differential, etc","Integrate and interpret knowledge of signs and symptoms, lab values, test results, appropriate antimicrobial therapy and monitoring parameters for individual patients with varying infectious diseases.","Design pharmacy care plans based on presenting diagnosis or signs and symptoms and taking into consideration diagnosis, patient medical history, allergy history, medication history, efficacy, toxicity, cost, route of administration, current literature and guidelines etc.",Apply principles of pharmacokinetics and pharmacodynamics of antimicrobials to patient cases.,Determine appropriate patient-specific therapy.,"Determine information necessary to counsel patients regarding appropriate use of the antimicrobial (including side effects and hypersensitivities), OTCs and herbals etc. â€¢ Identify actual and potential drug related problems relating to infectious diseases through a series of patient cases.",Determine appropriate measures for the prevention of bacterial infections with individual populations.,Develop an appreciation for the importance of appropriate antibiotic use in infectious diseases ,Develop an appreciation for the serious implications of antibiotic resistance to treatment of infections for the patient and health care system.,Develop an appreciation for the pharmacistâ€™s role in ensuring appropriate antibiotic use and prevention of antibiotic resistance.,"Develop an appreciation for Antimicrobial Stewardship, its importance in society and the important roles that pharmacists play in Antimicrobial Stewardship","Develop an appreciation for the importance of evaluating, integrating and using current literature, guidelines and antibiograms in the treatment of infectious",,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Quiz #3: Lower Respiratory Tract Infections,Quiz,Multiple choice,2,,16-11-04,,Identify the bacterial physiologic processes.,"Identify the mechanisms, contributing factors, impact and solutions for antimicrobial resistance.","Identify the mechanism of action, structure-activity relationships of antibacterial agents â€¢ Identify relevant adverse effects and drug interactions, appropriate and inappropriate uses of antibacterial agents ",Identify preventative strategies for infectious diseases in individual populations.,Determine appropriate antibiotic therapy for an individual patient based on current literature and therapeutic guidelines,Evaluate the current literature and therapeutic guidelines associated with selected infectious diseases,"Interpret laboratory & clinical tests used to diagnose and monitor bacterial infections including gram stains, MIC, WBC and differential, etc","Integrate and interpret knowledge of signs and symptoms, lab values, test results, appropriate antimicrobial therapy and monitoring parameters for individual patients with varying infectious diseases.","Design pharmacy care plans based on presenting diagnosis or signs and symptoms and taking into consideration diagnosis, patient medical history, allergy history, medication history, efficacy, toxicity, cost, route of administration, current literature and guidelines etc.",Apply principles of pharmacokinetics and pharmacodynamics of antimicrobials to patient cases.,Determine appropriate patient-specific therapy.,"Determine information necessary to counsel patients regarding appropriate use of the antimicrobial (including side effects and hypersensitivities), OTCs and herbals etc. â€¢ Identify actual and potential drug related problems relating to infectious diseases through a series of patient cases.",Determine appropriate measures for the prevention of bacterial infections with individual populations.,Develop an appreciation for the importance of appropriate antibiotic use in infectious diseases ,Develop an appreciation for the serious implications of antibiotic resistance to treatment of infections for the patient and health care system.,Develop an appreciation for the pharmacistâ€™s role in ensuring appropriate antibiotic use and prevention of antibiotic resistance.,"Develop an appreciation for Antimicrobial Stewardship, its importance in society and the important roles that pharmacists play in Antimicrobial Stewardship","Develop an appreciation for the importance of evaluating, integrating and using current literature, guidelines and antibiograms in the treatment of infectious",,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Quiz #4: Urinary Tract Infections,Quiz,Multiple choice,2,,16-11-18,,Identify the bacterial physiologic processes.,"Identify the mechanisms, contributing factors, impact and solutions for antimicrobial resistance.","Identify the mechanism of action, structure-activity relationships of antibacterial agents â€¢ Identify relevant adverse effects and drug interactions, appropriate and inappropriate uses of antibacterial agents ",Identify preventative strategies for infectious diseases in individual populations.,Determine appropriate antibiotic therapy for an individual patient based on current literature and therapeutic guidelines,Evaluate the current literature and therapeutic guidelines associated with selected infectious diseases,"Interpret laboratory & clinical tests used to diagnose and monitor bacterial infections including gram stains, MIC, WBC and differential, etc","Integrate and interpret knowledge of signs and symptoms, lab values, test results, appropriate antimicrobial therapy and monitoring parameters for individual patients with varying infectious diseases.","Design pharmacy care plans based on presenting diagnosis or signs and symptoms and taking into consideration diagnosis, patient medical history, allergy history, medication history, efficacy, toxicity, cost, route of administration, current literature and guidelines etc.",Apply principles of pharmacokinetics and pharmacodynamics of antimicrobials to patient cases.,Determine appropriate patient-specific therapy.,"Determine information necessary to counsel patients regarding appropriate use of the antimicrobial (including side effects and hypersensitivities), OTCs and herbals etc. â€¢ Identify actual and potential drug related problems relating to infectious diseases through a series of patient cases.",Determine appropriate measures for the prevention of bacterial infections with individual populations.,Develop an appreciation for the importance of appropriate antibiotic use in infectious diseases ,Develop an appreciation for the serious implications of antibiotic resistance to treatment of infections for the patient and health care system.,Develop an appreciation for the pharmacistâ€™s role in ensuring appropriate antibiotic use and prevention of antibiotic resistance.,"Develop an appreciation for Antimicrobial Stewardship, its importance in society and the important roles that pharmacists play in Antimicrobial Stewardship","Develop an appreciation for the importance of evaluating, integrating and using current literature, guidelines and antibiograms in the treatment of infectious",,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Quiz #5: Meningitis,Quiz,Multiple choice,2,,16-11-25,,Identify the bacterial physiologic processes.,"Identify the mechanisms, contributing factors, impact and solutions for antimicrobial resistance.","Identify the mechanism of action, structure-activity relationships of antibacterial agents â€¢ Identify relevant adverse effects and drug interactions, appropriate and inappropriate uses of antibacterial agents ",Identify preventative strategies for infectious diseases in individual populations.,Determine appropriate antibiotic therapy for an individual patient based on current literature and therapeutic guidelines,Evaluate the current literature and therapeutic guidelines associated with selected infectious diseases,"Interpret laboratory & clinical tests used to diagnose and monitor bacterial infections including gram stains, MIC, WBC and differential, etc","Integrate and interpret knowledge of signs and symptoms, lab values, test results, appropriate antimicrobial therapy and monitoring parameters for individual patients with varying infectious diseases.","Design pharmacy care plans based on presenting diagnosis or signs and symptoms and taking into consideration diagnosis, patient medical history, allergy history, medication history, efficacy, toxicity, cost, route of administration, current literature and guidelines etc.",Apply principles of pharmacokinetics and pharmacodynamics of antimicrobials to patient cases.,Determine appropriate patient-specific therapy.,"Determine information necessary to counsel patients regarding appropriate use of the antimicrobial (including side effects and hypersensitivities), OTCs and herbals etc. â€¢ Identify actual and potential drug related problems relating to infectious diseases through a series of patient cases.",Determine appropriate measures for the prevention of bacterial infections with individual populations.,Develop an appreciation for the importance of appropriate antibiotic use in infectious diseases ,Develop an appreciation for the serious implications of antibiotic resistance to treatment of infections for the patient and health care system.,Develop an appreciation for the pharmacistâ€™s role in ensuring appropriate antibiotic use and prevention of antibiotic resistance.,"Develop an appreciation for Antimicrobial Stewardship, its importance in society and the important roles that pharmacists play in Antimicrobial Stewardship","Develop an appreciation for the importance of evaluating, integrating and using current literature, guidelines and antibiograms in the treatment of infectious",,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Quiz #6: Pharmacokinetics of Vancomycin and Aminoglycosides,Quiz,Multiple choice,2,,16-12-02,,"Design pharmacy care plans based on presenting diagnosis or signs and symptoms and taking into consideration diagnosis, patient medical history, allergy history, medication history, efficacy, toxicity, cost, route of administration, current literature and guidelines etc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Quiz #2: Otitis Media,Quiz,Multiple choice,2,,16-10-28,,Identify the bacterial physiologic processes.,"Identify the mechanisms, contributing factors, impact and solutions for antimicrobial resistance.",Identify preventative strategies for infectious diseases in individual populations.,Determine appropriate antibiotic therapy for an individual patient based on current literature and therapeutic guidelines,Evaluate the current literature and therapeutic guidelines associated with selected infectious diseases,"Interpret laboratory & clinical tests used to diagnose and monitor bacterial infections including gram stains, MIC, WBC and differential, etc","Integrate and interpret knowledge of signs and symptoms, lab values, test results, appropriate antimicrobial therapy and monitoring parameters for individual patients with varying infectious diseases.","Design pharmacy care plans based on presenting diagnosis or signs and symptoms and taking into consideration diagnosis, patient medical history, allergy history, medication history, efficacy, toxicity, cost, route of administration, current literature and guidelines etc.",Apply principles of pharmacokinetics and pharmacodynamics of antimicrobials to patient cases.,Determine appropriate patient-specific therapy.,"Determine information necessary to counsel patients regarding appropriate use of the antimicrobial (including side effects and hypersensitivities), OTCs and herbals etc. â€¢ Identify actual and potential drug related problems relating to infectious diseases through a series of patient cases.",Determine appropriate measures for the prevention of bacterial infections with individual populations.,Develop an appreciation for the importance of appropriate antibiotic use in infectious diseases ,Develop an appreciation for the serious implications of antibiotic resistance to treatment of infections for the patient and health care system.,Develop an appreciation for the pharmacistâ€™s role in ensuring appropriate antibiotic use and prevention of antibiotic resistance.,"Develop an appreciation for Antimicrobial Stewardship, its importance in society and the important roles that pharmacists play in Antimicrobial Stewardship","Develop an appreciation for the importance of evaluating, integrating and using current literature, guidelines and antibiograms in the treatment of infectious",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (LEC A1 Fa16),PHARM 407 INFECTIOUS DISEASES 1 (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Dr. Sharon Mitchell,,Final Exam,Exam,Written and multiple choice,50,,16-12-16,,Identify the bacterial physiologic processes.,"Identify the processes in bacterial cellular replication, DNA and RNA replication and protein synthesis ","Identify the mechanisms, contributing factors, impact and solutions for antimicrobial resistance.","Identify the mechanism of action, structure-activity relationships of antibacterial agents â€¢ Identify relevant adverse effects and drug interactions, appropriate and inappropriate uses of antibacterial agents ","Identify the pathogenesis, diagnosis, and appropriate treatment options for various bacterial infections.",Identify preventative strategies for infectious diseases in individual populations.,Determine appropriate antibiotic therapy for an individual patient based on current literature and therapeutic guidelines,Evaluate the current literature and therapeutic guidelines associated with selected infectious diseases,"Interpret laboratory & clinical tests used to diagnose and monitor bacterial infections including gram stains, MIC, WBC and differential, etc","Integrate and interpret knowledge of signs and symptoms, lab values, test results, appropriate antimicrobial therapy and monitoring parameters for individual patients with varying infectious diseases.","Design pharmacy care plans based on presenting diagnosis or signs and symptoms and taking into consideration diagnosis, patient medical history, allergy history, medication history, efficacy, toxicity, cost, route of administration, current literature and guidelines etc.",Apply principles of pharmacokinetics and pharmacodynamics of antimicrobials to patient cases.,Determine appropriate patient-specific therapy.,"Determine information necessary to counsel patients regarding appropriate use of the antimicrobial (including side effects and hypersensitivities), OTCs and herbals etc. â€¢ Identify actual and potential drug related problems relating to infectious diseases through a series of patient cases.",Determine appropriate measures for the prevention of bacterial infections with individual populations.,Develop an appreciation for the importance of appropriate antibiotic use in infectious diseases ,Develop an appreciation for the serious implications of antibiotic resistance to treatment of infections for the patient and health care system.,Develop an appreciation for the pharmacistâ€™s role in ensuring appropriate antibiotic use and prevention of antibiotic resistance.,"Develop an appreciation for Antimicrobial Stewardship, its importance in society and the important roles that pharmacists play in Antimicrobial Stewardship","Develop an appreciation for the importance of evaluating, integrating and using current literature, guidelines and antibiograms in the treatment of infectious",,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 467 (LEC A1 Fa16),PHARM 467 ONCOLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sharon Marsh,,Midterm Exam,Exam,Multiple choice,50,,16-09-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 467 (LEC A1 Fa16),PHARM 467 ONCOLOGY (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Sharon Marsh,,Final Exam,Exam,Written and multiple choice,50,,16-10-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 304 (Fall 2016 LAB LEC SEM),PHARM 304 Fa16 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Finding and Evaluating Information on the Web,Assignment,N/A,33,,16-09-23,,Describe the types of information found in some common pharmacy tertiary and secondary reference sources.,Identify strengths and weaknesses of the secondary and tertiary resources commonly used. ,Identify the functions and services offered by the health sciences library.,Use library resources and library facilities effectively to access relevant drug information. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 304 (Fall 2016 LAB LEC SEM),PHARM 304 Fa16 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Electronic Resources Assignment,Assignment,N/A,33,,16-10-03,,Describe the types of information found in some common pharmacy tertiary and secondary reference sources.,Identify strengths and weaknesses of the secondary and tertiary resources commonly used. ,Identify the functions and services offered by the health sciences library.,Formulate and communicate a clear and comprehensive verbal and/or written response that is appropriate to the requester's needs.,Use library resources and library facilities effectively to access relevant drug information. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 304 (Fall 2016 LAB LEC SEM),PHARM 304 Fa16 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lab 3 â€“ Drug Information Queries,Assignment,N/A,33,,16-10-24,,Follow-up on drug information requests where appropriate.,Demonstrate a systematic step-wise approach to answer drug information requests.,Determine the depth of response required for any given question. ,Formulate and communicate a clear and comprehensive verbal and/or written response that is appropriate to the requester's needs.,Use library resources and library facilities effectively to access relevant drug information. ,"Obtain relevant background information from the client about the patient, disease, and/or drug.",Appreciate the professional responsibility to act for the benefit of the patient.Outline the pharmacists ethical obligations.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Midterm Exam,Exam,Other,20,,16-12-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Semester 2,Assignment,N/A,12,,17-05-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Final Exam,Exam,Other,35,,17-05-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Integrated Cases (2),Assignment,N/A,0,,17-05-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 430A (Fall 2016 LAB D1 D2 LEC C1),PHARM 430A Fa16 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Jody Shkrobot, Teri Charrois, Gillian Johnson",,Semester 1,Assignment,N/A,12,,17-05-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Midterm Exam,Exam,Written and multiple choice,40,,16-11-28,,Identify ethical issues in the management of mental health conditions.,"Describe the risk factors, clinical presentation, and assessment parameters (signs and symptoms, laboratory values/tests, physical findings and diagnostic measurements) of the conditions covered.","Explain the mechanism of action, pharmacokinetic principles, clinical effect(s), and adverse effects and drug interactions for the medication classes covered.",Describe the role of therapeutic drug monitoring for selected medications in the provision of patient care.,Outline the economic and health policy issues as they relate to mental health conditions.,"Outline the epidemiology, etiology and pathophysiology of the mental health conditions covered.","Describe the therapeutic approach to managing the conditions covered, including: guideline recommendations and clinical targets, pharmacological (dose, duration of therapy, monitoring parameters), non-pharmacological treatments, and CAM.","Conduct a patient assessment using relevant data from the patient history, review of systems, laboratory tests, diagnostic imaging and medication history in order to provide patient care.",Identify and locate sources of information needed to provide patient care.,"Develop a therapeutic and monitoring plan, taking into consideration patient factors, efficacy, toxicity, cost, route of administration, etc."," Apply principles of therapeutic drug monitoring to deliver patient care, taking into consideration health system and economic factors.",Manage clinically significant drug interactions with drugs used to treat the psychiatric conditions covered.,Utilize an evidence based approach to therapeutic management of the psychiatric conditions covered.,Evaluate and apply information from literature and other resources to provide patient care.,Utilize independent and collaborative approaches to learning.,Develop lifelong learning skills that will enable maintenance of competence through keeping abreast of emerging technologies and drugs.,"Develop a caring, empathic attitude for patients experiencing the conditions covered.",Develop an appreciation of the interdisciplinary nature of patient care.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Seminar Quizzes,Quiz,Written and multiple choice,10,,17-05-31,,Identify ethical issues in the management of mental health conditions.,"Describe the risk factors, clinical presentation, and assessment parameters (signs and symptoms, laboratory values/tests, physical findings and diagnostic measurements) of the conditions covered.","Explain the mechanism of action, pharmacokinetic principles, clinical effect(s), and adverse effects and drug interactions for the medication classes covered.",Describe the role of therapeutic drug monitoring for selected medications in the provision of patient care.,Outline the economic and health policy issues as they relate to mental health conditions.,"Outline the epidemiology, etiology and pathophysiology of the mental health conditions covered.","Describe the therapeutic approach to managing the conditions covered, including: guideline recommendations and clinical targets, pharmacological (dose, duration of therapy, monitoring parameters), non-pharmacological treatments, and CAM.","Conduct a patient assessment using relevant data from the patient history, review of systems, laboratory tests, diagnostic imaging and medication history in order to provide patient care.",Identify and locate sources of information needed to provide patient care.,"Develop a therapeutic and monitoring plan, taking into consideration patient factors, efficacy, toxicity, cost, route of administration, etc."," Apply principles of therapeutic drug monitoring to deliver patient care, taking into consideration health system and economic factors.",Manage clinically significant drug interactions with drugs used to treat the psychiatric conditions covered.,Utilize an evidence based approach to therapeutic management of the psychiatric conditions covered.,Evaluate and apply information from literature and other resources to provide patient care.,Utilize independent and collaborative approaches to learning.,Develop lifelong learning skills that will enable maintenance of competence through keeping abreast of emerging technologies and drugs.,"Develop a caring, empathic attitude for patients experiencing the conditions covered.",Develop an appreciation of the interdisciplinary nature of patient care.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 447 (Fall 2016 LEC A1 SEM E1),PHARM 447 Fa16 - PSYCHIATRY Combined LEC SEM Fa16,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sheila Walter,,Final Exam,Exam,Written and multiple choice,50,,16-12-14,,Identify ethical issues in the management of mental health conditions.,"Describe the risk factors, clinical presentation, and assessment parameters (signs and symptoms, laboratory values/tests, physical findings and diagnostic measurements) of the conditions covered.","Explain the mechanism of action, pharmacokinetic principles, clinical effect(s), and adverse effects and drug interactions for the medication classes covered.",Describe the role of therapeutic drug monitoring for selected medications in the provision of patient care.,Outline the economic and health policy issues as they relate to mental health conditions.,"Outline the epidemiology, etiology and pathophysiology of the mental health conditions covered.","Describe the therapeutic approach to managing the conditions covered, including: guideline recommendations and clinical targets, pharmacological (dose, duration of therapy, monitoring parameters), non-pharmacological treatments, and CAM.","Conduct a patient assessment using relevant data from the patient history, review of systems, laboratory tests, diagnostic imaging and medication history in order to provide patient care.",Identify and locate sources of information needed to provide patient care.,"Develop a therapeutic and monitoring plan, taking into consideration patient factors, efficacy, toxicity, cost, route of administration, etc."," Apply principles of therapeutic drug monitoring to deliver patient care, taking into consideration health system and economic factors.",Manage clinically significant drug interactions with drugs used to treat the psychiatric conditions covered.,Utilize an evidence based approach to therapeutic management of the psychiatric conditions covered.,Evaluate and apply information from literature and other resources to provide patient care.,Utilize independent and collaborative approaches to learning.,Develop lifelong learning skills that will enable maintenance of competence through keeping abreast of emerging technologies and drugs.,"Develop a caring, empathic attitude for patients experiencing the conditions covered.",Develop an appreciation of the interdisciplinary nature of patient care.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Midterm Exam,Exam,Written and multiple choice,50,,16-10-21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 301 (LEC A1 Fa16),PHARM 301 PRINCIPLES OF DRUG ACTION,Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Final Exam,Exam,Written and multiple choice,50,,16-12-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 341 (LEC A1 Fa16),PHARM 341 PHARMACY MATH (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Wilson Cheng,,Assignment #1,Assignment,N/A,10,,16-12-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 341 (LEC A1 Fa16),PHARM 341 PHARMACY MATH (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Wilson Cheng,,Assignment #2,Assignment,N/A,10,,16-12-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 341 (LEC A1 Fa16),PHARM 341 PHARMACY MATH (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Wilson Cheng,,Final,Exam,Multiple choice,80,,16-12-14,,"Calculate  concentration and flow rates, infusion times and total volume of IV medications","Compute mathematical problems using the following principles; a: density and specific gravity, b: specific volume, c: alligations d: concentrations and dilutions e: isotonic and electrolyte solutions  f: proportions ",Formulate calculations patient specific parameters and data,Demonstrate proficiency in using the Aliquot method,"Calculate concentrations of mixtures (weight/weight, weight/volume, volume/weight and volume/volume) and dilutions of stock solutions",Perform conversions of measurement,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,MIDTERM,Exam,Other,20,,16-12-08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,"Semester 1: Labs 1,2,3,4",Lab,N/A,10,,17-05-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,Integrated Cases,Assignment,N/A,20,,17-05-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,FINAL,Exam,Other,35,,17-04-08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,IndividualÂ AssignmentÂ Badge,Participation,N/A,5,,17-05-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 330A (Fall 2016 LAB D1 D2 LEC C1),PHARM 330A Fa16 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa16,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Theresa Charrois, Gillian Johnson, Renette Bertholet",,"Semester 2 Labs 5,6,7,8,9,10",Lab,N/A,10,,17-05-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Cheryl Sadowski,,Design Presentation to Clients â€“ Interim (IP teams),Assignment,N/A,5,,16-10-11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Cheryl Sadowski,,Design Portfolio ,Assignment,N/A,15,,16-09-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Cheryl Sadowski,,Journal,Assignment,N/A,15,,16-09-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Cheryl Sadowski,,Analytical essay,Assignment,N/A,15,,16-11-26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Cheryl Sadowski,,Pharmacy Presentation ,Assignment,N/A,5,,16-12-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Cheryl Sadowski,,Pharmacy Continuing Professional Development Program Draft (collaborative with pharmacy team members),Assignment,N/A,30,,16-11-22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 452 (LEC A1 Fa16),PHARM 452 PHARM PRACTICE-DESIGN&FUNCTION (LEC A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Cheryl Sadowski,,Design Presentation - Final ,Assignment,N/A,15,,16-11-29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 300A (LEC C1 Fa16),PHARM 300A EXPERIENTIAL LEARNING,Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,"Cox, Cheryl",,Seminar #1 Self-Assessment ,Other,N/A,0,,16-11-08,,Develop an understanding of the role and expectations of experiential learning in the curriculum ,Explore the understanding of professionalism as the ability to identify and negotiate the expectations of others,"Through critical reflection, enhance understanding of multiple perspectives and factors which inform person-centred care realizing the complexity and challenges",Demonstrate initiative in service and learning ,Demonstrate critical thinking and reflection to optimize learning from experience and care for clients,Develop the ability to build collaborative relationships with clients and staff,Practice in an ethical manner to assure primary accountability to the client ,Explore the meanings of citizenship and community engagement within oneâ€™s experiences as a volunteer and professional,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 300A (LEC C1 Fa16),PHARM 300A EXPERIENTIAL LEARNING,Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,"Cox, Cheryl",,Seminar #2 Self-Assessment,Other,N/A,0,,16-12-08,,"Through critical reflection, enhance understanding of multiple perspectives and factors which inform person-centred care realizing the complexity and challenges",Demonstrate the provision of person-centred care for clients to enhance quality of life and fulfill professional obligations to individual(s) at the site,Explore how the critical thinking/reflective practice of person-centred care in Pharm 300 relates to the reflective practice of client centered care in pharmacy,Demonstrate critical thinking and reflection to optimize learning from experience and care for clients,Develop the ability to build collaborative relationships with clients and staff,"Through collaborative relationships, demonstrate the ability to determine the needs and perspectives of the client /resident",Practice in an ethical manner to assure primary accountability to the client ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 300A (LEC C1 Fa16),PHARM 300A EXPERIENTIAL LEARNING,Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,"Cox, Cheryl",,Self-Assessment,Other,N/A,0,,17-03-24,,"Through critical reflection, enhance understanding of multiple perspectives and factors which inform person-centred care realizing the complexity and challenges",Demonstrate the provision of person-centred care for clients to enhance quality of life and fulfill professional obligations to individual(s) at the site,Explore the meanings of citizenship and community engagement within oneâ€™s experiences as a volunteer and professional,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 300A (LEC C1 Fa16),PHARM 300A EXPERIENTIAL LEARNING,Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,"Cox, Cheryl",,Seminar #3 Assignment,Assignment,N/A,0,,17-02-17,,Demonstrate the provision of person-centred care for clients to enhance quality of life and fulfill professional obligations to individual(s) at the site,"Through collaborative relationships, demonstrate the ability to determine the needs and perspectives of the client /resident",Explore the meanings of citizenship and community engagement within oneâ€™s experiences as a volunteer and professional,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 300A (LEC C1 Fa16),PHARM 300A EXPERIENTIAL LEARNING,Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,"Cox, Cheryl",,Presentation ,Other,N/A,0,,17-03-01,,Demonstrate the provision of person-centred care for clients to enhance quality of life and fulfill professional obligations to individual(s) at the site,"Through collaborative relationships, demonstrate the ability to determine the needs and perspectives of the client /resident",Explore the meanings of citizenship and community engagement within oneâ€™s experiences as a volunteer and professional,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 300A (LEC C1 Fa16),PHARM 300A EXPERIENTIAL LEARNING,Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,"Cox, Cheryl",,Seminar #2 Person-Centred Care  and Collaboration ,Assignment,N/A,0,,16-12-08,,Demonstrate the provision of person-centred care for clients to enhance quality of life and fulfill professional obligations to individual(s) at the site,Explore how the critical thinking/reflective practice of person-centred care in Pharm 300 relates to the reflective practice of client centered care in pharmacy,Develop the ability to build collaborative relationships with clients and staff,"Through collaborative relationships, demonstrate the ability to determine the needs and perspectives of the client /resident",Explore the meanings of citizenship and community engagement within oneâ€™s experiences as a volunteer and professional,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Sherif Mahmoud,,Weekly Quizzes,Quiz,Multiple choice,10,,16-10-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Sherif Mahmoud,,Patient Case Scenario Assignment,Assignment,N/A,40,,16-10-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Sherif Mahmoud,,Therapeutic Decision-Making Assignment,Assignment,N/A,15,,16-10-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Sherif Mahmoud,,Participation (Coordinator and Facilitator),Participation,N/A,10,,16-12-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 489 (SEM A1 Fa16),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa16),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Sherif Mahmoud,,Final,Exam,Multiple choice,25,,16-12-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi17),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Jody Shkrobot,,Team Debate (Group) â€“ Peer evaluation,Other,N/A,5,,17-03-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi17),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Jody Shkrobot,,Final Exam,Exam,Written and multiple choice,50,,17-04-18,,"Describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically, Alberta.","List the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to the delivery of health care in Canada with particular emphasis on organizations that impact the profession of pharmacy.",Describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,Identify and debate key issues and challenges facing the Canadian healthcare system.,Develop and debate solutions to some of the challenges facing the Canadian healthcare system with emphasis on how pharmacists and pharmacies can be a part of those solutions.,"Develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Albertan health systems.",Develop an appreciation of the different pharmacy service delivery models in different provincial and relevant international jurisdictions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi17),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Jody Shkrobot,,Midterm Exam,Exam,Written and multiple choice,30,,17-02-27,,"Describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically, Alberta.","List the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to the delivery of health care in Canada with particular emphasis on organizations that impact the profession of pharmacy.",Describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,Identify and debate key issues and challenges facing the Canadian healthcare system.,Develop and debate solutions to some of the challenges facing the Canadian healthcare system with emphasis on how pharmacists and pharmacies can be a part of those solutions.,"Develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Albertan health systems.",Develop an appreciation of the different pharmacy service delivery models in different provincial and relevant international jurisdictions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi17),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Jody Shkrobot,,Team Debate (Group) â€“ Instructor evaluation,Exam,Multiple choice,10,,17-03-20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi17),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Jody Shkrobot,,Peer Assessment,Other,N/A,5,,17-03-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Quiz #2: Otitis Media,Quiz,Multiple choice,2,,16-10-28,,"Develop an appreciation for the importance of evaluating, integrating and using current literature, guidelines and antibiograms in the treatment of infectious","Develop an appreciation for Antimicrobial Stewardship, its importance in society and the important roles that pharmacists play in Antimicrobial Stewardship",Develop an appreciation for the pharmacistâ€™s role in ensuring appropriate antibiotic use and prevention of antibiotic resistance.,Develop an appreciation for the serious implications of antibiotic resistance to treatment of infections for the patient and health care system.,Develop an appreciation for the importance of appropriate antibiotic use in infectious diseases ,Determine appropriate measures for the prevention of bacterial infections with individual populations.,"Determine information necessary to counsel patients regarding appropriate use of the antimicrobial (including side effects and hypersensitivities), OTCs and herbals etc. â€¢ Identify actual and potential drug related problems relating to infectious diseases through a series of patient cases.",Determine appropriate patient-specific therapy.,Apply principles of pharmacokinetics and pharmacodynamics of antimicrobials to patient cases.,"Design pharmacy care plans based on presenting diagnosis or signs and symptoms and taking into consideration diagnosis, patient medical history, allergy history, medication history, efficacy, toxicity, cost, route of administration, current literature and guidelines etc.","Integrate and interpret knowledge of signs and symptoms, lab values, test results, appropriate antimicrobial therapy and monitoring parameters for individual patients with varying infectious diseases.","Interpret laboratory & clinical tests used to diagnose and monitor bacterial infections including gram stains, MIC, WBC and differential, etc",Evaluate the current literature and therapeutic guidelines associated with selected infectious diseases,Determine appropriate antibiotic therapy for an individual patient based on current literature and therapeutic guidelines,Identify preventative strategies for infectious diseases in individual populations.,"Identify the mechanisms, contributing factors, impact and solutions for antimicrobial resistance.",Identify the bacterial physiologic processes.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Quiz #3: Lower Respiratory Tract Infections,Quiz,Multiple choice,2,,16-11-04,,"Develop an appreciation for the importance of evaluating, integrating and using current literature, guidelines and antibiograms in the treatment of infectious","Develop an appreciation for Antimicrobial Stewardship, its importance in society and the important roles that pharmacists play in Antimicrobial Stewardship",Develop an appreciation for the pharmacistâ€™s role in ensuring appropriate antibiotic use and prevention of antibiotic resistance.,Develop an appreciation for the serious implications of antibiotic resistance to treatment of infections for the patient and health care system.,Develop an appreciation for the importance of appropriate antibiotic use in infectious diseases ,Determine appropriate measures for the prevention of bacterial infections with individual populations.,"Determine information necessary to counsel patients regarding appropriate use of the antimicrobial (including side effects and hypersensitivities), OTCs and herbals etc. â€¢ Identify actual and potential drug related problems relating to infectious diseases through a series of patient cases.",Determine appropriate patient-specific therapy.,Apply principles of pharmacokinetics and pharmacodynamics of antimicrobials to patient cases.,"Design pharmacy care plans based on presenting diagnosis or signs and symptoms and taking into consideration diagnosis, patient medical history, allergy history, medication history, efficacy, toxicity, cost, route of administration, current literature and guidelines etc.","Integrate and interpret knowledge of signs and symptoms, lab values, test results, appropriate antimicrobial therapy and monitoring parameters for individual patients with varying infectious diseases.","Interpret laboratory & clinical tests used to diagnose and monitor bacterial infections including gram stains, MIC, WBC and differential, etc",Evaluate the current literature and therapeutic guidelines associated with selected infectious diseases,Determine appropriate antibiotic therapy for an individual patient based on current literature and therapeutic guidelines,Identify preventative strategies for infectious diseases in individual populations.,"Identify the mechanism of action, structure-activity relationships of antibacterial agents â€¢ Identify relevant adverse effects and drug interactions, appropriate and inappropriate uses of antibacterial agents ","Identify the mechanisms, contributing factors, impact and solutions for antimicrobial resistance.",Identify the bacterial physiologic processes.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Quiz #4: Urinary Tract Infections,Quiz,Multiple choice,2,,16-11-18,,"Develop an appreciation for the importance of evaluating, integrating and using current literature, guidelines and antibiograms in the treatment of infectious","Develop an appreciation for Antimicrobial Stewardship, its importance in society and the important roles that pharmacists play in Antimicrobial Stewardship",Develop an appreciation for the pharmacistâ€™s role in ensuring appropriate antibiotic use and prevention of antibiotic resistance.,Develop an appreciation for the serious implications of antibiotic resistance to treatment of infections for the patient and health care system.,Develop an appreciation for the importance of appropriate antibiotic use in infectious diseases ,Determine appropriate measures for the prevention of bacterial infections with individual populations.,"Determine information necessary to counsel patients regarding appropriate use of the antimicrobial (including side effects and hypersensitivities), OTCs and herbals etc. â€¢ Identify actual and potential drug related problems relating to infectious diseases through a series of patient cases.",Determine appropriate patient-specific therapy.,Apply principles of pharmacokinetics and pharmacodynamics of antimicrobials to patient cases.,"Design pharmacy care plans based on presenting diagnosis or signs and symptoms and taking into consideration diagnosis, patient medical history, allergy history, medication history, efficacy, toxicity, cost, route of administration, current literature and guidelines etc.","Integrate and interpret knowledge of signs and symptoms, lab values, test results, appropriate antimicrobial therapy and monitoring parameters for individual patients with varying infectious diseases.","Interpret laboratory & clinical tests used to diagnose and monitor bacterial infections including gram stains, MIC, WBC and differential, etc",Evaluate the current literature and therapeutic guidelines associated with selected infectious diseases,Determine appropriate antibiotic therapy for an individual patient based on current literature and therapeutic guidelines,Identify preventative strategies for infectious diseases in individual populations.,"Identify the mechanism of action, structure-activity relationships of antibacterial agents â€¢ Identify relevant adverse effects and drug interactions, appropriate and inappropriate uses of antibacterial agents ","Identify the mechanisms, contributing factors, impact and solutions for antimicrobial resistance.",Identify the bacterial physiologic processes.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Quiz #5: Meningitis,Quiz,Multiple choice,2,,16-11-25,,"Develop an appreciation for the importance of evaluating, integrating and using current literature, guidelines and antibiograms in the treatment of infectious","Develop an appreciation for Antimicrobial Stewardship, its importance in society and the important roles that pharmacists play in Antimicrobial Stewardship",Develop an appreciation for the pharmacistâ€™s role in ensuring appropriate antibiotic use and prevention of antibiotic resistance.,Develop an appreciation for the serious implications of antibiotic resistance to treatment of infections for the patient and health care system.,Develop an appreciation for the importance of appropriate antibiotic use in infectious diseases ,Determine appropriate measures for the prevention of bacterial infections with individual populations.,"Determine information necessary to counsel patients regarding appropriate use of the antimicrobial (including side effects and hypersensitivities), OTCs and herbals etc. â€¢ Identify actual and potential drug related problems relating to infectious diseases through a series of patient cases.",Determine appropriate patient-specific therapy.,Apply principles of pharmacokinetics and pharmacodynamics of antimicrobials to patient cases.,"Design pharmacy care plans based on presenting diagnosis or signs and symptoms and taking into consideration diagnosis, patient medical history, allergy history, medication history, efficacy, toxicity, cost, route of administration, current literature and guidelines etc.","Integrate and interpret knowledge of signs and symptoms, lab values, test results, appropriate antimicrobial therapy and monitoring parameters for individual patients with varying infectious diseases.","Interpret laboratory & clinical tests used to diagnose and monitor bacterial infections including gram stains, MIC, WBC and differential, etc",Evaluate the current literature and therapeutic guidelines associated with selected infectious diseases,Determine appropriate antibiotic therapy for an individual patient based on current literature and therapeutic guidelines,Identify preventative strategies for infectious diseases in individual populations.,"Identify the mechanism of action, structure-activity relationships of antibacterial agents â€¢ Identify relevant adverse effects and drug interactions, appropriate and inappropriate uses of antibacterial agents ","Identify the mechanisms, contributing factors, impact and solutions for antimicrobial resistance.",Identify the bacterial physiologic processes.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Quiz #6: Pharmacokinetics of Vancomycin and Aminoglycosides,Quiz,Multiple choice,2,,16-12-02,,"Design pharmacy care plans based on presenting diagnosis or signs and symptoms and taking into consideration diagnosis, patient medical history, allergy history, medication history, efficacy, toxicity, cost, route of administration, current literature and guidelines etc.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Midterm Exam,Exam,Written and multiple choice,40,,16-10-13,,Identify the structural components of bacteria.,Identify the bacterial physiologic processes.,"Identify the processes in bacterial cellular replication, DNA and RNA replication and protein synthesis ","Identify the taxonomic categories, source, virulence factors, and diseases caused by bacteria","Identify the pharmacodynamic parameters relating to successful antimicrobial therapy. â€¢ Identify factors that influence choice of antimicrobial therapy (i.e. age, pregnancy, renal & hepatic function, site of infection, immune function etc.).",Identify the role of the immune system in response to infection. ,"Identify the mechanism of action, structure-activity relationships of antibacterial agents â€¢ Identify relevant adverse effects and drug interactions, appropriate and inappropriate uses of antibacterial agents ","Identify the pathogenesis, diagnosis, and appropriate treatment options for various bacterial infections.",Identify preventative strategies for infectious diseases in individual populations.,Determine appropriate antibiotic therapy for an individual patient based on current literature and therapeutic guidelines,Evaluate the current literature and therapeutic guidelines associated with selected infectious diseases,"Interpret laboratory & clinical tests used to diagnose and monitor bacterial infections including gram stains, MIC, WBC and differential, etc","Integrate and interpret knowledge of signs and symptoms, lab values, test results, appropriate antimicrobial therapy and monitoring parameters for individual patients with varying infectious diseases.","Design pharmacy care plans based on presenting diagnosis or signs and symptoms and taking into consideration diagnosis, patient medical history, allergy history, medication history, efficacy, toxicity, cost, route of administration, current literature and guidelines etc.",Apply principles of pharmacokinetics and pharmacodynamics of antimicrobials to patient cases.,Determine appropriate patient-specific therapy.,"Determine information necessary to counsel patients regarding appropriate use of the antimicrobial (including side effects and hypersensitivities), OTCs and herbals etc. â€¢ Identify actual and potential drug related problems relating to infectious diseases through a series of patient cases.",Determine appropriate measures for the prevention of bacterial infections with individual populations.,Develop an appreciation for the importance of appropriate antibiotic use in infectious diseases ,Develop an appreciation for the serious implications of antibiotic resistance to treatment of infections for the patient and health care system.,Develop an appreciation for the pharmacistâ€™s role in ensuring appropriate antibiotic use and prevention of antibiotic resistance.,"Develop an appreciation for Antimicrobial Stewardship, its importance in society and the important roles that pharmacists play in Antimicrobial Stewardship","Develop an appreciation for the importance of evaluating, integrating and using current literature, guidelines and antibiograms in the treatment of infectious",,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (Fall 2017 LEC A1 SEM E1),PHARM 407 Fa17 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa17,Cross Listed Courses,,Dr. Sharon Mitchell,,Final Exam,Exam,Written and multiple choice,50,,16-12-16,,"Develop an appreciation for the importance of evaluating, integrating and using current literature, guidelines and antibiograms in the treatment of infectious","Develop an appreciation for Antimicrobial Stewardship, its importance in society and the important roles that pharmacists play in Antimicrobial Stewardship",Develop an appreciation for the pharmacistâ€™s role in ensuring appropriate antibiotic use and prevention of antibiotic resistance.,Develop an appreciation for the serious implications of antibiotic resistance to treatment of infections for the patient and health care system.,Develop an appreciation for the importance of appropriate antibiotic use in infectious diseases ,Determine appropriate measures for the prevention of bacterial infections with individual populations.,"Determine information necessary to counsel patients regarding appropriate use of the antimicrobial (including side effects and hypersensitivities), OTCs and herbals etc. â€¢ Identify actual and potential drug related problems relating to infectious diseases through a series of patient cases.",Determine appropriate patient-specific therapy.,Apply principles of pharmacokinetics and pharmacodynamics of antimicrobials to patient cases.,"Design pharmacy care plans based on presenting diagnosis or signs and symptoms and taking into consideration diagnosis, patient medical history, allergy history, medication history, efficacy, toxicity, cost, route of administration, current literature and guidelines etc.","Integrate and interpret knowledge of signs and symptoms, lab values, test results, appropriate antimicrobial therapy and monitoring parameters for individual patients with varying infectious diseases.","Interpret laboratory & clinical tests used to diagnose and monitor bacterial infections including gram stains, MIC, WBC and differential, etc",Evaluate the current literature and therapeutic guidelines associated with selected infectious diseases,Determine appropriate antibiotic therapy for an individual patient based on current literature and therapeutic guidelines,Identify preventative strategies for infectious diseases in individual populations.,"Identify the pathogenesis, diagnosis, and appropriate treatment options for various bacterial infections.","Identify the mechanism of action, structure-activity relationships of antibacterial agents â€¢ Identify relevant adverse effects and drug interactions, appropriate and inappropriate uses of antibacterial agents ","Identify the mechanisms, contributing factors, impact and solutions for antimicrobial resistance.","Identify the processes in bacterial cellular replication, DNA and RNA replication and protein synthesis ",Identify the bacterial physiologic processes.,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Midterm,Exam,Written and multiple choice,35,,16-02-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Final,Exam,Multiple choice,50,,16-03-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 437 (Winter 2017 LEC B1 B2 SEM J1 J2),PHARM 437 Wi17 - BONE AND JOINT Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Michael R. Doschak,,Anatomy/Physiology Assignments,Assignment,N/A,15,,16-02-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,In-Class Quiz,Quiz,Multiple choice,5,,16-02-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Midterm,Exam,Written and multiple choice,40,,16-02-29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,FInal,Exam,Multiple choice,40,,16-04-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 392 (Winter 2016 LEC B1 B2 SEM J1 J2),PHARM 392 Wi16 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi16,Cross Listed Courses,"Pharmacy Practice,",Scot H. Simpson,,Group Assignment,Assignment,N/A,15,,16-03-23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Class Participation,Participation,N/A,5,,17-01-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Midterm,Exam,Written and multiple choice,40,,17-02-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 427 (Winter 2017 LEC B1 SEM J1),PHARM 427 Wi17 - PAIN Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Final,Exam,Written and multiple choice,55,,17-04-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Midterm,Exam,Written and multiple choice,35,,17-02-08,,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the anatomy of the heart and great blood vessels.,"Discuss the physiology of the blood supply, lymphatic system and cardiovascular system of the human body.",Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Final,Exam,Written and multiple choice,45,,17-04-24,,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the anatomy of the heart and great blood vessels.,"Discuss the physiology of the blood supply, lymphatic system and cardiovascular system of the human body.",Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,BP Clinic and EJournal (most complete both),Assignment,N/A,5,,17-02-02,,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 367 (Winter 2017 LEC B1 SEM J1),PHARM 367 Wi17 - CARDIOLOGY Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Seminars,Participation,N/A,15,,17-01-18,,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the anatomy of the heart and great blood vessels.,"Discuss the physiology of the blood supply, lymphatic system and cardiovascular system of the human body.",Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab 4,Lab,N/A,5,,17-01-14,,Identify the basic process requirements in utilizing the Patient Care Process:,a. Construct a patient care database,b. Identify the drug related problem,c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products and practicing within the professions scope.,Identify legal requirements when accepting/receiving written & verbal prescriptions.,"For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.","Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Identify and document potential medication prescribing errors in written and verbal prescriptions.,Apply concepts of third party billing and prescription pricing in the drug use process. ,Recognize issues surrounding drug diversion and security.,Demonstrate an introductory level of adverse drug reporting and management.,Relate the concepts of the culture of patient safety to the drug use process.,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Document search process for drug information questions, citing references used.",Communicate effectively when having a dialogue with a simulated patient and other health care practitioners,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Midterm,Exam,Written and multiple choice,25,,17-02-13,,Identify the basic process requirements in utilizing the Patient Care Process:,a. Construct a patient care database,b. Identify the drug related problem,c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products and practicing within the professions scope.,Identify legal requirements when accepting/receiving written & verbal prescriptions.,"For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.","Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Document search process for drug information questions, citing references used.",Communicate effectively when having a dialogue with a simulated patient and other health care practitioners,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Final,Exam,Multiple choice,45,,17-03-14,,Identify the basic process requirements in utilizing the Patient Care Process:,a. Construct a patient care database,b. Identify the drug related problem,c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products and practicing within the professions scope.,Identify legal requirements when accepting/receiving written & verbal prescriptions.,"For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.","Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Identify and document potential medication prescribing errors in written and verbal prescriptions.,Apply concepts of third party billing and prescription pricing in the drug use process. ,Recognize issues surrounding drug diversion and security.,Demonstrate an introductory level of adverse drug reporting and management.,Relate the concepts of the culture of patient safety to the drug use process.,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Document search process for drug information questions, citing references used.",Communicate effectively when having a dialogue with a simulated patient and other health care practitioners,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Self-Reflection (Community Pharmacy Visit),Assignment,N/A,10,,17-01-14,,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab 2,Lab,N/A,5,,17-01-14,,Identify the basic process requirements in utilizing the Patient Care Process:,a. Construct a patient care database,b. Identify the drug related problem,c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products and practicing within the professions scope.,Identify legal requirements when accepting/receiving written & verbal prescriptions.,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Document search process for drug information questions, citing references used.",Communicate effectively when having a dialogue with a simulated patient and other health care practitioners,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab 3,Lab,N/A,5,,17-01-14,,Identify the basic process requirements in utilizing the Patient Care Process:,a. Construct a patient care database,b. Identify the drug related problem,c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products and practicing within the professions scope.,Identify legal requirements when accepting/receiving written & verbal prescriptions.,"For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.","Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Identify and document potential medication prescribing errors in written and verbal prescriptions.,Apply concepts of third party billing and prescription pricing in the drug use process. ,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Document search process for drug information questions, citing references used.",Communicate effectively when having a dialogue with a simulated patient and other health care practitioners,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 342 (Winter 2017 LAB LEC SEM),PHARM 342 Wi17 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab 1,Lab,N/A,5,,17-01-14,,Identify the basic process requirements in utilizing the Patient Care Process:,a. Construct a patient care database,b. Identify the drug related problem,c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products and practicing within the professions scope.,Identify legal requirements when accepting/receiving written & verbal prescriptions.,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Seminar 3 Quiz,Quiz,Multiple choice,5,,17-04-05,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Seminar 1 Quiz,Quiz,Multiple choice,5,,17-03-22,,Discuss the methods of contraception available for men and women and describe the efficacy of each.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Midterm,Exam,Multiple choice,40,,17-03-20,,Explain the anatomy of the female and male reproductive systems.,Describe the physiology of the female and male reproductive systems.,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,PHARM 499 (Winter 2017 LEC B1 SEM J1),PHARM 499 Wi17 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Final,Exam,Multiple choice,50,,17-04-24,,"Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Midterm,Exam,Written and multiple choice,40,,17-01-24,,"Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases.","Understand the application of various tools for nutritional assessment, nutritional deficiencies and toxicities, components of healthy diets, and principles of non-prescription natural health products, functional food regulations, food safety and food processing technologies.","Explain the interrelation of the biochemical, pharmacological and physiological functions of nutrients.",Explain the interaction of food and drug.,Explain how dietary agents (functional foods and nutraceuticals) may preventor delay the onset of some chronic diseases.,Explain their learning and knowledge of nutrition to those who are disease state.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Discuss dietary management for prophylactic and therapeutic approach of patient care.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).",Search and report on a topic of relevance to nutrition and health.,"By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 327 (LEC B1 Wi17),PHARM 327 NUTRITION (LEC B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Hoon Sunwoo,,Final,Exam,Written and multiple choice,60,,17-02-17,,"Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases.","Understand the application of various tools for nutritional assessment, nutritional deficiencies and toxicities, components of healthy diets, and principles of non-prescription natural health products, functional food regulations, food safety and food processing technologies.","Explain the interrelation of the biochemical, pharmacological and physiological functions of nutrients.",Explain the interaction of food and drug.,Explain how dietary agents (functional foods and nutraceuticals) may preventor delay the onset of some chronic diseases.,Explain their learning and knowledge of nutrition to those who are disease state.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Discuss dietary management for prophylactic and therapeutic approach of patient care.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).",Search and report on a topic of relevance to nutrition and health.,"By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Participation (Coordinator and Facilitator),Participation,N/A,10,,17-01-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Weekly Quizzes,Quiz,Multiple choice,10,,17-03-06,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.","Demonstrate use of a therapeutic process to identify, prioritize, and resolve actual and/or potential drug-related problems using a patient care centered approach.",Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Therapeutic Decision-Making Assignment,Assignment,N/A,15,,17-02-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Patient Case Scenario Assignment,Assignment,N/A,40,,17-03-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 489 (SEM B1 Wi17),PHARM 489 THERAP & PROF PRACT (SEM B1 Wi17),Faculty of Pharmacy and Pharmaceutical Sciences,,Sherif Mahmoud,,Final Exam,Exam,Multiple choice,25,,17-04-18,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.","Demonstrate use of a therapeutic process to identify, prioritize, and resolve actual and/or potential drug-related problems using a patient care centered approach.",Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Examination 2 (Pediatrics),Exam,Written and multiple choice,37,,17-02-08,," Explain the significant differences in physiologic parameters between adolescents, children, toddlers and infants, including premature babies, and neonates","Identify and discuss appropriate management plans for common pediatric gastrointestinal illnesses (e.g. vomiting, diarrhea, dehydration, colic, and constipation).",Discuss presentation and treatment for common pulmonary pediatric illnesses; croup and bronchiolitis.,"Describe the various forms of pediatric abuse and discuss the Child, Youth and Family Enhancement Act and the responsibilities that are associated with the Act","Explain the demographics of the pediatric population in society, and explain how that may impact our role as pharmacists. (e.g. improvement of childhood illnesses, trend towards chronic disease management)","Identify and discuss some of the challenges involved in treating the pediatric population, including communication strategies, presentation of illness and the management and administration of medications to infants and children.",Discuss the importance of medication safety and identify measures used to ensure safe medication practices,Review pediatric toxicology and discuss preventative interventions that pharmacists can promote to patients or utilize in their practice to minimize pediatric toxicological poisonings or incidences.,Discuss basic neonatal care and challenges including premature birth.,Explain how pharmacokinetic parameters are different in infants and children versus adults.,Identify and discuss appropriate management plans for common pediatric concerns such as teething and fevers.,Describe the challenges of providing care in a population with limited evidence.,"Describe the use and effect of drugs, pharmacoepidemiology, including prescription, non-prescription medication, and natural health products.","Describe risks for adverse drug events in pediatric and geriatric patients, and explain why they are more susceptible to adverse events.",Identify and describe age-appropriate communication strategies.,"Describe the role that culture, religion, and ethnicity may play in health and decision-making.",Identify controversial health issues involving pediatric and geriatric populations,Discuss the management and implications involved with a diagnosis of autism.,Apply applicable pharmacokinetic parameters to monitor patients and assess appropriate use of medications., Apply knowledge and skills to establish safe and effective drug use.,Utilize when available an evidence-based approach to therapeutic management of pediatric and geriatric patients.,Identify sources of information needed to solve drug-related problems specific to the populations being studied.,"Empathize with children, older adults, and caregivers regarding challenging decision-making.","Develop a caring, empathic attitude for and response to pediatric and geriatric patients","Develop an appreciation of the comprehensive, interdisciplinary nature of patient care for children and older adults",Appreciate the challenges related to decision-making and advocacy in grey areas of clinical practice and health.,,,,,,,,,,,,,,,,,,,,,PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Examination 1 (Geriatrics),Exam,Written and multiple choice,37,,17-01-23,,Categorize the types of abuse commonly suffered by seniors.,Describe the role of the pharmacist in reducing elder abuse,Describe the challenges of providing care in a population with limited evidence.,"Describe the use and effect of drugs, pharmacoepidemiology, including prescription, non-prescription medication, and natural health products.",Identify controversial health issues involving pediatric and geriatric populations,"Define and be able to use the following terms in a clinical context: geriatrics, gerontology, elderly, aging, frailty.",Describe common stereotypes and biases toward aging in our western society.," Explain the demographics of aging, and how that may impact society and the healthcare system.",Briefly describe the psychosocial aspects of aging and be able to explain the role of the pharmacist in dealing with these aspects.,Describe the physiologic alterations associated with normal aging that modify drug response in the elderly patient.,"Describe the pharmacokinetic and pharmacodynamic changes associated with aging, and apply the principles to medications commonly used in geriatrics.", List the most common chronic diseases and causes of death in seniors.,Contrast disease presentation between the young adult and the elderly adult.,Identify medications that are considered inappropriate or high risk in older adults and explain why they are inappropriate or high risk.,Describe how criteria were developed to classify medications as appropriate or inappropriate in seniors.,Define polypharmacy and underutilization in terms of medications in seniors.,Contrast the presentation of adverse events in the elderly compared to the young adult.,Describe the impact of falls on the senior population.,Identify risk factors for falls in older individuals.,Describe appropriate interventions for falls.,Contrast how a geriatric syndrome is different than a disease state.,List the common geriatric syndromes.,Discuss the role of the pharmacist in medication management of seniors.,Identify methods of appropriately communicating with older adults who are hard of hearing.,Describe the role of the pharmacist in working with home care.,Identify appropriate home care supports for a given patient.,Use tools to assess medication appropriateness and medication management in seniors.,Be able to triage patients in a community setting and refer them to medical attention as appropriate.,Apply applicable pharmacokinetic parameters to monitor patients and assess appropriate use of medications., Apply knowledge and skills to establish safe and effective drug use.,Utilize when available an evidence-based approach to therapeutic management of pediatric and geriatric patients.,Identify sources of information needed to solve drug-related problems specific to the populations being studied.,Identify and be able to recommend aids to assist in medication management and administration.,"Empathize with children, older adults, and caregivers regarding challenging decision-making.","Develop a caring, empathic attitude for and response to pediatric and geriatric patients","Develop an appreciation of the comprehensive, interdisciplinary nature of patient care for children and older adults",Appreciate the challenges related to decision-making and advocacy in grey areas of clinical practice and health.,,,,,,,,,,PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Assignment â€“ Part III: Response,Assignment,N/A,10,,17-02-20,,Take and defend a position on a controversy related to pediatrics and geriatrics using evidence-based arguments.,Prepare and present a personal script to address a controversial topic.,Communicate position through oral and written formats.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Assignment â€“ Part I: Position Outline and Bibliography,Assignment,N/A,5,,17-01-26,,Take and defend a position on a controversy related to pediatrics and geriatrics using evidence-based arguments.,Prepare and present a personal script to address a controversial topic.,Communicate position through oral and written formats.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 387 (Winter 2017 LEC B1 SEM J1),PHARM 387 Wi17 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Assignment â€“ Part II: Debate,Assignment,N/A,10,,17-01-26,,Take and defend a position on a controversy related to pediatrics and geriatrics using evidence-based arguments.,Prepare and present a personal script to address a controversial topic.,Communicate position through oral and written formats.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Final,Exam,Multiple choice,45,,17-04-19,,Relate differences in pharmaceutical vehicles for topical or transdermal drug delivery.,Describe the specific laboratory tests used in the monitoring of isotretinoin.," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ","Explain the anatomy of the integumentary system, eye, ear, nose and throat. ","Describe the physiology of the skin, eyes, ears, nose and throat.",Explain the physical conditions that lead to skin breakdown and wound development.,Describe the physiology of chronic wound healing.,Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences.,"Describe the mechanisms, pathophysiology and clinical presentation of various drug-induced topical reactions.", follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,"Lab # 1 Patient Care Process (Eye, Ear and Lice)",Lab,N/A,5,,17-01-12,," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ","Explain the anatomy of the integumentary system, eye, ear, nose and throat. ","Describe the physiology of the skin, eyes, ears, nose and throat.", follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab # 2: Patient Care Process (Dermatologic Conditions),Lab,N/A,5,,17-01-12,,Relate differences in pharmaceutical vehicles for topical or transdermal drug delivery.,Describe the specific laboratory tests used in the monitoring of isotretinoin.," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ","Explain the anatomy of the integumentary system, eye, ear, nose and throat. ","Describe the physiology of the skin, eyes, ears, nose and throat.",Explain the physical conditions that lead to skin breakdown and wound development.,Describe the physiology of chronic wound healing.,Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences.,"Describe the mechanisms, pathophysiology and clinical presentation of various drug-induced topical reactions.", follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Medical Terminology Quiz #4,Quiz,Multiple choice,2,,17-01-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Medical Terminology Quiz #1,Quiz,Multiple choice,2,,17-01-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Medical Terminology Quiz #2,Quiz,Multiple choice,2,,17-01-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Medical Terminology Quiz #3,Quiz,Multiple choice,2,,17-01-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Medical Terminology Quiz #5,Quiz,Multiple choice,2,,17-01-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Midterm,Exam,Multiple choice,25,,17-03-30,,Relate differences in pharmaceutical vehicles for topical or transdermal drug delivery.,Describe the specific laboratory tests used in the monitoring of isotretinoin.," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ","Explain the anatomy of the integumentary system, eye, ear, nose and throat. ","Describe the physiology of the skin, eyes, ears, nose and throat.",Explain the physical conditions that lead to skin breakdown and wound development.,Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences.,"Describe the mechanisms, pathophysiology and clinical presentation of various drug-induced topical reactions.", follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.",Refer patients to medical attention as appropriate.,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients,"Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.","Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,PHARM 307 (Winter 2017 LAB LEC SEM),"PHARM 307 Wi17 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,OTC Submission,Assignment,N/A,10,,17-01-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Midterm,Exam,Written and multiple choice,30,,17-01-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Final,Exam,Written and multiple choice,40,,17-03-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab assignments average of 7 lab marks,Assignment,N/A,20,,17-01-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 331 (Winter 2017 LAB LEC SEM),PHARM 331 Wi17 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab Exam,Exam,Multiple choice,10,,17-03-20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Seminar Quiz,Quiz,Written and multiple choice,5,,17-02-08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Seminar Quiz,Quiz,Written and multiple choice,5,,17-03-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Final,Exam,Multiple choice,50,,17-04-21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 477 (Winter 2017 LEC B1 SEM J1),PHARM 477 Wi17 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Christine Hughes,,Midterm,Exam,Multiple choice,40,,16-03-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,EBCP Literacy Assignment,Assignment,N/A,20,,16-02-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Seminar #2 Critical Appraisal,Assignment,N/A,5,,16-02-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Final,Exam,Written and multiple choice,50,,16-11-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 324 (Winter 2017 LEC SEM),PHARM 324 Wi17 - HLTH PROF EVED BASED MED Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Mark Makowsky,,Group EBM Project,Exam,Multiple choice,25,,16-02-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Midterm,Exam,Written and multiple choice,40,,17-02-14,,Identify the main anatomical components of the endocrine system.,Describe the physiological effects of endocrine hormones.,Identify applicable health system resources for the management of endocrine disorders.,"Describe the epidemiology, etiology, and risk factors of endocrine disorders.",Describe the specific laboratory tests used in the diagnosis and management of endocrine disorders.,Recognize the main structural features of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used to manage endocrine disorders.,Describe the adverse effects of drugs used to manage endocrine disorders.,"Describe the therapeutic approach, incorporating non-pharmacologic and pharmacologic treatments to the prevention and management of endocrine disorders; including use of specific target drugs (dose, route of administration, length of therapy, monitoring parameters) for each condition as well as alternative therapies.","Recognize and understand the appropriate diabetes management strategies for various activities, such as travel, exercise, and acute illness.",Identify ethical and cultural issues surrounding endocrine disorders.,Identify the pharmacist's role and the responsibility within the management of endocrine disorders.,"Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Apply pharmacokinetic and pharmacodynamic principles to the drug treatment of endocrine disorders.,Describe actions and adverse effects of common natural health products used to manage endocrine disorders.,"Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus. ",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Final,Exam,Written and multiple choice,45,,17-04-19,,Identify the main anatomical components of the endocrine system.,Describe the physiological effects of endocrine hormones.,Identify applicable health system resources for the management of endocrine disorders.,"Describe the epidemiology, etiology, and risk factors of endocrine disorders.",Describe the specific laboratory tests used in the diagnosis and management of endocrine disorders.,Recognize the main structural features of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used to manage endocrine disorders.,Describe the adverse effects of drugs used to manage endocrine disorders.,"Describe the therapeutic approach, incorporating non-pharmacologic and pharmacologic treatments to the prevention and management of endocrine disorders; including use of specific target drugs (dose, route of administration, length of therapy, monitoring parameters) for each condition as well as alternative therapies.","Recognize and understand the appropriate diabetes management strategies for various activities, such as travel, exercise, and acute illness.",Identify ethical and cultural issues surrounding endocrine disorders.,Identify the pharmacist's role and the responsibility within the management of endocrine disorders.,"Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Apply pharmacokinetic and pharmacodynamic principles to the drug treatment of endocrine disorders.,Describe actions and adverse effects of common natural health products used to manage endocrine disorders.,"Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus. ",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Pre-Seminar Quiz 1,Quiz,Written and multiple choice,7,,17-02-03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 497 (Winter 2017 LEC B1 SEM J1),PHARM 497 Wi17 - ENDOCRINE Combined LEC SEM Wi17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Candace Necyk,,Pre-Seminar Quiz 2,Exam,Written and multiple choice,0,,17-02-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 531 (Spring 2017 LEC A1 A2 SEM E2),PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Morgan Basiuk,,EBCP Literacy Assignment,Assignment,N/A,5,,17-06-02,,Demonstrate the EBCP process for answering clinical questions in practice.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 531 (Spring 2017 LEC A1 A2 SEM E2),PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Morgan Basiuk,,Journal Club ,Research,N/A,20,,17-06-20,,Demonstrate the ability to search for and find the best evidence according to the type of question being asked.,Effectively provide a verbal study synopsis.,"Critically appraise the most common types of clinical studies pertinent to clinical pharmacist practice for validity, clinical relevance, and applicability. ",Calculate and interpret various estimates of treatment effect.,"Apply evidence, patient values, and clinical expertise and the principles of shared decision making to confidently & competently manage a patientâ€™s medication therapy.",Demonstrate skills in selfâ€“directed learning and self-reflection as required for continuous professional development.,Demonstrate professional attitude and behaviour consistently and work collaboratively with other group members to achieve an evidence-based clinical practice.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 531 (Spring 2017 LEC A1 A2 SEM E2),PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Morgan Basiuk,,Individual Critical Appraisal Assignments,Assignment,N/A,10,,17-01-30,,Demonstrate the ability to search for and find the best evidence according to the type of question being asked.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 531 (Spring 2017 LEC A1 A2 SEM E2),PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Morgan Basiuk,,Final Exam,Exam,Written and multiple choice,40,,17-07-11,,Demonstrate the EBCP process for answering clinical questions in practice.,Apply verbal and written communication skills important for collaboration in professional team environments.,Demonstrate the ability to search for and find the best evidence according to the type of question being asked.,Effectively provide a verbal study synopsis.,"Critically appraise the most common types of clinical studies pertinent to clinical pharmacist practice for validity, clinical relevance, and applicability. ",Calculate and interpret various estimates of treatment effect.,"Apply evidence, patient values, and clinical expertise and the principles of shared decision making to confidently & competently manage a patientâ€™s medication therapy.",Demonstrate skills in selfâ€“directed learning and self-reflection as required for continuous professional development.,Demonstrate professional attitude and behaviour consistently and work collaboratively with other group members to achieve an evidence-based clinical practice.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 531 (Spring 2017 LEC A1 A2 SEM E2),PHARM 531 Sp17 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Morgan Basiuk,,Group Critical Appraisal Assignments,Assignment,N/A,25,,17-01-30,,Demonstrate the ability to search for and find the best evidence according to the type of question being asked.,Effectively provide a verbal study synopsis.,"Critically appraise the most common types of clinical studies pertinent to clinical pharmacist practice for validity, clinical relevance, and applicability. ",Calculate and interpret various estimates of treatment effect.,"Apply evidence, patient values, and clinical expertise and the principles of shared decision making to confidently & competently manage a patientâ€™s medication therapy.",Demonstrate skills in selfâ€“directed learning and self-reflection as required for continuous professional development.,Demonstrate professional attitude and behaviour consistently and work collaboratively with other group members to achieve an evidence-based clinical practice.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Individual readiness assessment test (iRAT) (individual),Assignment,N/A,25,,17-01-30,,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Team readiness assessment test (tRAT) (group),Assignment,N/A,10,,17-01-30,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,TDM Assignment (individual),Assignment,N/A,1,,17-01-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Submission of Appropriate Key Learning Issues on Google Forms (individual),Assignment,N/A,10,,17-01-30,,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Tutorial Evaluation ,Assignment,N/A,10,,17-01-30,,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Care Plans (group),Exam,Multiple choice,10,,17-07-02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Final Exam,Exam,Multiple choice,20,,17-08-10,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Collaboration & Professional Learning Reflections (individual),Assignment,N/A,12,,17-06-25,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 547 (Summer 2017 LEC B1 B2 SEM J1),PHARM 547 Su17 - ADVANCED THERAPEUTICS Combined LEC SEM Su17,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD)",Jill Hall,,Documentation Notes (group) ,Assignment,N/A,10,,17-07-02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Participation,Participation,N/A,5,,17-01-31,,Demonstrate professional attitude and behavior consistently and work collaboratively with other group members.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Symptom Assessment Assignment,Assignment,N/A,15,,17-06-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Case assessment documentation (5% each x 6),Assignment,N/A,30,,17-06-02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Patient Assessment Lab Quizzes (5% each x 3),Quiz,Multiple choice,15,,17-06-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 532 (Spring 2017 LAB D1 LEC A1 A2 SEM E2),PHARM 532 Spring 17 - PATIENT ASSESSMENT,Faculty of Pharmacy and Pharmaceutical Sciences,", Doctor of Pharmacy (PharmD) for BScPharm Students",Dr. Sherif Mahmoud,,Final Exam,Exam,Written and multiple choice,35,,17-07-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 341 (LEC A1 Fa17),PHARM 341 PHARMACY MATH (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ","Gillian Johnson, Ravina Sanghera",,Quiz #1,Quiz,Multiple choice,10,,17-10-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 341 (LEC A1 Fa17),PHARM 341 PHARMACY MATH (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ","Gillian Johnson, Ravina Sanghera",,Quiz #2,Quiz,Multiple choice,10,,17-11-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 341 (LEC A1 Fa17),PHARM 341 PHARMACY MATH (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ","Gillian Johnson, Ravina Sanghera",,Quiz #3,Quiz,Multiple choice,10,,17-12-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 341 (LEC A1 Fa17),PHARM 341 PHARMACY MATH (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ","Gillian Johnson, Ravina Sanghera",,Final,Exam,Written and multiple choice,70,,17-12-11,,Perform conversions of measurement,"Compute mathematical problems using the following principles; a: density and specific gravity, b: specific volume, c: alligations d: concentrations and dilutions e: isotonic and electrolyte solutions  f: proportions ",Formulate calculations patient specific parameters and data,Demonstrate proficiency in using the Aliquot method,"Calculate concentrations of mixtures (weight/weight, weight/volume, volume/weight and volume/volume) and dilutions of stock solutions","Calculate  concentration and flow rates, infusion times and total volume of IV medications",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Midterm,Exam,Multiple choice,40,,17-10-20,,Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of primary focus.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify ethical issues surrounding treatment of the conditions of primary focus,"Explain the anatomy of the central, peripheral and autonomic nervous system, cranial nerves and sensory and motor system","Describe the physiology of the spinal reflexes, somatosensory system, motor control and higher nervous function.",Describe the pathophysiology of the conditions of primary focus.,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Describe the clinical presentation and symptomatology of the conditions of primary focus.,Describe the laboratory tests used in the diagnosis and monitoring of the conditions of primary focus.,"Apply concepts and knowledge of medicinal chemistry, pharmacology/toxicology, and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe the societal and economic impact of the conditions of primary focus.,Appreciate the interdisciplinary approach to management of the conditions of primary focus.,Describe the long term health consequences of the conditions of primary focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments for the conditions of primary focus, including use of specific target drugs for condition as well as alternative therapies (including dose, route of administration, duration of therapy, monitoring parameters)",Synthesize information gained from various literature resources to solve problems or make recommendations,Calculate and apply the applicable pharmacokinetic parameters to monitor patients using these medications.,Identify actual and potential drug-related problems relating to of the conditions of primary focus in patient case studies.,Identify clinically significant drug interactions with drugs used to treat the conditions of primary focus.,Identify presenting symptoms that would be integrated into a triage approach for patients.,"Select appropriate treatment for special groups (e.g. pediatrics, geriatrics, pregnancy, lactation)",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug-related problems,Identify when to inform caregivers and other members of the health care team if there are danger signs apparent in the assessment.,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.","Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",,,,,,,,,,,,,,,,,,,,,,PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Final,Exam,Written and multiple choice,50,,16-11-01,,Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of primary focus.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify ethical issues surrounding treatment of the conditions of primary focus,"Explain the anatomy of the central, peripheral and autonomic nervous system, cranial nerves and sensory and motor system","Describe the physiology of the spinal reflexes, somatosensory system, motor control and higher nervous function.",Describe the pathophysiology of the conditions of primary focus.,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Describe the clinical presentation and symptomatology of the conditions of primary focus.,Describe the laboratory tests used in the diagnosis and monitoring of the conditions of primary focus.,"Apply concepts and knowledge of medicinal chemistry, pharmacology/toxicology, and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe the societal and economic impact of the conditions of primary focus.,Appreciate the interdisciplinary approach to management of the conditions of primary focus.,Describe the long term health consequences of the conditions of primary focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments for the conditions of primary focus, including use of specific target drugs for condition as well as alternative therapies (including dose, route of administration, duration of therapy, monitoring parameters)",Synthesize information gained from various literature resources to solve problems or make recommendations,Calculate and apply the applicable pharmacokinetic parameters to monitor patients using these medications.,Identify actual and potential drug-related problems relating to of the conditions of primary focus in patient case studies.,Identify clinically significant drug interactions with drugs used to treat the conditions of primary focus.,Identify presenting symptoms that would be integrated into a triage approach for patients.,"Select appropriate treatment for special groups (e.g. pediatrics, geriatrics, pregnancy, lactation)",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug-related problems,Identify when to inform caregivers and other members of the health care team if there are danger signs apparent in the assessment.,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.","Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",,,,,,,,,,,,,,,,,,,,,,PHARM 417 (Fall 2017 LEC A1 SEM E1),PHARM 417 Fall 2017 - NEUROLOGY,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Rare Neurologic Disorders Assignment,Assignment,N/A,10,,17-06-29,,Summarize the impact on and care for patients with rare neurologic disorders.,Synthesize information gained from various literature resources to solve problems or make recommendations,Utilize self-directed learning abilities.,Calculate and apply the applicable pharmacokinetic parameters to monitor patients using these medications.,Identify actual and potential drug-related problems relating to of the conditions of primary focus in patient case studies.,Identify clinically significant drug interactions with drugs used to treat the conditions of primary focus.,Identify presenting symptoms that would be integrated into a triage approach for patients.,"Select appropriate treatment for special groups (e.g. pediatrics, geriatrics, pregnancy, lactation)",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug-related problems,Identify when to inform caregivers and other members of the health care team if there are danger signs apparent in the assessment.,"For each of the conditions described the student should: review the presenting signs and symptoms of the conditions of primary focus, and describe criteria used to make the diagnosis and to be able to relate the severity of the disease; discuss the therapeutic options with peers, including risks and benefits, and medication and alternative therapy choices; recommend appropriate monitoring parameters; recommend appropriate changes to therapy based on patient outcomes and monitoring parameters","Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Accept responsibility for keeping abreast of emerging technologies and drugs.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation for advocacy required for individuals with neurologic disorders.,Appreciate the roles of members of the healthcare team in caring for patients with neurologic conditions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Midterm,Exam,Written and multiple choice,40,,17-10-19,,"Describe the etiology, pathophysiology, clinical presentation, and compensatory mechanism of the four acid-base disorders.","Assess fluid balance based on medical history as well as presenting signs and symptoms, and recommend appropriate management of the patient.",Calculate creatinine clearance and adjust doses for medications that are renally eliminated.,"Identify the presenting signs and symptoms of electrolyte disorders, acid-base disorders, acute kidney injury, chronic kidney disease, nephrolithiasis, and LUTS and describe criteria used to make the diagnosis.",Accept responsibility for keeping abreast of emerging technologies and drugs,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus. ",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Online Quiz #2,Quiz,Multiple choice,3,,17-11-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Online Quiz #3,Quiz,Multiple choice,3,,17-11-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Online Quiz #1,Quiz,Multiple choice,3,,17-10-03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 397 (Fall 2017 LEC A1 A2 SEM E1 E2),"PHARM 397 Fa17 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa17",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Ravina Sanghera,,Final,Exam,Written and multiple choice,50,,17-12-18,,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters.,Work effectively within the healthcare team.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 311 (LEC A1 Fa17),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Midterm Exam ,Exam,Multiple choice,40,,16-09-15,,"This module has been designed to familiarize pharmacy students with basic principles of diagnostic imaging, with emphasis on the use of radiation and radioactive drugs and contrast agents in medical diagnosis and therapy. The biological effects of radiation are presented from the viewpoint of a pharmacist's perspective as a health sciences team member.",To indicate the levels of radiation dose received from common radiopharmaceutical diagnostic procedures and the inherent dangers with contrast materials and to place these into a benefit vs. risk concept.,"To acquaint students with basic physical fundamentals regarding concepts of radioactivity, rates and types of radioactive decay; units of radiation; biological effects of radiation â€“ toxicity and therapy; free radical formation and detoxification; diagnostic imaging techniques, instrumentation, and utilization of radiopharmaceuticals.",To consider the various types of radiation and their characteristics and interactions with matter from the viewpoint of how these factors: Influence the utility of different radiations for clinical diagnosis or for therapy; Can present a health hazard from improper use or handling; Determine the methods of radiation detection and measurement,To present the basic principles underlying the biological effects observed with exposure to various levels of radioactivity.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 311 (LEC A1 Fa17),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,In Class Quiz #2,Quiz,Multiple choice,10,,16-09-22,,"To develop a basic understanding of the contemporary diagnostic imaging modalities, including nuclear medicine imaging, x-ray, CT, ultrasound, and MRI, and an understanding of the nature of the clinical information provided by each modality","This course will provide general knowledge regarding diagnostic imaging and radioactivity, and will allow the pharmacist to place a proper perspective on such common concerns in a community as: Radiation safety in general; Biological hazards of radioactive material and installations utilizing radioactivity (eg. xray units) in hospitals and in the community; Risk â€“ benefit concepts in diagnostic imaging; General familiarity with imaging techniques/underlying principles.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 311 (LEC A1 Fa17),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,Final Exam ,Exam,Multiple choice,50,,16-10-05,,"This module has been designed to familiarize pharmacy students with basic principles of diagnostic imaging, with emphasis on the use of radiation and radioactive drugs and contrast agents in medical diagnosis and therapy. The biological effects of radiation are presented from the viewpoint of a pharmacist's perspective as a health sciences team member.",To illustrate the rationale for the use of radioactive drugs and contrast agents for diagnosis by discussing: the various agents presently available from commercial suppliers; the physiological basis of their utility and clinical applications; their formulation and manufacture; methods of quality control and dispensing and inventory control. The use of radioactive drugs for therapy will be examined.,"This course will provide a basis for further training (either formally or on-the-job) which will provide the expertise for safe and effective handling, preparation and dispensing of radiopharmaceuticals and maintaining proper quality control and inventory.",To indicate the levels of radiation dose received from common radiopharmaceutical diagnostic procedures and the inherent dangers with contrast materials and to place these into a benefit vs. risk concept.,"To acquaint students with basic physical fundamentals regarding concepts of radioactivity, rates and types of radioactive decay; units of radiation; biological effects of radiation â€“ toxicity and therapy; free radical formation and detoxification; diagnostic imaging techniques, instrumentation, and utilization of radiopharmaceuticals.",To consider the various types of radiation and their characteristics and interactions with matter from the viewpoint of how these factors: Influence the utility of different radiations for clinical diagnosis or for therapy; Can present a health hazard from improper use or handling; Determine the methods of radiation detection and measurement,To present the basic principles underlying the biological effects observed with exposure to various levels of radioactivity.,"To illustrate ""radiopharmaceutical kits"", and radionuclide generators for daily preparation of short-lived radiopharmaceuticals in a hospital.","To develop a basic understanding of the contemporary diagnostic imaging modalities, including nuclear medicine imaging, x-ray, CT, ultrasound, and MRI, and an understanding of the nature of the clinical information provided by each modality","This course will provide general knowledge regarding diagnostic imaging and radioactivity, and will allow the pharmacist to place a proper perspective on such common concerns in a community as: Radiation safety in general; Biological hazards of radioactive material and installations utilizing radioactivity (eg. xray units) in hospitals and in the community; Risk â€“ benefit concepts in diagnostic imaging; General familiarity with imaging techniques/underlying principles.","Following this course, students should be able to interpret the labels on radiopharmaceuticals; perform simple calculations related to radioactive decay.","This course will provide pharmacists with fundamental knowledge of contemporary clinical imaging modalities, including the use of radiopharmaceuticals and contrast agents in clinical diagnosis and therapy. Such a basic understanding will enable pharmacists, as members of a Health Team, to communicate knowledgeably with physicians, nurses, technicians and patients regarding the use of various imaging techniques. Emphasis will be placed on radiopharmaceuticals and contrast agents used with these procedures. The use of radioactive materials for in vitro and in vivo tests, and for radiation therapy, will be addressed. An understanding of the general principles underlying the biologic effects of various levels of radiation will assist the pharmacist in allaying patients' fears and misapprehensions regarding radioactivity.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 311 (LEC A1 Fa17),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", , BSc in Pharmacy, ",Arno G. Siraki,,In Class Quiz #1,Quiz,Multiple choice,10,,16-09-07,,"This module has been designed to familiarize pharmacy students with basic principles of diagnostic imaging, with emphasis on the use of radiation and radioactive drugs and contrast agents in medical diagnosis and therapy. The biological effects of radiation are presented from the viewpoint of a pharmacist's perspective as a health sciences team member.","This course will provide general knowledge regarding diagnostic imaging and radioactivity, and will allow the pharmacist to place a proper perspective on such common concerns in a community as: Radiation safety in general; Biological hazards of radioactive material and installations utilizing radioactivity (eg. xray units) in hospitals and in the community; Risk â€“ benefit concepts in diagnostic imaging; General familiarity with imaging techniques/underlying principles.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Final Exam,Exam,Written and multiple choice,50,,17-12-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 301 (LEC A1 Fa17),PHARM 301 PRINCIPLES OF DRUG ACTION (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Carlos A. VelÃ¡zquez,,Midterm Exam,Exam,Written and multiple choice,50,,17-10-23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,Final Exam,Exam,Written,23,,17-12-11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,TDM Assessment ,Assignment,N/A,5,,17-08-24,,Demonstrate an understanding of key concepts in pharmacokinetics and therapeutic drug monitoring and apply pharmacokinetic principles to resolve drug therapy problems and optimize pharmacotherapy outcomes.,"Apply acquired therapeutic knowledge to confidently and competently manage medication therapy (including monitoring and follow-up) for patients with both the common disease states covered and those beyond, even if complex interplay between disease states exists. ","Demonstrate critical thinking, therapeutic knowledge, and the use of a therapeutic thought process (patient care process) in prioritizing and resolving a patientâ€™s drug related problems, making appropriate recommendations related to ambiguous medication-related issues and those where evidence is limited or contradictory. ","Develop and defend a detailed care plan (with supporting chart documentation) to resolve and/or prevent drug related problems, applying principles of evidence-based medicine. ","Effectively translate therapeutic knowledge to patients with complex care issues and/or those of a sensitive nature that present challenges in communication, in a variety of settings. ","Demonstrate the self-directed learning, self-reflection, and peer assessment skills required for continuous professional development and precepting students. ","Apply the communication, collaboration, and leadership skills gained through teamwork to other professional team environments.",Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patientsâ€™ pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,Tutorial Evaluation: TMCA and TACL,Assignment,N/A,12,,17-08-24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,Documentation Notes ,Assignment,N/A,15,,17-08-24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,Key Learning Issues and Care Plans  ,Assignment,N/A,2,,17-08-24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,Exam 1: Midterm,Exam,Written,19,,17-10-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 503 (Fall 2017 LEC A1 SEM E1),PHARM 503 Fa17 - ADVANCED PHARMACOTHERAPY Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Jill Hall,,Exam 2: Midterm ,Exam,Written,23,,17-11-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Midterm,Exam,Multiple choice,34,,17-10-23,,"Comprehend one and two compartmental models, including the underlying reasons for the appearance of more than one compartment in a plasma concentration vs. time profile.","Use the knowledge obtained from determination of pharmacokinetic parameters to devise an individualized dosing regimen for a patient, tailored to achieve a therapeutic goal of concentration and/or effect.",Comprehend concepts related to nonlinear elimination of drug.,Recognize factors that can influence the relationship between plasma concentrations and pharmacodynamics potency of drugs,"Understand the relationship between organ clearance and total body clearance, and detail the mechanisms involved in renal and hepatic drug clearance of a particular drug.","Identify the relationships between different pharmacokinetic parameters and blood fluid concentrations after drug administration by the intravenous, oral and injectable routes.",Grasp the concept of steady state and its dependency on half-life in relation to constant intravenous infusion and repeated dose administration.,"Determine CL, Vd, and other dependent pharmacokinetic parameters (half-life, maximum concentration after dosing, area under the concentration vs. time curve) from plasma concentration vs. time data.",Become proactive in including and considering concepts of therapeutic drug monitoring in practice skills.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Final,Exam,Multiple choice,44,,17-12-20,,Recognize the relationship between pharmacokinetics and therapeutic relevance in: a. Extremes of age b. Genetic differences in drug metabolism (polymorphism) c. Diminished renal function d. Concomitant administration of interacting drugs e. Drug disposition in maternal and infants (pregnancy and breastmilk,"Explain the following pharmacokinetic concepts:a. First and zero order rate processes. b. Rates, rate constants, and intercepts. c. Total body clearance (CL). d. Volume of distribution (Vd).","Use knowledge related to measures of organ clearance to predict changes in blood levels when physiological 3 factors or clinical conditions are present that may affect blood flows, intrinsic clearance and transporter function.",Become proactive in including and considering concepts of therapeutic drug monitoring in practice skills.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Lecture Participation,Participation,N/A,2,,16-12-14,,"Comprehend one and two compartmental models, including the underlying reasons for the appearance of more than one compartment in a plasma concentration vs. time profile.","Use the knowledge obtained from determination of pharmacokinetic parameters to devise an individualized dosing regimen for a patient, tailored to achieve a therapeutic goal of concentration and/or effect.",Comprehend concepts related to nonlinear elimination of drug.,Recognize factors that can influence the relationship between plasma concentrations and pharmacodynamics potency of drugs,Recognize the relationship between pharmacokinetics and therapeutic relevance in: a. Extremes of age b. Genetic differences in drug metabolism (polymorphism) c. Diminished renal function d. Concomitant administration of interacting drugs e. Drug disposition in maternal and infants (pregnancy and breastmilk,"Explain the following pharmacokinetic concepts:a. First and zero order rate processes. b. Rates, rate constants, and intercepts. c. Total body clearance (CL). d. Volume of distribution (Vd).","Understand the relationship between organ clearance and total body clearance, and detail the mechanisms involved in renal and hepatic drug clearance of a particular drug.","Identify the relationships between different pharmacokinetic parameters and blood fluid concentrations after drug administration by the intravenous, oral and injectable routes.",Grasp the concept of steady state and its dependency on half-life in relation to constant intravenous infusion and repeated dose administration.,"Determine CL, Vd, and other dependent pharmacokinetic parameters (half-life, maximum concentration after dosing, area under the concentration vs. time curve) from plasma concentration vs. time data.","Use knowledge related to measures of organ clearance to predict changes in blood levels when physiological 3 factors or clinical conditions are present that may affect blood flows, intrinsic clearance and transporter function.",Become proactive in including and considering concepts of therapeutic drug monitoring in practice skills.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 351 (LEC A1 Fa17),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC AL FA17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Dr. Dion Brocks,,Pharmacokinetic web-based problem assignments (15 in total),Assignment,N/A,20,,17-08-29,,"Comprehend one and two compartmental models, including the underlying reasons for the appearance of more than one compartment in a plasma concentration vs. time profile.","Use the knowledge obtained from determination of pharmacokinetic parameters to devise an individualized dosing regimen for a patient, tailored to achieve a therapeutic goal of concentration and/or effect.",Comprehend concepts related to nonlinear elimination of drug.,Recognize factors that can influence the relationship between plasma concentrations and pharmacodynamics potency of drugs,Recognize the relationship between pharmacokinetics and therapeutic relevance in: a. Extremes of age b. Genetic differences in drug metabolism (polymorphism) c. Diminished renal function d. Concomitant administration of interacting drugs e. Drug disposition in maternal and infants (pregnancy and breastmilk,"Explain the following pharmacokinetic concepts:a. First and zero order rate processes. b. Rates, rate constants, and intercepts. c. Total body clearance (CL). d. Volume of distribution (Vd).","Understand the relationship between organ clearance and total body clearance, and detail the mechanisms involved in renal and hepatic drug clearance of a particular drug.","Identify the relationships between different pharmacokinetic parameters and blood fluid concentrations after drug administration by the intravenous, oral and injectable routes.",Grasp the concept of steady state and its dependency on half-life in relation to constant intravenous infusion and repeated dose administration.,"Determine CL, Vd, and other dependent pharmacokinetic parameters (half-life, maximum concentration after dosing, area under the concentration vs. time curve) from plasma concentration vs. time data.","Use knowledge related to measures of organ clearance to predict changes in blood levels when physiological 3 factors or clinical conditions are present that may affect blood flows, intrinsic clearance and transporter function.",Become proactive in including and considering concepts of therapeutic drug monitoring in practice skills.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,Midterm Exam,Exam,Multiple choice,50,,17-09-20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 467 (Fall 2017 LEC A1 SEM E1),PHARM 467 Fa17 - ONCOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Dr. Victor Samokhvalov,,Final Exam,Exam,Written and multiple choice,50,,17-10-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Finding and Evaluating Information on the Web,Assignment,N/A,0,,17-09-25,,Describe the types of information found in some common pharmacy tertiary and secondary reference sources.,Identify the functions and services offered by the health sciences library.,Use library resources and library facilities effectively to access relevant drug information. ,Identify strengths and weaknesses of the secondary and tertiary resources commonly used. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lab 3 â€“ Drug Information Queries 1,Assignment,N/A,50,,17-10-23,,Use library resources and library facilities effectively to access relevant drug information. ,"Obtain relevant background information from the client about the patient, disease, and/or drug.",Demonstrate a systematic step-wise approach to answer drug information requests.,Determine the depth of response required for any given question. ,Formulate and communicate a clear and comprehensive verbal and/or written response that is appropriate to the requester's needs.,Follow-up on drug information requests where appropriate.,Appreciate the professional responsibility to act for the benefit of the patient.Outline the pharmacists ethical obligations.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Electronic Resources Assignment,Assignment,N/A,0,,17-10-03,,Describe the types of information found in some common pharmacy tertiary and secondary reference sources.,Identify the functions and services offered by the health sciences library.,Use library resources and library facilities effectively to access relevant drug information. ,Identify strengths and weaknesses of the secondary and tertiary resources commonly used. ,Formulate and communicate a clear and comprehensive verbal and/or written response that is appropriate to the requester's needs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 304 (Fall 2017 LAB LEC SEM),PHARM 304 Fa17 - HLTH PROF DRUG INFORMATION Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Ken Cor,,Lab 3 â€“ Drug Information Queries 2,Assignment,N/A,50,,17-10-24,,Use library resources and library facilities effectively to access relevant drug information. ,"Obtain relevant background information from the client about the patient, disease, and/or drug.",Demonstrate a systematic step-wise approach to answer drug information requests.,Determine the depth of response required for any given question. ,Formulate and communicate a clear and comprehensive verbal and/or written response that is appropriate to the requester's needs.,Follow-up on drug information requests where appropriate.,Appreciate the professional responsibility to act for the benefit of the patient.Outline the pharmacists ethical obligations.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 524 (LEC 800 Fa17),"PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,Reflective Paper - Evaluation of Group Experience (40%),Essay,N/A,40,,17-12-10,,"Describe elements of group development, group dynamics, and group effectiveness.",Apply principles of program evaluation to plan and evaluate a group experience.,Present information and views effectively in written and oral presentation formats.,Apply critical thinking skills.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 524 (LEC 800 Fa17),"PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,Group Assignment - Learning Theories (40%),Group,N/A,40,,17-10-28,,"Discuss and contrast theories of learning including: behavioral, cognitive, humanist, social cognitive, constructivist, critical.","Develop education plans using principles of needs assessment, planning, development, and evaluation for diverse audiences including professionals, public, patients and groups of patients.",Present information and views effectively in written and oral presentation formats.,Facilitate professional learning.,Demonstrate collaboration in learning.,Demonstrate self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 524 (LEC 800 Fa17),"PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,Contribution to Discussions - Sessions 4-6,Participation,N/A,10,,17-08-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 524 (LEC 800 Fa17),"PHARM 524 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 1 (Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,Contribution to Discussions - Sessions 1-3,Participation,N/A,10,,17-08-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 489 (SEM A1 Fa17),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,,Tony KL Kiang,,Final Exam,Exam,Written,25,,17-07-28,,Demonstrate the ability to research and develop practical therapeutic knowledge for the management of several disease states.,"Demonstrate in-depth knowledge of a controversial topic, critical thinking skills, decision-making skills, and verbal communication skills.","Demonstrate use of a therapeutic process to identify, prioritize, and resolve actual and/or potential drug-related problems using a patient care centered approach.",Answer a focused clinical question and create a patient care plan using a systematic problem-solving approach.,"Demonstrate refinement of critical appraisal, written and oral communication skills.",Incorporate principles of evidence-based medicine into therapeutic decision making.,Demonstrate a confident and competent approach to solving patient concerns.,Utilize a seamless care approach to promote optimal patient outcomes in acute and chronic care settings.,Apply appropriate documentation skills to facilitate care throughout a variety of settings.,"Demonstrate appropriate presentation skills (i.e. content, language) through case presentations.",Demonstrate self-directed learning abilities and team skills.,Accept responsibility of keeping current with emerging therapeutic modalities.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 489 (SEM A1 Fa17),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,,Tony KL Kiang,,Patient Case Scenario Assignment,Assignment,N/A,40,,17-07-28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 489 (SEM A1 Fa17),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,,Tony KL Kiang,,Therapeutic Decision-Making Assignment,Exam,Other,15,,17-07-28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 489 (SEM A1 Fa17),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,,Tony KL Kiang,,Weekly Quizzes ,Exam,Multiple choice,10,,17-07-28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 489 (SEM A1 Fa17),PHARM 489 THERAP & PROF PRACT (SEM A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,,Tony KL Kiang,,Participation (Coordinator and Facilitator),Participation,N/A,10,,17-07-28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Midterm ,Exam,Written,30,,17-10-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Participation/Professionalism ,Participation,N/A,10,,17-08-21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Symptom Assessment Assignment ,Assignment,N/A,10,,17-11-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Physical Assessment Quizes,Quiz,Multiple choice,10,,17-08-21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 502 (Fall 2017 LAB D1 LEC A1),PHARM 502 Fa17 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Final Exam,Exam,Written and multiple choice,40,,17-12-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 300A (Fall 2017 LEC C1 SEM E1 E2),PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17,Cross Listed Courses,Masters of Science,Cheryl Cox,,Performance Review Midpoint and Final ,Other,N/A,0,,16-12-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 300A (Fall 2017 LEC C1 SEM E1 E2),PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17,Cross Listed Courses,Masters of Science,Cheryl Cox,,20 hours Deadline,Other,N/A,0,,16-12-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 300A (Fall 2017 LEC C1 SEM E1 E2),PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17,Cross Listed Courses,Masters of Science,Cheryl Cox,,25 Hour Deadline,Other,N/A,0,,16-12-08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 300A (Fall 2017 LEC C1 SEM E1 E2),PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17,Cross Listed Courses,Masters of Science,Cheryl Cox,,Assignment Presentations,Performance,N/A,0,,17-03-08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 300A (Fall 2017 LEC C1 SEM E1 E2),PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17,Cross Listed Courses,Masters of Science,Cheryl Cox,,Final Performance Review ,Other,N/A,0,,17-04-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 300A (Fall 2017 LEC C1 SEM E1 E2),PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17,Cross Listed Courses,Masters of Science,Cheryl Cox,,Small Group Meetings,Other,N/A,0,,17-07-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 300A (Fall 2017 LEC C1 SEM E1 E2),PHARM 300A Fa17 - EXPERIENTIAL LEARNING Fa17 - PART 1 Combined LEC SEM Fa17,Cross Listed Courses,Masters of Science,Cheryl Cox,,Overview Reflection Assignment ,Assignment,N/A,0,,17-07-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Midterm,Exam,Multiple choice,35,,16-09-28,,Define the types of toxins which create problems in the environment.,"Pathophysiology: Explain the events which occur in two major pathways of cell death, and in sublethal cell injury.",Be familiar with the autonomic pharmacology of the eye as an example of basic principles governing drug mechanisms.,Understand basic processes governing pharmacokinetic behaviour of drugs.,". Understand how and why drugs work in a concentration-dependent manner, and be familiar with related graphing approaches and core equations.","Pharmacology: Describe how and why drugs interact with their targets, and how this affects the functioning of tissues",Describe the types and organization of muscles.,Describe nerve conduction and neuromuscular and synaptic transmission.,Explain how the various sensory mechanisms function.,Describe action potential,Describe membrane transport.,Explain resting potential.,"Describe lysosomal function, membrane function and membrane transport.","Physiology: Describe body composition, body fluids, and fluid compartments.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 306 (LEC A1 Fa17),PHARM 306 INTRO BIOMEDICAL SCIENCE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,", BSc in Pharmacy, ",Ayman El-Kadi,,Final,Exam,Multiple choice,65,,16-10-25,,"Anatomy: Describe cell structure, cell function and tissue types","Physiology: Describe body composition, body fluids, and fluid compartments.","Describe lysosomal function, membrane function and membrane transport.",Explain resting potential.,Describe membrane transport.,Describe action potential,Explain how the various sensory mechanisms function.,Describe nerve conduction and neuromuscular and synaptic transmission.,Describe the types and organization of muscles.,"Pharmacology: Describe how and why drugs interact with their targets, and how this affects the functioning of tissues",". Understand how and why drugs work in a concentration-dependent manner, and be familiar with related graphing approaches and core equations.",Understand basic processes governing pharmacokinetic behaviour of drugs.,Be familiar with the autonomic pharmacology of the eye as an example of basic principles governing drug mechanisms.,"Pathophysiology: Explain the events which occur in two major pathways of cell death, and in sublethal cell injury.","List seven basic classes of disease based on disease mechanisms, and give examples.",Discuss the molecular and cellular events underlying the different classes of disease.,Correlate drug therapy with disease mechanisms for representative major diseases.,"Understand and use medical terminology related to disease, to a degree sufficient to understand the pathophysiology content in the subsequent blocks","Toxicology: Understand basic toxicological concepts, and the different areas of toxicology.",Define the types of toxins which create problems in the environment.,Explain the mechanism of toxicity of individual toxins which cause problems in the environment,Describe hazard identification and assessment methods,Determine dose-response assessment,Determine exposure assessment,Examine applicable Canadian and American legislation governing environmental discharge. Understand where forensic toxicology is used ,Understand toxicity and safety assessment of natural health products,,,,,,,,,,,,,,,,,,,,,PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Weekly Tasks/ Appraisals,Assignment,N/A,10,,17-06-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,EBCP Literacy Assignment,Assignment,N/A,5,,17-10-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,"""Tools for Practice"" Evidence Summary ",Assignment,N/A,25,,17-11-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Final Exam,Exam,Written and multiple choice,30,,17-12-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 501 (Fall 2017 LEC A1 SEM E1),PHARM 501 Fa17 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Midterm Exam,Exam,Written and multiple choice,30,,17-10-26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Hot Topic Assignment,Assignment,N/A,2,,16-10-16,,Be aware of recent trends in development of new drug delivery systems,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab reports,Assignment,N/A,12,,16-12-07,,Apply knowledge of sterility requirements,Explain how to maintain a clean work environment,Explain importance of quality of ingredients including bioburden,Identify risks of cross contamination in a laminar flow work bench,Explain importance of monitoring programs and training of personnel,Explain how Health Canada Guidelines (GMP and GLP) are related to the pharmacistâ€™s role in compounding.,"Gain and apply knowledge on the formulation needs and process involved for the manufacturing of solid dosage forms, controlled release products, transdermal delivery systems and aerosols in pharmaceutical industry",Perform compounding and packaging of drug products in small quantities according to legal and professional standards,"Develop skills and techniques that are important for the handling of drugs, excipients and pharmaceutical equipment and instruments.",Apply modern pharmacopeia standards and methods to assess the quality of dosage forms,"Interpret official compendia standards and specifications for pharmaceutical preparations including USP standards, International pharmacopoeias, and Professional standards.",Perform aseptic compounding techniques,Evaluate various sterilization methods,Develop standard operation procedures,Apply knowledge of a quality assurance program for sterile compounding,Evaluate risk levels,Set up an aseptic work environment and maintain the quality of the work environment,Conduct quality control of the final product,Apply appropriate parenteral technique in clinical situations.,Evaluate the stability and the shelf life of drugs under different storage conditions,Evaluate and interpret literature with respect to existing and new dosage forms as related to Pharmaceutics and Compounding procedures. ,Identify and locate sources of information needed to solve a problem related to Pharmaceutics,Critically evaluate the appropriateness and reliability of information from literature resources related to Pharmaceutics.,Synthesize information gained from various literature resources to solve problems or make recommendations related to Pharmaceutics,Demonstrate appropriate documentation practices in compounding.,Be aware of recent trends in development of new drug delivery systems,,,,,,,,,,,,,,,,,,,,,PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Final,Exam,Written and multiple choice,48,,16-11-04,,Apply knowledge of sterility requirements,Explain how to maintain a clean work environment,Explain importance of quality of ingredients including bioburden,Identify risks of cross contamination in a laminar flow work bench,Explain importance of monitoring programs and training of personnel,Explain how Health Canada Guidelines (GMP and GLP) are related to the pharmacistâ€™s role in compounding.,"Gain and apply knowledge on the formulation needs and process involved for the manufacturing of solid dosage forms, controlled release products, transdermal delivery systems and aerosols in pharmaceutical industry",Perform compounding and packaging of drug products in small quantities according to legal and professional standards,"Develop skills and techniques that are important for the handling of drugs, excipients and pharmaceutical equipment and instruments.",Apply modern pharmacopeia standards and methods to assess the quality of dosage forms,"Interpret official compendia standards and specifications for pharmaceutical preparations including USP standards, International pharmacopoeias, and Professional standards.",Perform aseptic compounding techniques,Evaluate various sterilization methods,Develop standard operation procedures,Apply knowledge of a quality assurance program for sterile compounding,Evaluate risk levels,Set up an aseptic work environment and maintain the quality of the work environment,Conduct quality control of the final product,Apply appropriate parenteral technique in clinical situations.,Evaluate the stability and the shelf life of drugs under different storage conditions,Evaluate and interpret literature with respect to existing and new dosage forms as related to Pharmaceutics and Compounding procedures. ,Identify and locate sources of information needed to solve a problem related to Pharmaceutics,Critically evaluate the appropriateness and reliability of information from literature resources related to Pharmaceutics.,Synthesize information gained from various literature resources to solve problems or make recommendations related to Pharmaceutics,Demonstrate appropriate documentation practices in compounding.,Be aware of recent trends in development of new drug delivery systems,,,,,,,,,,,,,,,,,,,,,PHARM 361 (Fall 2017 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa17 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Midterm,Exam,Written and multiple choice,38,,16-09-28,,Apply knowledge of sterility requirements,Explain how to maintain a clean work environment,Explain importance of quality of ingredients including bioburden,Identify risks of cross contamination in a laminar flow work bench,Explain importance of monitoring programs and training of personnel,Explain how Health Canada Guidelines (GMP and GLP) are related to the pharmacistâ€™s role in compounding.,"Gain and apply knowledge on the formulation needs and process involved for the manufacturing of solid dosage forms, controlled release products, transdermal delivery systems and aerosols in pharmaceutical industry",Perform compounding and packaging of drug products in small quantities according to legal and professional standards,"Develop skills and techniques that are important for the handling of drugs, excipients and pharmaceutical equipment and instruments.",Apply modern pharmacopeia standards and methods to assess the quality of dosage forms,"Interpret official compendia standards and specifications for pharmaceutical preparations including USP standards, International pharmacopoeias, and Professional standards.",Perform aseptic compounding techniques,Evaluate various sterilization methods,Develop standard operation procedures,Apply knowledge of a quality assurance program for sterile compounding,Evaluate risk levels,Set up an aseptic work environment and maintain the quality of the work environment,Conduct quality control of the final product,Apply appropriate parenteral technique in clinical situations.,Evaluate the stability and the shelf life of drugs under different storage conditions,Evaluate and interpret literature with respect to existing and new dosage forms as related to Pharmaceutics and Compounding procedures. ,Identify and locate sources of information needed to solve a problem related to Pharmaceutics,Critically evaluate the appropriateness and reliability of information from literature resources related to Pharmaceutics.,Synthesize information gained from various literature resources to solve problems or make recommendations related to Pharmaceutics,Demonstrate appropriate documentation practices in compounding.,,,,,,,,,,,,,,,,,,,,,,PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Midterm,Exam,Written and multiple choice,35,,17-10-13,,Demonstrate an awareness of the evolving practice environment of pharmacy.,Demonstrate an understanding of the concept of professionalism ,Understand the pharmacy regulatory bodies in Canada ,"Identify basic concepts, principles, and components of health care delivery and the health care system in Canada and the province of Alberta. ",Understand the role of Complementary and Alternative Medicine providers in the health care system and how pharmacists can collaborate with them to optimize patient care and safety.,Discuss the payment model within the realm of pharmacy ,Demonstrate an understanding of the concepts and principles of Health and Health Promotion.,Describe the role of health behaviour theory in pharmacy practice. ,"Describe, compare and contrast the impact of the social determinants of health",Describe the historical development of pharmacy through trends that have led to the current practice philosophy.,Integrate knowledge from various sources/activities with respect to pharmacy practice.,Appreciate the pharmacist as a member of the health care team ,"Accept that a patient's perspective of health and health behaviour may be different than your own, and may impact (positively or negatively) treatment strategies.","Demonstrate a professional image and positive attitude through behaviour, language, personal presentation and interaction with others.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Final,Exam,Written and multiple choice,40,,17-12-15,,Summarize the patient care process and how it relates to the pharmacistâ€™s role in the health care system. ,Understand the interprofessional learning pathway and roles of students in other health professions ,Describe the role of theory in health care,Apply introductory knowledge of the health care system for solving problems in practice.,Apply the patient care process to solve problems,Demonstrate appropriate writing skills at post-secondary level.,Apply theories of patient behaviours to identify methods of intervention for treatment outcomes.,Analyse your own personal health beliefs and how they impact your clinical decision making process.,Integrate knowledge from various sources/activities with respect to pharmacy practice.,Appreciate the pharmacist as a member of the health care team ,"Accept that a patient's perspective of health and health behaviour may be different than your own, and may impact (positively or negatively) treatment strategies.","Demonstrate a professional image and positive attitude through behaviour, language, personal presentation and interaction with others.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Pharmacy Organizations Quiz,Quiz,Multiple choice,10,,17-09-29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 322 (LEC A1 Fa17),PHARM 322 ROLE PHARM CDN HLTH CARE (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Chowdhury Farhana Faruquee,,Interprofessional (IP) Launch Self Reflection,Assignment,N/A,15,,17-10-05,,Appreciate the pharmacist as a member of the health care team ,"Accept that a patient's perspective of health and health behaviour may be different than your own, and may impact (positively or negatively) treatment strategies.","Demonstrate a professional image and positive attitude through behaviour, language, personal presentation and interaction with others.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 523 (Fall 2017 LEC 800 801),PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Sarah Woodworth-Giroux,,Quizzes (Lecture and Pre-case Readings),Quiz,Multiple choice,5,,17-06-26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 523 (Fall 2017 LEC 800 801),PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Sarah Woodworth-Giroux,,Midterm Examination (Case Topics 1-3),Exam,Written and multiple choice,30,,17-10-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 523 (Fall 2017 LEC 800 801),PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Sarah Woodworth-Giroux,,Pharmacokinetic/TDM Assignment,Assignment,N/A,10,,17-11-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 523 (Fall 2017 LEC 800 801),PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Sarah Woodworth-Giroux,,Tutorial Evaluation ,Performance,N/A,15,,17-06-26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 523 (Fall 2017 LEC 800 801),PHARM 523 Fa17 - ADVANCED PHARMACOTHERAPY PT 1 Combined LEC Fa17,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Sarah Woodworth-Giroux,,Final Examination,Exam,Written and multiple choice,40,,17-12-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab Reflection,Assignment,N/A,10,,17-01-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab Final,Exam,Other,35,,17-03-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,, Learning Opportunities (In-Class),Participation,N/A,10,,17-01-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 334 (Winter 2017 LEC B1 SEM J1 J2),PHARM 334 Wi17 - HLTH PROF COMM PART 2 Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Written Final,Exam,Written and multiple choice,35,,17-03-17,,Identify communication challenges associated with providing care to a patient whose first language is not English. ,Outline effective patient education skills,Describe the appropriate process for working with an interpreter in a healthcare setting. ,Define shared decision making and differentiate it from other decision making models.,Identify several strategies for effectively communicating risk,Select and integrate communication techniques to effectively communicate with other healthcare professionals.,Explain a process to manage emotional consults,Identify core principles and key skills of motivational interviewing,"Compare and contrast concordance, compliance, and adherence frameworks ",Differentiate strategies to communicate with patients with vision and hearing loss. ,Compare and contrast intentional and unintentional medication taking behaviours ,Identify supportive communication techniques to assess patients medication to assess med taking behaviours and detect barriers,Describe the elements of a medication history,Apply communication techniques for monitoring medications ,Explain the importance of stress management in professional life,Reflect on communication skills,Establish organization and flow while taking a full medication history,"Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.", Practice self-care activities to manage stress in professional life, Detect and address barriers to patients medication taking behaviors using supportive probing techniques ," Provide timely, clear responses that are tailored to the context and audience.","Demonstrate appropriate techniques for dealing with anger, conflict, and lack of trust ","Communicate effectively with people with vision, hearing loss or who are using a translator",Apply the Three Talk model to make a shared decisions,Select and integrate communication techniques to effectively communicate risk to patients,"Engage in respectful, empathetic, compassionate, non-judgmental, culturally safe, tactful conversations with patients and health team members.",Engage in effective partnerships with their patients to support positive behaviour changes,Accept responsibility for communicating professionally through both student and professional career ,Advocate for pharmacists role in monitoring medication therapy at the medication refill,Foster curiosity to understand and appreciate patients unique life experience,,,,,,,,,,,,,,,,,PHARM 504 (LEC A1 Fa17),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Contributions to eClass/Participation ,Participation,N/A,20,,17-08-21,,Discuss the role of feedback  related to preceptorship of pharmacy students.,Examine the application of learning styles in the education of professionals. ,Apply theoretical frameworks for collaboration and  groups. ,"Explore current issues on collaboration: teamwork, leadership, communication. ",Present information and views effectively in written and oral presentation formats.,Apply reflective and critical thinking skills. ,Facilitate student and professional learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 504 (LEC A1 Fa17),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Reflective Paper ,Assignment,N/A,20,,17-10-03,,Relate core beliefs about teaching and learning to educational experiences.,Discuss the role of feedback  related to preceptorship of pharmacy students.,Examine the application of learning styles in the education of professionals. ,Present information and views effectively in written and oral presentation formats.,Demonstrate appreciation for self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 504 (LEC A1 Fa17),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Final Paper,Assignment,N/A,40,,17-12-05,,Apply theoretical frameworks for collaboration and  groups. ,"Explore current issues on collaboration: teamwork, leadership, communication. ",Present information and views effectively in written and oral presentation formats.,Apply reflective and critical thinking skills. ,Demonstrate respect for diversity of views and experiences. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 504 (LEC A1 Fa17),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa17)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Education Plan ,Assignment,N/A,20,,17-10-31,,"Design, deliver, and evaluate education plans using theoretical frameworks ",Examine the application of learning styles in the education of professionals. ,"Explore current issues on collaboration: teamwork, leadership, communication. ",Present information and views effectively in written and oral presentation formats.,Facilitate student and professional learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Midterm,Exam,Multiple choice,40,,17-11-22,,Describe the specific laboratory tests and other diagnostic tests used in the diagnosis and monitoring of the conditions of primary focus.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the conditions of primary focus.",Discuss the complementary and alternative medicine used in GI diseases.,"Describe the pathophysiology of the conditions of primary focus including clinical presentations, symptomatology, and complications. ",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of primary focus,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.","Describe the mechanisms, efficacy, side effect profiles and role of each of the following drugs or drug classes: i. Antidiarrheals ii. Laxatives iii. Antinauseants iv. Antiemetics v. Antacids vi. Anti-gas vii. Antispasmodics viii. Drugs Stimulating Gastrointestinal Motility (Prokinetic Agents) ix. Proton-Pump Inhibitors x. H2 receptor antagonists xi. Mucosal protective agents Sucralfate, Prostaglandin analogs (ie misoprostil), Colloidal Bismuth Compounds xii. Antibiotics used for PUD xiii. Aminosalicylates xiv. Corticosteroids used in IBD xv. Immunosuppressants used in IBD (including azathioprine, 6-mercaptopurine, cyclosporine, methotrexate) xvi. Tumour necrosis factor â€“ alpha antagonists (infliximab, adalimumab, certolizumab, golimumab) xvii. Pharmacotherapy for complications of cirrhosis (ie diuretics, spironolactone, beta-blockers, octreotide, lactulose, and metronidazole)",Describe the societal and economic impact of the conditions of primary focus.,Identify ethical issues surrounding treatment of the conditions of primary focus,Discuss drugs that can be toxic to the liver,"Describe the treatment options for oral health such as canker sores, dry mouth, and mouth care.",Discuss the types of ostomy supplies used by patients with ostomies,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments to the conditions of primary focus, including use of specific target drugs for condition as well as complementary and alternative therapies",Discuss monitoring parameters for each of the disease of focus,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Select appropriate treatment for special groups (pediatrics, elderly, pregnancy)",Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Final,Exam,Written and multiple choice,50,,17-12-15,,Explain the anatomy of the gastrointestinal tract; describe the functions of the gastrointestinal tract.  ,Explain the anatomy of the liver; describe the functions of the liver . ,Identify applicable health system resources.,Appreciate the interdisciplinary approach to management of the condition,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Discuss monitoring parameters for each of the disease of focus,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Select appropriate treatment for special groups (pediatrics, elderly, pregnancy)",Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Seminar 2 Quiz,Quiz,Written,5,,17-06-23,,"Describe the pathophysiology of the conditions of primary focus including clinical presentations, symptomatology, and complications. ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 357 (Fall 2017 LEC A1 SEM E1 E2),PHARM 357 Fa17 - GASTROINTESTINAL Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,",to be assigned,,Seminar 1 Quiz,Quiz,Written,5,,17-06-23,,"Describe the pathophysiology of the conditions of primary focus including clinical presentations, symptomatology, and complications. ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Written Final,Exam,Multiple choice,30,,17-11-07,,Describe the impact of communication in health and health care ,Explain the importance of communication in the practice of pharmacy,Explain the link between effective communication skills and patient care ,Understand the importance of listening,Understand the meaning of a patient-centred care,Understand the impact of empathetic responding in patient-provider interactions ,"Recognize the difference between aggressive, passive, and assertive communication ",Define a medication experience,Describe the importance of a patient'sâ€™ medication experience,Describe the health care experiences of low-literacy patients,Discuss health literacy and medication ,Review techniques to improve communication with low-literacy patients,Identify different types of question asking,Discuss the link between reflection and lifelong learning ,Identify appropriate uses of social media in health care,Demonstrate effective public speaking and presentation skills,Write in a clear and concise manner using the rules of grammar and punctuation,Work effectively in groups,Offer and receive constructive feedback,Demonstrate professional communication,Critically reflect on communication in patient care,Tailor communication to specific contexts and audiences,Write data section of a clinical documentation note after a standardized patient encounter,Introduce self and identify patient,Use small talk to establish rapport,Solicit the full patient agenda ,Use appropriate question style,Use active listening skills to explore the patient experience and concerns,Gather sufficient information to evaluate medication appropriateness,"Identify and name patient feelings (i.e., empathetic responding) ",Demonstrate effective non-verbal communication skills,Establish flow and organization in a patient encounter,Display confidence in a patient encounter,,,,,,,,,,,,,,PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,In-Class Learning Opportunities,Quiz,Multiple choice,5,,17-09-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lab grades,Participation,N/A,0,,17-09-01,,Describe the impact of communication in health and health care ,Explain the importance of communication in the practice of pharmacy,Explain the link between effective communication skills and patient care ,Understand the importance of listening,Understand the meaning of a patient-centred care,Understand the impact of empathetic responding in patient-provider interactions ,"Recognize the difference between aggressive, passive, and assertive communication ",Define a medication experience,Describe the importance of a patient'sâ€™ medication experience,Describe the health care experiences of low-literacy patients,Discuss health literacy and medication ,Review techniques to improve communication with low-literacy patients,Identify different types of question asking,Discuss the link between reflection and lifelong learning ,Identify appropriate uses of social media in health care,Demonstrate effective public speaking and presentation skills,Write in a clear and concise manner using the rules of grammar and punctuation,Work effectively in groups,Offer and receive constructive feedback,Demonstrate professional communication,Critically reflect on communication in patient care,Tailor communication to specific contexts and audiences,Write data section of a clinical documentation note after a standardized patient encounter,Introduce self and identify patient,Use small talk to establish rapport,Solicit the full patient agenda ,Use appropriate question style,Use active listening skills to explore the patient experience and concerns,Gather sufficient information to evaluate medication appropriateness,"Identify and name patient feelings (i.e., empathetic responding) ",Demonstrate effective non-verbal communication skills,Establish flow and organization in a patient encounter,Display confidence in a patient encounter,Appreciate the patientâ€™s experience and perspective in health care ,Accept responsibility for communicating professionally through both student and professional career ,Value reflection and its role in lifelong learning,,,,,,,,,,,PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Reflection,Assignment,N/A,15,,17-09-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Lab Final,Performance,N/A,50,,17-11-01,,Describe the impact of communication in health and health care ,Explain the importance of communication in the practice of pharmacy,Explain the link between effective communication skills and patient care ,Understand the importance of listening,Understand the meaning of a patient-centred care,Understand the impact of empathetic responding in patient-provider interactions ,"Recognize the difference between aggressive, passive, and assertive communication ",Define a medication experience,Describe the importance of a patient'sâ€™ medication experience,Describe the health care experiences of low-literacy patients,Discuss health literacy and medication ,Review techniques to improve communication with low-literacy patients,Identify different types of question asking,Discuss the link between reflection and lifelong learning ,Identify appropriate uses of social media in health care,Demonstrate effective public speaking and presentation skills,Write in a clear and concise manner using the rules of grammar and punctuation,Work effectively in groups,Offer and receive constructive feedback,Demonstrate professional communication,Critically reflect on communication in patient care,Tailor communication to specific contexts and audiences,Write data section of a clinical documentation note after a standardized patient encounter,Introduce self and identify patient,Use small talk to establish rapport,Solicit the full patient agenda ,Use appropriate question style,Use active listening skills to explore the patient experience and concerns,Gather sufficient information to evaluate medication appropriateness,"Identify and name patient feelings (i.e., empathetic responding) ",Demonstrate effective non-verbal communication skills,Establish flow and organization in a patient encounter,Display confidence in a patient encounter,,,,,,,,,,,,,,PHARM 314 (Fall 2017 LAB LEC SEM),PHARM 314 Fa17 - HLTH PROF-COMMUNICATION I Combined LAB LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Chowdhury Farhana Faruquee,,Pharmacy Speechcraft by Toastmasters,Participation,N/A,0,,17-09-01,,Demonstrate effective public speaking and presentation skills,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Midterm Exam,Exam,Other,25,,17-12-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Final Exam,Exam,Other,35,,18-04-23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Professionalism,Participation,N/A,5,,17-09-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Semester 2,Assignment,N/A,10,,17-09-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Integrated Cases (2),Assignment,N/A,15,,17-09-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 430A (Fall 2017 LAB LEC),PHARM 430A Fa17 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year","Candace Necyk, Teri Charrois, Gillian Johnson",,Semester 1,Assignment,N/A,10,,17-09-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,7 Specified online exercises,Other,N/A,8,,17-08-22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Midterm,Exam,Written and multiple choice,25,,17-09-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,7 Quizzes ,Quiz,Multiple choice,19,,17-08-22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Assignment #2: Case reflection and learning application,Assignment,N/A,2,,17-09-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Final,Exam,Written and multiple choice,45,,17-10-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 487 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 487 Fa17 - PULMONARY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Assignment #1: Case Submission and question,Assignment,N/A,1,,17-09-05,,"Develop a caring, empathetic attitude for patients experiencing the conditions covered.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,"Semester 2 Labs 5,6,7,8,9,10",Assignment,N/A,12,,17-09-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,FINAL,Exam,Other,35,,18-04-25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Professionalism ,Participation,N/A,5,,17-09-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,Integrated Cases,Assignment,N/A,15,,17-09-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,"Semester 1: Labs 1,2,3,4",Assignment,N/A,8,,17-09-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 330A (Fall 2017 LAB D1 D2 LEC C1),PHARM 330A Fa17 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa17,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 2nd year","Renette Bertholet, Theresa Charrois, Gillian Johnson",,MIDTERM,Exam,Other,25,,17-12-21,,Describe the principles of shared decision making (SDM) ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Seminar Assessments/Activities,Quiz,Multiple choice,15,,17-10-23,,"Outline the epidemiology, etiology and pathophysiology of the mental health conditions covered.","Describe the risk factors, clinical presentation, and assessment parameters (signs and symptoms, laboratory values/tests, physical findings and diagnostic measurements) of the conditions covered.","Explain the mechanism of action, pharmacokinetic principles, clinical effect(s), and adverse effects and drug interactions for the medication classes covered.","Describe the therapeutic approach to managing the conditions covered, including: guideline recommendations and clinical targets, pharmacological (dose, duration of therapy, monitoring parameters), non-pharmacological treatments, and CAM.",Describe the role of therapeutic drug monitoring for selected medications in the provision of patient care.,Outline the economic and health policy issues as they relate to mental health conditions.,Identify ethical issues in the management of mental health conditions.,"Conduct a patient assessment using relevant data from the patient history, review of systems, laboratory tests, diagnostic imaging and medication history in order to provide patient care.",Identify and locate sources of information needed to provide patient care.,"Develop a therapeutic and monitoring plan, taking into consideration patient factors, efficacy, toxicity, cost, route of administration, etc."," Apply principles of therapeutic drug monitoring to deliver patient care, taking into consideration health system and economic factors.",Manage clinically significant drug interactions with drugs used to treat the psychiatric conditions covered.,Utilize an evidence based approach to therapeutic management of the psychiatric conditions covered.,Evaluate and apply information from literature and other resources to provide patient care.,Utilize independent and collaborative approaches to learning.,"Develop a caring, empathic attitude for patients experiencing the conditions covered.",Develop an appreciation of the interdisciplinary nature of patient care.,Develop lifelong learning skills that will enable maintenance of competence through keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Midterm Exam,Exam,Written and multiple choice,40,,17-11-27,,"Outline the epidemiology, etiology and pathophysiology of the mental health conditions covered.","Describe the risk factors, clinical presentation, and assessment parameters (signs and symptoms, laboratory values/tests, physical findings and diagnostic measurements) of the conditions covered.","Explain the mechanism of action, pharmacokinetic principles, clinical effect(s), and adverse effects and drug interactions for the medication classes covered.","Describe the therapeutic approach to managing the conditions covered, including: guideline recommendations and clinical targets, pharmacological (dose, duration of therapy, monitoring parameters), non-pharmacological treatments, and CAM.",Describe the role of therapeutic drug monitoring for selected medications in the provision of patient care.,Outline the economic and health policy issues as they relate to mental health conditions.,Identify ethical issues in the management of mental health conditions.,"Conduct a patient assessment using relevant data from the patient history, review of systems, laboratory tests, diagnostic imaging and medication history in order to provide patient care.",Identify and locate sources of information needed to provide patient care.,"Develop a therapeutic and monitoring plan, taking into consideration patient factors, efficacy, toxicity, cost, route of administration, etc."," Apply principles of therapeutic drug monitoring to deliver patient care, taking into consideration health system and economic factors.",Manage clinically significant drug interactions with drugs used to treat the psychiatric conditions covered.,Utilize an evidence based approach to therapeutic management of the psychiatric conditions covered.,Evaluate and apply information from literature and other resources to provide patient care.,Utilize independent and collaborative approaches to learning.,"Develop a caring, empathic attitude for patients experiencing the conditions covered.",Develop an appreciation of the interdisciplinary nature of patient care.,Develop lifelong learning skills that will enable maintenance of competence through keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 447 (Fall 2017 LEC A1 A2 SEM E1 E2),PHARM 447 Fa17 - PSYCHIATRY Combined LEC SEM Fa17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Final Exam,Exam,Written and multiple choice,45,,17-12-13,,"Outline the epidemiology, etiology and pathophysiology of the mental health conditions covered.","Describe the risk factors, clinical presentation, and assessment parameters (signs and symptoms, laboratory values/tests, physical findings and diagnostic measurements) of the conditions covered.","Explain the mechanism of action, pharmacokinetic principles, clinical effect(s), and adverse effects and drug interactions for the medication classes covered.","Describe the therapeutic approach to managing the conditions covered, including: guideline recommendations and clinical targets, pharmacological (dose, duration of therapy, monitoring parameters), non-pharmacological treatments, and CAM.",Describe the role of therapeutic drug monitoring for selected medications in the provision of patient care.,Outline the economic and health policy issues as they relate to mental health conditions.,Identify ethical issues in the management of mental health conditions.,"Conduct a patient assessment using relevant data from the patient history, review of systems, laboratory tests, diagnostic imaging and medication history in order to provide patient care.",Identify and locate sources of information needed to provide patient care.,"Develop a therapeutic and monitoring plan, taking into consideration patient factors, efficacy, toxicity, cost, route of administration, etc."," Apply principles of therapeutic drug monitoring to deliver patient care, taking into consideration health system and economic factors.",Manage clinically significant drug interactions with drugs used to treat the psychiatric conditions covered.,Utilize an evidence based approach to therapeutic management of the psychiatric conditions covered.,Evaluate and apply information from literature and other resources to provide patient care.,Utilize independent and collaborative approaches to learning.,"Develop a caring, empathic attitude for patients experiencing the conditions covered.",Develop an appreciation of the interdisciplinary nature of patient care.,Develop lifelong learning skills that will enable maintenance of competence through keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 347 (Fall 2017 LEC A1 SEM E1),PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Final ,Exam,Written and multiple choice,65,,17-12-13,,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the anatomy of blood supply and the lymphatic system of the human.,"Discuss the physiology of the blood supply and lymphatic system including the composition and properties of blood, blood groups and selected functions of blood.","Describe the pathophysiology of the conditions of primary focus, including clinical presentation and symptomatology and long term health consequences.",Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)","Describe the mechanisms, efficacy, side effect profiles and role of each of the following drugs or drug classes: i. Anticoagulants ii. Antiplatelets iii. Fibrinolytics iv. Antifibrinolytics v. Stimulating Factors vi. Iron products",Identify ethical issues surrounding treatment of the conditions of primary focus.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Apply concepts and knowledge of pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of primary focus.,Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of primary focus.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).","Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring",Utilize an evidence based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems,Critically evaluate the appropriateness and reliability of information from literature resources,Utilize self-directed learning abilities,"Develop a caring, empathic attitude for patients experiencing anemia and thrombosis.",Accept responsibility for keeping abreast of emerging technologies and drugs,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 347 (Fall 2017 LEC A1 SEM E1),PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Midterm,Exam,Multiple choice,30,,17-11-02,,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the anatomy of blood supply and the lymphatic system of the human.,"Discuss the physiology of the blood supply and lymphatic system including the composition and properties of blood, blood groups and selected functions of blood.","Describe the pathophysiology of the conditions of primary focus, including clinical presentation and symptomatology and long term health consequences.",Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)","Describe the mechanisms, efficacy, side effect profiles and role of each of the following drugs or drug classes: i. Anticoagulants ii. Antiplatelets iii. Fibrinolytics iv. Antifibrinolytics v. Stimulating Factors vi. Iron products",Identify ethical issues surrounding treatment of the conditions of primary focus.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Apply concepts and knowledge of pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of primary focus.,Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of primary focus.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).","Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring",Utilize an evidence based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems,Critically evaluate the appropriateness and reliability of information from literature resources,Utilize self-directed learning abilities,"Develop a caring, empathic attitude for patients experiencing anemia and thrombosis.",Accept responsibility for keeping abreast of emerging technologies and drugs,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 347 (Fall 2017 LEC A1 SEM E1),PHARM 347 Fa17 - HEMATOLOGY Combined LEC SEM Fa17,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Seminar Quiz,Quiz,Multiple choice,5,,17-12-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Peer Performance Evaluation (Final),Participation,N/A,2,,17-12-04,,"Apply best practices in staff selection, training, development and evaluation.",Help maintain a healthy work environment and assist with conflict management.,Develop a willingness to accept leadership roles where appropriate.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Midterm,Exam,Written and multiple choice,25,,17-10-16,,"Clarify roles, responsibilities and expertise of team members, identifying overlaps and gaps.",Apply regulatory and profession best practices to manage the distribution of medications in a variety of practice settings.,"Evaluate factors critical to safe and efficient medication distribution systems including pharmacy layout, workflow, technology and automation.","Apply best practices in staff selection, training, development and evaluation.",Critique the impact of funding and payment policies on the provision of professional services.,Describe strategic planning principles.,Describe marketing principles in the context of supply and demand for professional services.,Utilize inventory control concepts to maintain an inventory control system.,Help maintain a healthy work environment and assist with conflict management.,"Contribute to planning, organizing and performing of work to be done, and integrating evidence while evaluating the results.","Set priorities and manage their time to balance patient care, workflow and practice requirements.",Adapt their practice to fulfill evolving professional roles.,"Anticipate, recognize and manage human, environmental and medication distribution situations that place patients at risk.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #3,Quiz,Written and multiple choice,1,,17-09-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #4,Quiz,Written and multiple choice,1,,17-09-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #5,Quiz,Written and multiple choice,1,,17-09-25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #6,Quiz,Written and multiple choice,1,,17-10-02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #7,Quiz,Written and multiple choice,1,,17-10-23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #8,Quiz,Written and multiple choice,1,,17-11-20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #1,Quiz,Written and multiple choice,1,,17-09-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #2,Quiz,Written and multiple choice,1,,17-09-11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #9,Quiz,Written and multiple choice,1,,17-11-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #10,Quiz,Written and multiple choice,1,,17-12-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Business Plan Presentation â€“ Student Evaluation (Group Mark),Group,N/A,5,,17-11-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Business Plan Presentation â€“ Instructor / Guest Panel Evaluation (Group Mark),Group,N/A,10,,17-10-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Peer Performance Evaluation (Midpoint),Participation,N/A,2,,17-10-02,,"Apply best practices in staff selection, training, development and evaluation.",Help maintain a healthy work environment and assist with conflict management.,Develop a willingness to accept leadership roles where appropriate.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Business Plan Written Report (Group Mark),Assignment,N/A,10,,17-11-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa17),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Final,Exam,Written and multiple choice,35,,17-12-11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Final,Exam,Multiple choice,60,NA,17-12-14,,"Compare and contrast the immune responses witnessed in situations of infection, allergy & hypersensitivity, and autoimmune disease",Distinguish between active and passive immunity,Distinguish between humoral and cell mediated immune effector mechanisms,Distinguish between the Innate and Adaptive arms of the immune system,Describe the elements of the human immune system,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 321 (LEC A1 Fa17),PHARM 321 PHARM BIOTECHNOLOGY/IMMUN (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Michael R. Doschak,,Midterm,Exam,Multiple choice,40,NA,17-11-04,,"Describe how antisense therapy, gene therapy and stem cell therapy work",Appreciate the range of drug delivery systems currently employed to administer biotechnology-based pharmaceuticals,Understand and demonstrate how recombinant DNA technology is used in the manufacture of biotechnology-based pharmaceuticals,"Describe the four major classes of biotechnology-based pharmaceuticals (peptides, blood products, vaccines, therapeutic proteins [including monoclonal antibodies])",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 362 (LEC A1 Fa17),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Group Writing Assignment,Assignment,N/A,30,NA,16-12-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 362 (LEC A1 Fa17),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Midterm,Exam,Multiple choice,30,NA,17-11-21,,Be sensitive to ethical/legal issues that arise in contemporary pharmacy practice.,"Accept possible differences between personal values, morals and rights versus professional obligations and ethics.",Demonstrate caring and respect for others.,Accept the professional responsibility to act for the benefit of the patient.,"Demonstrate ability to distinguish an ethical problem from a legal one, and to identify points of intersection, divergence or confrontation.",Apply actions that a pharmacist can take to avoid ethical breaches and professional discipline,"Utilize the problem-solving method (e.g. identify the problem, identify possible alternatives, evaluate the alternatives, choose the best course of action, and defend the action) to integrate ethical and legal principles, and professionalism into pharmacy practice.","Analyze an ethical or legal issue by determining principles involved, clarifying facts, prioritizing principles, assessing alternatives, determining duty and justifying decisions.","Apply actions that a pharmacist can take in order to avoid legal liability (e.g. avoiding medication errors, proper documentation, etc.).","Argue both sides of an ethical or legal issue using ethical and legal principles derived from statutes, case law, bioethics literature and the Alberta College of Pharmacists Code of Ethics",Apply legal and ethical principles to issues that may occur in practice.,"Demonstrate awareness of the demands of professional, ethical and legal responsibility.",Participate in debating a legal/ethical issue with oneâ€™s peers,Describe the course of action taken by the Alberta College of Pharmacists on the issue of substance abuse by pharmacists.,Explain the process of disciplinary action by the Alberta College of Pharmacists.,Describe the court system in the Province of Alberta.,Outline the pharmacists ethical obligations.,"Define and explain the following ethical concepts: beneficence, nonmaleficence, autonomy, and informed consent.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 362 (LEC A1 Fa17),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa17),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Final,Exam,Multiple choice,40,NA,16-12-09,,Be sensitive to ethical/legal issues that arise in contemporary pharmacy practice.,"Accept possible differences between personal values, morals and rights versus professional obligations and ethics.",Demonstrate caring and respect for others.,Accept the professional responsibility to act for the benefit of the patient.,"Demonstrate ability to distinguish an ethical problem from a legal one, and to identify points of intersection, divergence or confrontation.",Apply actions that a pharmacist can take to avoid ethical breaches and professional discipline,"Utilize the problem-solving method (e.g. identify the problem, identify possible alternatives, evaluate the alternatives, choose the best course of action, and defend the action) to integrate ethical and legal principles, and professionalism into pharmacy practice.","Analyze an ethical or legal issue by determining principles involved, clarifying facts, prioritizing principles, assessing alternatives, determining duty and justifying decisions.","Apply actions that a pharmacist can take in order to avoid legal liability (e.g. avoiding medication errors, proper documentation, etc.).","Argue both sides of an ethical or legal issue using ethical and legal principles derived from statutes, case law, bioethics literature and the Alberta College of Pharmacists Code of Ethics",Apply legal and ethical principles to issues that may occur in practice.,"Demonstrate awareness of the demands of professional, ethical and legal responsibility.",Participate in debating a legal/ethical issue with oneâ€™s peers,Define and explain the meaning and relevance of law and legal institutions.,Describe notable events in the history of medical ethics as relates to the pharmacy profession.,Describe the course of action taken by the Alberta College of Pharmacists on the issue of substance abuse by pharmacists.,Explain the process of disciplinary action by the Alberta College of Pharmacists.,Describe the legal and professional rules governing medical aid in dying.,Describe the unique health care issues faced by the Aboriginal Peoples of Canada.,Explain the legal implications of a personal directives and enduring powers of attorney.,Explain the legal requirements for privacy and confidentiality of health information under the Alberta Health Information Act.,Describe ways that a pharmacist can avoid being sued for negligence.,Explain how compensation for a negligence lawsuit is determined.,Describe the defenses to a negligence or malpractice lawsuit.,Explain the elements of negligence.,"Describe the types of legal actions: Criminal prosecution, civil actions and professional discipline",,,,,,,,,,,,,,,,,,,,,PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Electronic Resources Assignment,Assignment,N/A,0,,17-10-03,,Formulate and communicate a clear and comprehensive verbal and/or written response that is appropriate to the requester's needs.,Identify strengths and weaknesses of the secondary and tertiary resources commonly used. ,Use library resources and library facilities effectively to access relevant drug information. ,Identify the functions and services offered by the health sciences library.,Describe the types of information found in some common pharmacy tertiary and secondary reference sources.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Finding and Evaluating Information on the Web,Assignment,N/A,0,,17-09-25,,Identify strengths and weaknesses of the secondary and tertiary resources commonly used. ,Use library resources and library facilities effectively to access relevant drug information. ,Identify the functions and services offered by the health sciences library.,Describe the types of information found in some common pharmacy tertiary and secondary reference sources.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Lab 3 â€“ Drug Information Queries 2,Assignment,N/A,50,,17-10-24,,Appreciate the professional responsibility to act for the benefit of the patient.Outline the pharmacists ethical obligations.,Follow-up on drug information requests where appropriate.,Formulate and communicate a clear and comprehensive verbal and/or written response that is appropriate to the requester's needs.,Determine the depth of response required for any given question. ,Demonstrate a systematic step-wise approach to answer drug information requests.,"Obtain relevant background information from the client about the patient, disease, and/or drug.",Use library resources and library facilities effectively to access relevant drug information. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 304 (LEC A2 Fa17),PHARM 304 - DRUG INFORMATION (Fall 2017),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Ken Cor,,Lab 3 â€“ Drug Information Queries 1,Assignment,N/A,50,,17-10-23,,Appreciate the professional responsibility to act for the benefit of the patient.Outline the pharmacists ethical obligations.,Follow-up on drug information requests where appropriate.,Formulate and communicate a clear and comprehensive verbal and/or written response that is appropriate to the requester's needs.,Determine the depth of response required for any given question. ,Demonstrate a systematic step-wise approach to answer drug information requests.,"Obtain relevant background information from the client about the patient, disease, and/or drug.",Use library resources and library facilities effectively to access relevant drug information. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,In-Class Quiz,Quiz,Multiple choice,5,,17-02-10,,Describe the inherent limitations of the drug approval process and pre-marketing clinical trials with regard to assessment of drug safety and effectiveness.,Recognize the difference between type I and type II errors.,Define power and other factors that can influence sample size when trying to detect a difference in risk.,Describe the role of observational studies and randomized controlled trials to support evidence based clinical decisions about safety.,Identify the advantages and limitations of each pharmacoepidemiologic study design. Examples of different studies will be used to illustrate these elements.,Interpret different measures of association reported in pharmacoepidemiologic studies.,Define and interpret effect modification.,Define causal inference.,List Sir Bradford-Hills considerations for inferring causation from observational data.,Classify and describe common types of bias that threaten internal validity of pharmacoepidemiologic studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Midterm,Exam,Written and multiple choice,40,,17-03-08,,Describe the inherent limitations of the drug approval process and pre-marketing clinical trials with regard to assessment of drug safety and effectiveness.,Recognize the difference between type I and type II errors.,Define power and other factors that can influence sample size when trying to detect a difference in risk.,Describe the role of observational studies and randomized controlled trials to support evidence based clinical decisions about safety.,Identify the advantages and limitations of each pharmacoepidemiologic study design. Examples of different studies will be used to illustrate these elements.,Interpret different measures of association reported in pharmacoepidemiologic studies.,Define and interpret effect modification.,Define causal inference.,List Sir Bradford-Hills considerations for inferring causation from observational data.,Classify and describe common types of bias that threaten internal validity of pharmacoepidemiologic studies,Explain how specific biases may affect measures of association.,Define confounding and explain how it can affect the interpretation of an association.,Describe methods used to minimize the effects of confounding in pharmacoepidemiologic studies.,Explain why we need adverse drug reaction reporting systems and why pharmacists should contribute to this process.,Recognize the difference between type A and type B drug reactions and explain which drug reactions are the focus of pharmacoepidemiologic studies.,Explain the role of systematic reviews and meta-analyses.,Describe the major elements of a systematic review and meta-analysis.,Explain how we can use pharmacoepidemiologic studies to assess the suspected causal relationship between a drug and an adverse reaction.,"Demonstrate critical appraisal skills to assess validity, relevance, and applicability of the pharmacoepidemiologic literature.",,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Final,Exam,Written and multiple choice,40,,17-04-19,,Describe the inherent limitations of the drug approval process and pre-marketing clinical trials with regard to assessment of drug safety and effectiveness.,Recognize the difference between type I and type II errors.,Define power and other factors that can influence sample size when trying to detect a difference in risk.,Describe the role of observational studies and randomized controlled trials to support evidence based clinical decisions about safety.,Identify the advantages and limitations of each pharmacoepidemiologic study design. Examples of different studies will be used to illustrate these elements.,Interpret different measures of association reported in pharmacoepidemiologic studies.,Define and interpret effect modification.,Define causal inference.,List Sir Bradford-Hills considerations for inferring causation from observational data.,Classify and describe common types of bias that threaten internal validity of pharmacoepidemiologic studies,Explain how specific biases may affect measures of association.,Define confounding and explain how it can affect the interpretation of an association.,Describe methods used to minimize the effects of confounding in pharmacoepidemiologic studies.,Explain why we need adverse drug reaction reporting systems and why pharmacists should contribute to this process.,Recognize the difference between type A and type B drug reactions and explain which drug reactions are the focus of pharmacoepidemiologic studies.,Explain the role of systematic reviews and meta-analyses.,Describe the major elements of a systematic review and meta-analysis.,Describe the major elements of a quality improvement framework.,List common challenges and solutions when integrating research into practice settings.,Explain how the guiding ethical principles from the Tri-Council Policy Statement (TCPS) apply when conducting practice based research.,Describe the major elements of a survey.,Describe how validity of a survey is measured.,Describe the major elements of pharmacoeconomic evaluations.,Explain how we can use pharmacoepidemiologic studies to assess the suspected causal relationship between a drug and an adverse reaction.,Describe the structure-process-outcomes model for evaluating quality of health services.,Define care gap.,Define knowledge translation.,Describe the knowledge-to-action cycle.,Describe different study designs that are commonly used in pharmacy practice research. Examples will be used to illustrate the advantages and limitations of these different study designs.,Define safety signal and explain how it may be generated.,Describe the common data sources used in pharmacoepidemiologic studies. Examples will be presented to highlight the advantages and limitations of each data source.,"Describe the major elements of cross-sectional, case-control and cohort studies.","Demonstrate critical appraisal skills to assess validity, relevance, and applicability of the pharmacoepidemiologic literature.",,,,,,,,,,,,,,PHARM 392 (Winter 2017 LEC B1 SEM J1),PHARM 392 Wi17 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi17,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year",Scot H. Simpson,,Group Homework Assignment,Assignment,N/A,15,,17-03-29,,"Demonstrate critical appraisal skills to assess validity, relevance, and applicability of the pharmacoepidemiologic literature.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 505 (Spring 2017 SEM 800Summer 2017 850Winter 2017 850),PHARM 505 Wi17 Sp17 Su17 - PHARMD SEMINARS Combined SEM Wi17 Sp17 Su17,Cross Listed Courses,,to be assigned,,"Participation in Peer feedback, peer evaluation and seminar engagement (google form for peer component)",Exam,Multiple choice,10,NA,18-11-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 505 (Spring 2017 SEM 800Summer 2017 850Winter 2017 850),PHARM 505 Wi17 Sp17 Su17 - PHARMD SEMINARS Combined SEM Wi17 Sp17 Su17,Cross Listed Courses,,to be assigned,,Self-Assessment (google form),Assignment,N/A,10,NA,18-11-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 505 (Spring 2017 SEM 800Summer 2017 850Winter 2017 850),PHARM 505 Wi17 Sp17 Su17 - PHARMD SEMINARS Combined SEM Wi17 Sp17 Su17,Cross Listed Courses,,to be assigned,,Informative Seminar (live presentation),Assignment,N/A,50,NA,18-11-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 505 (Spring 2017 SEM 800Summer 2017 850Winter 2017 850),PHARM 505 Wi17 Sp17 Su17 - PHARMD SEMINARS Combined SEM Wi17 Sp17 Su17,Cross Listed Courses,,to be assigned,,Delivering Effective Presentation Assignment (e-class) ,Assignment,N/A,30,NA,17-02-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Midterm,Exam,Multiple choice,40,,18-03-28,,Explain the anatomy of the female and male reproductive systems.,Describe the physiology of the female and male reproductive systems.,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Seminar 3 Quiz,Quiz,Written,5,,18-04-04,,"Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).","Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Final,Exam,Multiple choice,50,,18-04-18,,"Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,Describe the societal and economic impact of the conditions of focus.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 499 (Winter 2018 LEC B1 SEM J1),PHARM 499 Wi18 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Seminar 1 Quiz,Quiz,Written,5,,18-03-21,,Discuss the methods of contraception available for men and women and describe the efficacy of each.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.","Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Discuss monitoring parameters for each of the condition of focus.,Utilize self-directed learning abilities.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 495 (LEC A1 Sp18),PHARM 495 LEADERSHIP HEALTHCARE DECISION (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for BScPharm Students,"Tatiana Makhinova, BSP, PhD",,Group Project Executive Summary ,Group,N/A,15,,18-05-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 495 (LEC A1 Sp18),PHARM 495 LEADERSHIP HEALTHCARE DECISION (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for BScPharm Students,"Tatiana Makhinova, BSP, PhD",,Peer evaluation,Performance,N/A,5,,18-03-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 495 (LEC A1 Sp18),PHARM 495 LEADERSHIP HEALTHCARE DECISION (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for BScPharm Students,"Tatiana Makhinova, BSP, PhD",,Pre-class activity,Assignment,N/A,10,,18-03-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 495 (LEC A1 Sp18),PHARM 495 LEADERSHIP HEALTHCARE DECISION (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for BScPharm Students,"Tatiana Makhinova, BSP, PhD",,Class participation,Participation,N/A,10,,18-03-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 495 (LEC A1 Sp18),PHARM 495 LEADERSHIP HEALTHCARE DECISION (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for BScPharm Students,"Tatiana Makhinova, BSP, PhD",,Personal Leadership Portfolio ,Portfolio,N/A,30,,18-05-21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 495 (LEC A1 Sp18),PHARM 495 LEADERSHIP HEALTHCARE DECISION (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for BScPharm Students,"Tatiana Makhinova, BSP, PhD",,In-class Presentation ,Assignment,N/A,10,,18-03-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 495 (LEC A1 Sp18),PHARM 495 LEADERSHIP HEALTHCARE DECISION (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for BScPharm Students,"Tatiana Makhinova, BSP, PhD",,Group Project Presentation ,Group,N/A,20,,18-05-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 522 (LEC 850 Wi18),PHARM 522 ADV PATIENT CARE SKILLS (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Dr. Rene Breault,,Symptom Assessment Assignment ,Assignment,N/A,15,,18-02-03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 522 (LEC 850 Wi18),PHARM 522 ADV PATIENT CARE SKILLS (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Dr. Rene Breault,,Midterm Exam,Exam,Written and multiple choice,30,,18-02-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 522 (LEC 850 Wi18),PHARM 522 ADV PATIENT CARE SKILLS (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Dr. Rene Breault,,Final Exam ,Exam,Other,45,,18-04-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 522 (LEC 850 Wi18),PHARM 522 ADV PATIENT CARE SKILLS (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Dr. Rene Breault,,Participation ,Participation,N/A,15,,18-04-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 522 (LEC 850 Wi18),PHARM 522 ADV PATIENT CARE SKILLS (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Dr. Rene Breault,,Documentation Note,Assignment,N/A,0,,18-01-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Final,Exam,Written and multiple choice,40,NA,18-03-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab Exam,Exam,Multiple choice,10,NA,18-03-20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Lab assignments average of 7 lab marks,Assignment,N/A,20,NA,18-01-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 331 (Winter 2018 LAB LEC SEM),PHARM 331 Wi18 - PHARMACEUTICS 1 Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 1st year",Raimar LÃ¶benberg/Afsaneh Lavasanifar,,Midterm,Exam,Written and multiple choice,30,NA,18-01-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi18),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #1,Quiz,Written and multiple choice,1,,18-01-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi18),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #2,Quiz,Written and multiple choice,1,,18-01-22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi18),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #3,Quiz,Written and multiple choice,1,,18-02-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi18),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #4,Quiz,Written and multiple choice,1,,18-03-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi18),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Quiz #5,Quiz,Written and multiple choice,1,,18-03-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi18),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Peer Assessment,Group,N/A,2,,17-10-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi18),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Team Debate (Group) â€“ Peer evaluation,Other,N/A,5,,17-10-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi18),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Team Debate (Group) â€“ Instructor evaluation,Assignment,N/A,8,,17-10-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi18),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Midterm Exam,Exam,Written and multiple choice,30,,18-02-26,,"Describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically, Alberta.","List the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to the delivery of health care in Canada with particular emphasis on organizations that impact the profession of pharmacy.",Describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,Identify and debate key issues and challenges facing the Canadian healthcare system.,Develop and debate solutions to some of the challenges facing the Canadian healthcare system with emphasis on how pharmacists and pharmacies can be a part of those solutions.,"Develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Albertan health systems.",Develop an appreciation of the different pharmacy service delivery models in different provincial and relevant international jurisdictions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi18),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,"BSc in Pharmacy, ",Jody Shkrobot,,Final Exam,Exam,Written and multiple choice,50,,18-04-05,,"Describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically, Alberta.","List the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to the delivery of health care in Canada with particular emphasis on organizations that impact the profession of pharmacy.",Describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,Identify and debate key issues and challenges facing the Canadian healthcare system.,Develop and debate solutions to some of the challenges facing the Canadian healthcare system with emphasis on how pharmacists and pharmacies can be a part of those solutions.,"Develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Albertan health systems.",Develop an appreciation of the different pharmacy service delivery models in different provincial and relevant international jurisdictions.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Medical Terminology Quiz #2,Quiz,Multiple choice,2,,17-11-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Midterm,Exam,Multiple choice,25,,18-03-27,,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ","Explain the anatomy of the integumentary system, eye, ear, nose and throat. ","Describe the physiology of the skin, eyes, ears, nose and throat.",Explain the physical conditions that lead to skin breakdown and wound development.,Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences.,"Describe the mechanisms, pathophysiology and clinical presentation of various drug-induced topical reactions.",Relate differences in pharmaceutical vehicles for topical or transdermal drug delivery.,Describe the specific laboratory tests used in the monitoring of isotretinoin.," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients, follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.","Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.",Refer patients to medical attention as appropriate.,"Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Medical Terminology Quiz #4,Quiz,Multiple choice,2,,17-11-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Medical Terminology Quiz #1,Quiz,Multiple choice,2,,17-11-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Medical Terminology Quiz #3,Quiz,Multiple choice,2,,17-11-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Medical Terminology Quiz #5,Quiz,Multiple choice,2,,17-11-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,"Lab # 1 Patient Care Process (Eye, Ear and Lice)",Lab,N/A,5,,17-01-12,,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ","Explain the anatomy of the integumentary system, eye, ear, nose and throat. ","Describe the physiology of the skin, eyes, ears, nose and throat."," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients, follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.","Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.",Refer patients to medical attention as appropriate.,"Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab # 2: Patient Care Process (Dermatologic Conditions),Lab,N/A,5,,17-01-12,,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ","Explain the anatomy of the integumentary system, eye, ear, nose and throat. ","Describe the physiology of the skin, eyes, ears, nose and throat.",Explain the physical conditions that lead to skin breakdown and wound development.,Describe the physiology of chronic wound healing.,Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences.,"Describe the mechanisms, pathophysiology and clinical presentation of various drug-induced topical reactions.",Relate differences in pharmaceutical vehicles for topical or transdermal drug delivery.,Describe the specific laboratory tests used in the monitoring of isotretinoin.," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients, follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.","Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.",Refer patients to medical attention as appropriate.,"Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,OTC Submission,Assignment,N/A,10,,18-04-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 307 (Winter 2018 LAB LEC SEM),"PHARM 307 Wi18 - DERMATOL/EYE,NOSE,THROAT Combined LAB LEC SEM Wi18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Final,Exam,Multiple choice,45,,17-11-01,,"Describe the epidemiology, etiology, and risk factors for the conditions of primary focus. ","Explain the anatomy of the integumentary system, eye, ear, nose and throat. ","Describe the physiology of the skin, eyes, ears, nose and throat.",Explain the physical conditions that lead to skin breakdown and wound development.,Describe the physiology of chronic wound healing.,Describe the pathophysiology of the primary focus conditions including clinical presentation and symptoms and long term health consequences.,"Describe the mechanisms, pathophysiology and clinical presentation of various drug-induced topical reactions.",Relate differences in pharmaceutical vehicles for topical or transdermal drug delivery.,Describe the specific laboratory tests used in the monitoring of isotretinoin.," Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the primary focus conditions including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe and manage the toxicity of medications used in the management of the primary focus conditions,Describe the societal and economic impact of the primary focus conditions.,Identify ethical issues surrounding treatment of the primary focus conditions,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,For the conditions described the student should:, obtain a relevant history from a patient.," review the presenting signs and symptoms of conditions relating to the skin, eyes, ears, nose and throat.", describe criteria used to make the diagnosis and to be able to relate the severity of the disease.," discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices", apply and demonstrate appropriate counseling and communication with patients, follow appropriate monitoring parameters, recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the primary focus conditions.","Design simple pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the primary focus conditions.",Identify actual and potential drug related problems relating to the primary focus conditions and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the primary focus conditions.,"Demonstrate appropriate physical assessment skills relating to acne, dry skin, eczema and psoriasis.",Refer patients to medical attention as appropriate.,"Counsel patients on the use of therapies (non-pharmacologic, Rx and OTC) in the primary focus conditions.","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring.","Recall, select and apply appropriate knowledge and skills to establish safe and effective drug use.",Utilize an evidence-based approach to therapeutic management of the primary focus conditions.,Apply an evidence-based approach to complementary medicine.,Evaluate and interpret literature with respect to existing and new dosage forms, Identify and locate sources of information needed to solve a problem , Critically evaluate the appropriateness and reliability of information from literature resources, Synthesize information gained from various literature resources to solve problems or make recommendations ,Be aware of recent trends in development of new drug delivery systems.,Utilize self-directed learning abilities to synthesize a well-researched review of a non-prescription product. ,Interpret scientific literature to make a clinical recommendation.,"Develop a caring, empathic attitude for patients experiencing the primary focus conditions.",Work effectively within the healthcare team.,Develop an appreciation of the interdisciplinary nature of patient care,Accept responsibility for keeping abreast of emerging technologies and drugs.PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Midterm,Exam,Written and multiple choice,40,,18-03-28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Seminar Quiz,Quiz,Written and multiple choice,5,,18-02-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Seminar Quiz,Quiz,Written and multiple choice,5,,18-03-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 477 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 477 Wi18 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Final,Exam,Written and multiple choice,50,,18-04-20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Pre-Seminar Quiz 1,Quiz,Written and multiple choice,5,,18-02-08,,Recognize the main structural features of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used to manage endocrine disorders.,Describe the adverse effects of drugs used to manage endocrine disorders.,"Describe the therapeutic approach, incorporating non-pharmacologic and pharmacologic treatments to the prevention and management of endocrine disorders; including use of specific target drugs (dose, route of administration, length of therapy, monitoring parameters) for each condition as well as alternative therapies.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Midterm,Exam,Written and multiple choice,40,,18-02-15,,Identify the main anatomical components of the endocrine system.,Describe the physiological effects of endocrine hormones.,"Describe the epidemiology, etiology, and risk factors of endocrine disorders.","Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Describe the specific laboratory tests used in the diagnosis and management of endocrine disorders.,Recognize the main structural features of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used to manage endocrine disorders.,Describe the adverse effects of drugs used to manage endocrine disorders.,Describe actions and adverse effects of common natural health products used to manage endocrine disorders.,"Describe the therapeutic approach, incorporating non-pharmacologic and pharmacologic treatments to the prevention and management of endocrine disorders; including use of specific target drugs (dose, route of administration, length of therapy, monitoring parameters) for each condition as well as alternative therapies.","Recognize and understand the appropriate diabetes management strategies for various activities, such as travel, exercise, and acute illness.",Identify ethical and cultural issues surrounding endocrine disorders.,Identify the pharmacist's role and the responsibility within the management of endocrine disorders.,Identify applicable health system resources for the management of endocrine disorders.,"Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus. ",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Pre-Seminar Quiz 2,Quiz,Written and multiple choice,5,,18-03-01,,"Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Recognize the main structural features of drugs used to manage endocrine disorders.,Describe the adverse effects of drugs used to manage endocrine disorders.,Describe actions and adverse effects of common natural health products used to manage endocrine disorders.,"Recognize and understand the appropriate diabetes management strategies for various activities, such as travel, exercise, and acute illness.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 497 (Winter 2018 LEC B1 SEM J1),PHARM 497 Wi18 - ENDOCRINE Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Final,Exam,Written and multiple choice,50,,18-04-16,,Identify the main anatomical components of the endocrine system.,Describe the physiological effects of endocrine hormones.,"Describe the epidemiology, etiology, and risk factors of endocrine disorders.","Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",Describe the specific laboratory tests used in the diagnosis and management of endocrine disorders.,Recognize the main structural features of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used to manage endocrine disorders.,Apply pharmacokinetic and pharmacodynamic principles to the drug treatment of endocrine disorders.,Describe the adverse effects of drugs used to manage endocrine disorders.,Describe actions and adverse effects of common natural health products used to manage endocrine disorders.,"Describe the therapeutic approach, incorporating non-pharmacologic and pharmacologic treatments to the prevention and management of endocrine disorders; including use of specific target drugs (dose, route of administration, length of therapy, monitoring parameters) for each condition as well as alternative therapies.","Recognize and understand the appropriate diabetes management strategies for various activities, such as travel, exercise, and acute illness.",Identify ethical and cultural issues surrounding endocrine disorders.,Identify the pharmacist's role and the responsibility within the management of endocrine disorders.,Identify applicable health system resources for the management of endocrine disorders.,"Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify and resolve clinically significant drug interactions.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).",Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus. ",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Final,Exam,Written and multiple choice,45,,18-04-23,,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the anatomy of the heart and great blood vessels.,"Discuss the physiology of the blood supply, lymphatic system and cardiovascular system of the human body.",Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,BP Clinic and EJournal (most complete both),Assignment,N/A,5,,17-02-02,,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Midterm,Exam,Written and multiple choice,35,,18-02-14,,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the anatomy of the heart and great blood vessels.,"Discuss the physiology of the blood supply, lymphatic system and cardiovascular system of the human body.",Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,PHARM 367 (Winter 2018 LEC B1 B2 SEM J1 J2),PHARM 367 Wi18 - CARDIOLOGY Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Seubert,,Seminars,Participation,N/A,15,,17-01-18,,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Explain the anatomy of the heart and great blood vessels.,"Discuss the physiology of the blood supply, lymphatic system and cardiovascular system of the human body.",Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction","Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe how to manage the toxicity of cardiac medications,Describe the societal and economic impact of the conditions of primary focus,Identify ethical issues surrounding treatment of the conditions of primary focus,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify applicable health system resources,Obtain a relevant history from a patient,Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Apply and demonstrate appropriate counseling and communication with patients,Follow appropriate monitoring parameters,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug related problems.,Critically evaluate the appropriateness and reliability of information from literature resources.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Develop and practice skills for measuring blood pressure and heart rate.,Utilize self-directed learning abilities.,Work effectively in a healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,Tutorial Evaluation - Summative Assessment,Participation,N/A,7,,18-04-22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,Pharmacogenomic/Drug Interaction Assignment,Assignment,N/A,10,,18-01-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,Quiz for Case Topic 1,Quiz,Multiple choice,0,,18-01-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,Quiz for Case Topic 2,Exam,Multiple choice,0,,18-01-21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,Quiz for Case Topic 3,Quiz,Multiple choice,0,,18-02-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,Tutorial Evaluation- Formative,Participation,N/A,7,,18-02-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,Quiz for Case Topic 4,Quiz,Multiple choice,0,,18-02-24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,Midterm ,Exam,Written and multiple choice,30,,18-02-28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,Quiz for Case Topic 5,Quiz,Multiple choice,0,,18-03-11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,Quiz for Case Topic 6,Exam,Multiple choice,0,,18-03-25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,Quiz for Case Topic 7,Exam,Multiple choice,0,,18-04-08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 533 (LEC 850 Wi18),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie McLeod BSP, ACPR, PharmD, BCPP",,Final Exam,Exam,Written and multiple choice,40,,18-04-25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 377 (Winter 2018 LEC B1 SEM J1),PHARM 377 Wi18 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time), 2nd year",Patrick Mayo,,Midterm,Exam,Multiple choice,40,,18-03-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 377 (Winter 2018 LEC B1 SEM J1),PHARM 377 Wi18 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time), 2nd year",Patrick Mayo,,Final Exam,Exam,Multiple choice,60,,18-04-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 544 (Spring 2018 LAB 801 LEC 800),"PHARM 544  - FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE- PART 3 (Sp18)",Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,Participation,Participation,N/A,10,,18-04-30,,Facilitate professional learning. ,Demonstrate respect for diversity of views and experiences. ,Demonstrate collaboration in learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 544 (Spring 2018 LAB 801 LEC 800),"PHARM 544  - FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE- PART 3 (Sp18)",Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,Teaching Assignment,Group,N/A,50,,18-05-11,,"Develop education plans using principles of needs assessment, planning, development, and evaluation for diverse audiences, including professionals, public, patients, and groups of patients.",Present information and views effectively in written and oral presentation formats. ,Facilitate professional learning. ,Demonstrate respect for diversity of views and experiences. ,Demonstrate self-directed and life-long learning. ,Demonstrate collaboration in learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 544 (Spring 2018 LAB 801 LEC 800),"PHARM 544  - FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE- PART 3 (Sp18)",Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd ",,Final Reflective Paper,Essay,N/A,40,,18-05-27,,Relate core beliefs about teaching and learning to educational experiences.,Discuss topics related to the preceptorship of pharmacy students.,Critically examine issues in professional and workplace learning.,Present information and views effectively in written and oral presentation formats. ,Apply critical thinking skills. ,Demonstrate self-directed and life-long learning. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Midterm ,Exam,Written,35,,18-10-26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Physical Assessment Quizes,Quiz,Multiple choice,10,,18-08-23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Final Exam,Exam,Written and multiple choice,35,,18-12-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Participation/Professionalism ,Participation,N/A,10,,18-08-23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 502 (Fall 2018 LAB D1 LEC A1),PHARM 502 Fa18 - ADV PATIENT CARE SKILLS HLTH Combined LAB LEC Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Dr. Rene Breault,,Symptom Assessment Assignment ,Assignment,N/A,10,,18-08-23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 534 (LEC 850 Wi18),"PHARM 534 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 2 (Wi18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd",,Case Study Facilitation,Group,N/A,40,,18-01-06,,"Explore current issues and research on interprofessional teams: teamwork, leadership, and communication.",Critically examine issues in professional and workplace learning.,Demonstrate collaboration in learning.,Facilitate professional learning.,Apply critical thinking skills.,Present information and views effectively in written and oral presentation formats.,Demonstrate self-directed and life-long learning.,Demonstrate respect for diversity of views and experiences.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 534 (LEC 850 Wi18),"PHARM 534 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 2 (Wi18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd",,Contribution to Discussions and Learning Activities,Participation,N/A,20,,18-01-06,,"Explore current issues and research on interprofessional teams: teamwork, leadership, and communication.",Critically examine issues in professional and workplace learning.,Demonstrate collaboration in learning.,Facilitate professional learning.,Apply critical thinking skills.,Present information and views effectively in written and oral presentation formats.,Demonstrate self-directed and life-long learning.,Demonstrate respect for diversity of views and experiences.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 534 (LEC 850 Wi18),"PHARM 534 FRAMEWORKS FOR TEAMS, COLLABORATION AND EDUCATION IN PHARMACY PRACTICE - PART 2 (Wi18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),"Melanie Danilak, BSc. Pharm, ACPR, MEd",,Final Reflective Paper,Essay,N/A,40,,18-04-03,,"Explore current issues and research on interprofessional teams: teamwork, leadership, and communication.",Apply critical thinking skills.,Present information and views effectively in written and oral presentation formats.,Demonstrate self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 547 (Summer 2018 LEC B1 SEM J1),PHARM 547 Su18 - ADVANCED THERAPEUTICS Combined LEC SEM Su18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for BScPharm Students,Rene Breault,,Documentation Notes (group) ,Group,N/A,10,,18-04-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 547 (Summer 2018 LEC B1 SEM J1),PHARM 547 Su18 - ADVANCED THERAPEUTICS Combined LEC SEM Su18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for BScPharm Students,Rene Breault,,Team readiness assessment test (tRAT) (group),Quiz,Multiple choice,10,,18-04-09,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 547 (Summer 2018 LEC B1 SEM J1),PHARM 547 Su18 - ADVANCED THERAPEUTICS Combined LEC SEM Su18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for BScPharm Students,Rene Breault,,Submission of Appropriate Key Learning Issues on Google Forms (individual),Participation,N/A,1,,18-04-09,,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 547 (Summer 2018 LEC B1 SEM J1),PHARM 547 Su18 - ADVANCED THERAPEUTICS Combined LEC SEM Su18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for BScPharm Students,Rene Breault,,Collaboration & Professional Learning Reflections (individual),Assignment,N/A,8,,18-04-09,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 547 (Summer 2018 LEC B1 SEM J1),PHARM 547 Su18 - ADVANCED THERAPEUTICS Combined LEC SEM Su18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for BScPharm Students,Rene Breault,,Final Exam,Exam,Multiple choice,30,,18-04-09,,Demonstrate professional attitude and behaviour consistently and work collaboratively with other team members to optimize patients pharmacotherapy outcomes. ,Demonstrate respect for diversity of views and experiences.,Embrace self-directed and life-long learning.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 547 (Summer 2018 LEC B1 SEM J1),PHARM 547 Su18 - ADVANCED THERAPEUTICS Combined LEC SEM Su18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for BScPharm Students,Rene Breault,,TDM Assignment (individual),Assignment,N/A,1,,18-07-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 547 (Summer 2018 LEC B1 SEM J1),PHARM 547 Su18 - ADVANCED THERAPEUTICS Combined LEC SEM Su18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for BScPharm Students,Rene Breault,,Individual Readiness Assessment Test (iRAT),Quiz,Multiple choice,14,,18-04-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 547 (Summer 2018 LEC B1 SEM J1),PHARM 547 Su18 - ADVANCED THERAPEUTICS Combined LEC SEM Su18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for BScPharm Students,Rene Breault,,Tutorial Evaluation - Peer Assessment,Assignment,N/A,10,,18-04-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 547 (Summer 2018 LEC B1 SEM J1),PHARM 547 Su18 - ADVANCED THERAPEUTICS Combined LEC SEM Su18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for BScPharm Students,Rene Breault,,Care Plans (group),Group,N/A,15,,18-04-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab 4,Lab,N/A,5,,18-01-04,,"For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.",Identify legal requirements when accepting/receiving written & verbal prescriptions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products and practicing within the professions scope.,"Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Identify the basic process requirements in utilizing the Patient Care Process:,a. Construct a patient care database,b. Identify the drug related problem,c. Manage a patient care profile electronically,Identify and document potential medication prescribing errors in written and verbal prescriptions.,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Apply concepts of third party billing and prescription pricing in the drug use process. ,Recognize issues surrounding drug diversion and security.,Demonstrate an introductory level of adverse drug reporting and management.,Relate the concepts of the culture of patient safety to the drug use process.,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Document search process for drug information questions, citing references used.",Communicate effectively when having a dialogue with a simulated patient and other health care practitioners,Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.","Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Midterm,Exam,Written and multiple choice,25,,18-02-12,,"For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.",Identify legal requirements when accepting/receiving written & verbal prescriptions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products and practicing within the professions scope.,"Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Identify the basic process requirements in utilizing the Patient Care Process:,a. Construct a patient care database,b. Identify the drug related problem,c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Document search process for drug information questions, citing references used.",Communicate effectively when having a dialogue with a simulated patient and other health care practitioners,Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.","Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Final,Exam,Written and multiple choice,45,,18-03-13,,"For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.",Identify legal requirements when accepting/receiving written & verbal prescriptions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products and practicing within the professions scope.,"Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Identify the basic process requirements in utilizing the Patient Care Process:,a. Construct a patient care database,b. Identify the drug related problem,c. Manage a patient care profile electronically,Identify and document potential medication prescribing errors in written and verbal prescriptions.,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Apply concepts of third party billing and prescription pricing in the drug use process. ,Recognize issues surrounding drug diversion and security.,Demonstrate an introductory level of adverse drug reporting and management.,Relate the concepts of the culture of patient safety to the drug use process.,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Document search process for drug information questions, citing references used.",Communicate effectively when having a dialogue with a simulated patient and other health care practitioners,Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.","Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Self-Reflection (Community Pharmacy Visit),Assignment,N/A,10,,18-01-04,,"Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab 1,Lab,N/A,5,,18-01-04,,Identify legal requirements when accepting/receiving written & verbal prescriptions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products and practicing within the professions scope.,Identify the basic process requirements in utilizing the Patient Care Process:,a. Construct a patient care database,b. Identify the drug related problem,c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab 2,Lab,N/A,5,,18-01-04,,Identify legal requirements when accepting/receiving written & verbal prescriptions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products and practicing within the professions scope.,Identify the basic process requirements in utilizing the Patient Care Process:,a. Construct a patient care database,b. Identify the drug related problem,c. Manage a patient care profile electronically,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Document search process for drug information questions, citing references used.",Communicate effectively when having a dialogue with a simulated patient and other health care practitioners,Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.","Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 342 (Winter 2018 LAB LEC SEM),PHARM 342 Wi18 - DRUG USE & PATIENT CARE Combined LAB LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 1st year",Ravina Sanghera-Grewal,,Lab 3,Lab,N/A,5,,18-01-04,,"For each component in the patient care process, describe the related activities and responsibilities of pharmacists, pharmacy students, interns, and pharmacy technicians.",Identify legal requirements when accepting/receiving written & verbal prescriptions.,Identify federal and provincial pharmacy legislation with respect to the appropriate handling of drug products and practicing within the professions scope.,"Discuss how the medication-dispensing process intersects with the patient care process, and the respective roles of pharmacists, pharmacy students and pharmacy technicians and pharmacy technician students.",Identify the basic process requirements in utilizing the Patient Care Process:,a. Construct a patient care database,b. Identify the drug related problem,c. Manage a patient care profile electronically,Identify and document potential medication prescribing errors in written and verbal prescriptions.,Explain the basic concepts and principles applicable to professional responsibilities in the drug use control process and patient care interactions.,Apply concepts of third party billing and prescription pricing in the drug use process. ,"Function efficiently within the simulated pharmacy, both independently and within a group.",Complete an accurate patient record by gathering medication history and other relevant information.,"Document search process for drug information questions, citing references used.",Communicate effectively when having a dialogue with a simulated patient and other health care practitioners,Utilize critical thinking in the problem solving process.,"Accurately process written and verbal prescriptions, meeting all legal and technical requirements for medications.",Demonstrate competency of the prescription processing software (KROLL).,Apply relevant components of the Patient Care Process model to pharmacy practice.,"Demonstrate effective communication in clarifying prescription orders, providing drug information, documentation of errors and interacting with health care professionals and patients.","Demonstrate a responsible, caring, and professional attitude towards the profession of pharmacy, students, patients, and health care professionals.",,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Group Homework Assignment,Assignment,N/A,15,,18-03-28,,"Demonstrate critical appraisal skills to assess validity, relevance, and applicability of the pharmacoepidemiologic literature.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Final,Exam,Written and multiple choice,40,,18-04-16,,Describe the inherent limitations of the drug approval process and pre-marketing clinical trials with regard to assessment of drug safety and effectiveness.,Recognize the difference between type I and type II errors.,Define power and other factors that can influence sample size when trying to detect a difference in risk.,Describe the role of observational studies and randomized controlled trials to support evidence based clinical decisions about safety.,Explain why we need adverse drug reaction reporting systems and why pharmacists should contribute to this process.,Recognize the difference between type A and type B drug reactions and explain which drug reactions are the focus of pharmacoepidemiologic studies.,Define safety signal and explain how it may be generated.,Describe the common data sources used in pharmacoepidemiologic studies. Examples will be presented to highlight the advantages and limitations of each data source.,"Describe the major elements of cross-sectional, case-control and cohort studies.",Identify the advantages and limitations of each pharmacoepidemiologic study design. Examples of different studies will be used to illustrate these elements.,Interpret different measures of association reported in pharmacoepidemiologic studies.,Define and interpret effect modification.,Define causal inference.,List Sir Bradford-Hills considerations for inferring causation from observational data.,Classify and describe common types of bias that threaten internal validity of pharmacoepidemiologic studies,Explain how specific biases may affect measures of association.,Define confounding and explain how it can affect the interpretation of an association.,Describe methods used to minimize the effects of confounding in pharmacoepidemiologic studies.,Explain the role of systematic reviews and meta-analyses.,Describe the major elements of a systematic review and meta-analysis.,Explain how we can use pharmacoepidemiologic studies to assess the suspected causal relationship between a drug and an adverse reaction.,Describe the major elements of a quality improvement framework.,Describe the structure-process-outcomes model for evaluating quality of health services.,Define care gap.,Define knowledge translation.,Describe the knowledge-to-action cycle.,Describe different study designs that are commonly used in pharmacy practice research. Examples will be used to illustrate the advantages and limitations of these different study designs.,List common challenges and solutions when integrating research into practice settings.,Explain how the guiding ethical principles from the Tri-Council Policy Statement (TCPS) apply when conducting practice based research.,Describe the major elements of a survey.,Describe how validity of a survey is measured.,Describe the major elements of pharmacoeconomic evaluations.,"Demonstrate critical appraisal skills to assess validity, relevance, and applicability of the pharmacoepidemiologic literature.",,,,,,,,,,,,,,PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,In-Class Quiz,Quiz,Multiple choice,5,,18-02-09,,Describe the inherent limitations of the drug approval process and pre-marketing clinical trials with regard to assessment of drug safety and effectiveness.,Recognize the difference between type I and type II errors.,Define power and other factors that can influence sample size when trying to detect a difference in risk.,Describe the role of observational studies and randomized controlled trials to support evidence based clinical decisions about safety.,Identify the advantages and limitations of each pharmacoepidemiologic study design. Examples of different studies will be used to illustrate these elements.,Interpret different measures of association reported in pharmacoepidemiologic studies.,Define and interpret effect modification.,Define causal inference.,List Sir Bradford-Hills considerations for inferring causation from observational data.,Classify and describe common types of bias that threaten internal validity of pharmacoepidemiologic studies,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 392 (Winter 2018 LEC B1 SEM J1),PHARM 392 Wi18 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Midterm,Exam,Written and multiple choice,40,,18-03-07,,Describe the inherent limitations of the drug approval process and pre-marketing clinical trials with regard to assessment of drug safety and effectiveness.,Recognize the difference between type I and type II errors.,Define power and other factors that can influence sample size when trying to detect a difference in risk.,Describe the role of observational studies and randomized controlled trials to support evidence based clinical decisions about safety.,Explain why we need adverse drug reaction reporting systems and why pharmacists should contribute to this process.,Recognize the difference between type A and type B drug reactions and explain which drug reactions are the focus of pharmacoepidemiologic studies.,Identify the advantages and limitations of each pharmacoepidemiologic study design. Examples of different studies will be used to illustrate these elements.,Interpret different measures of association reported in pharmacoepidemiologic studies.,Define and interpret effect modification.,Define causal inference.,List Sir Bradford-Hills considerations for inferring causation from observational data.,Classify and describe common types of bias that threaten internal validity of pharmacoepidemiologic studies,Explain how specific biases may affect measures of association.,Define confounding and explain how it can affect the interpretation of an association.,Describe methods used to minimize the effects of confounding in pharmacoepidemiologic studies.,Explain the role of systematic reviews and meta-analyses.,Describe the major elements of a systematic review and meta-analysis.,Explain how we can use pharmacoepidemiologic studies to assess the suspected causal relationship between a drug and an adverse reaction.,"Demonstrate critical appraisal skills to assess validity, relevance, and applicability of the pharmacoepidemiologic literature.",,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Case assessment documentation (6% each x 5),Assignment,N/A,30,,17-06-02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Patient Assessment Labs (7% each x 3),Lab,N/A,21,,17-06-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Final Exam,Exam,Written and multiple choice,35,,18-07-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Participation,Participation,N/A,5,,17-01-31,,Demonstrate professional attitude and behavior consistently and work collaboratively with other group members.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 532 (Summer 2018 LAB H1 LEC B1 SEM J1),PHARM 532 - PATIENT ASSESSMENT (Spring/Summer 2018),Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD) for BScPharm Students, 4th year",Dr. Sherif Hanafy Mahmoud,,Symptom Assessment Assignment,Assignment,N/A,9,,18-06-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Final,Exam,Written and multiple choice,50,NA,19-04-17,,Accept responsibility for keeping abreast of emerging technologies and drugs.,Develop an appreciation of the interdisciplinary nature of patient care.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus. ",Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).",Identify and resolve clinically significant drug interactions.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,"Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify applicable health system resources for the management of endocrine disorders.,Identify the pharmacist's role and the responsibility within the management of endocrine disorders.,Identify ethical and cultural issues surrounding endocrine disorders.,"Recognize and understand the appropriate diabetes management strategies for various activities, such as travel, exercise, and acute illness.","Describe the therapeutic approach, incorporating non-pharmacologic and pharmacologic treatments to the prevention and management of endocrine disorders; including use of specific target drugs (dose, route of administration, length of therapy, monitoring parameters) for each condition as well as alternative therapies.",Describe actions and adverse effects of common natural health products used to manage endocrine disorders.,Describe the adverse effects of drugs used to manage endocrine disorders.,Apply pharmacokinetic and pharmacodynamic principles to the drug treatment of endocrine disorders.,Explain the pharmacologic effects of drugs used to manage endocrine disorders.,Recognize the main structural features of drugs used to manage endocrine disorders.,Describe the specific laboratory tests used in the diagnosis and management of endocrine disorders.,"Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.","Describe the epidemiology, etiology, and risk factors of endocrine disorders.",Describe the physiological effects of endocrine hormones.,Identify the main anatomical components of the endocrine system.,,,,,,,,,,,,,,,,,,,,,PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Midterm,Exam,Written and multiple choice,40,NA,19-02-14,,Accept responsibility for keeping abreast of emerging technologies and drugs.,Develop an appreciation of the interdisciplinary nature of patient care.,"Develop a caring, empathic attitude for patients experiencing of the conditions of primary focus. ",Use the principles of evidence-based medicine to critically evaluate the validity and applicability of information from various literature resources.,Identify and retrieve appropriate sources of information needed to resolve drug related problems.,Identify when to inform physicians and caregivers if there are danger signs apparent in the assessment.,"Select appropriate treatment for special groups (e.g., pediatrics, geriatrics, pregnant or lactating women).",Identify and resolve clinically significant drug interactions.,"Develop a patient care plan related to the care of patients with endocrine disorders, including appropriate monitoring and documentation.",Identify actual and potential drug-related problems associated with pharmacologic management of endocrine disorders.,"Apply concepts and knowledge of medicinal chemistry, pharmacology, and therapeutic principles for pharmacologic management of endocrine disorders.",Identify applicable health system resources for the management of endocrine disorders.,Identify the pharmacist's role and the responsibility within the management of endocrine disorders.,Identify ethical and cultural issues surrounding endocrine disorders.,"Recognize and understand the appropriate diabetes management strategies for various activities, such as travel, exercise, and acute illness.","Describe the therapeutic approach, incorporating non-pharmacologic and pharmacologic treatments to the prevention and management of endocrine disorders; including use of specific target drugs (dose, route of administration, length of therapy, monitoring parameters) for each condition as well as alternative therapies.",Describe actions and adverse effects of common natural health products used to manage endocrine disorders.,Describe the adverse effects of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used to manage endocrine disorders.,Recognize the main structural features of drugs used to manage endocrine disorders.,Describe the specific laboratory tests used in the diagnosis and management of endocrine disorders.,"Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.","Describe the epidemiology, etiology, and risk factors of endocrine disorders.",Describe the physiological effects of endocrine hormones.,Identify the main anatomical components of the endocrine system.,,,,,,,,,,,,,,,,,,,,,,PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Pre-Seminar Quiz 2,Quiz,Written and multiple choice,5,NA,19-02-07,,"Recognize and understand the appropriate diabetes management strategies for various activities, such as travel, exercise, and acute illness.",Describe actions and adverse effects of common natural health products used to manage endocrine disorders.,Describe the adverse effects of drugs used to manage endocrine disorders.,Recognize the main structural features of drugs used to manage endocrine disorders.,"Describe the pathophysiology of endocrine disorders, including clinical presentation, symptomatology, and long-term health consequences.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 497 (Winter 2019 LEC B1 SEM J1),PHARM 497 Wi19 - ENDOCRINE Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Scot Simpson,,Pre-Seminar Quiz 1,Quiz,Written and multiple choice,5,NA,19-02-01,,"Describe the therapeutic approach, incorporating non-pharmacologic and pharmacologic treatments to the prevention and management of endocrine disorders; including use of specific target drugs (dose, route of administration, length of therapy, monitoring parameters) for each condition as well as alternative therapies.",Describe the adverse effects of drugs used to manage endocrine disorders.,Explain the pharmacologic effects of drugs used to manage endocrine disorders.,Recognize the main structural features of drugs used to manage endocrine disorders.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,EBCP Literacy Assignment,Assignment,N/A,20,,18-02-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Seminar #2 Critical Appraisal,Assignment,N/A,5,,18-02-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Group EBM Project,Assignment,N/A,25,,18-02-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 324 (Winter 2018 LEC SEM),PHARM 324 Wi18 - HLTH PROF EVED BASED MED Combined LEC SEM Wi18,Cross Listed Courses,BSc in Pharmacy,Mark Makowsky,,Final,Exam,Written and multiple choice,50,,18-03-02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 347 (Fall 2018 LEC A1 SEM E1),PHARM 347 Fa18 - HEMATOLOGY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Seminar Quiz,Quiz,Multiple choice,5,NA,18-12-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 347 (Fall 2018 LEC A1 SEM E1),PHARM 347 Fa18 - HEMATOLOGY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Midterm,Exam,Multiple choice,30,NA,18-11-01,,Accept responsibility for keeping abreast of emerging technologies and drugs,"Develop a caring, empathic attitude for patients experiencing anemia and thrombosis.",Utilize self-directed learning abilities,Critically evaluate the appropriateness and reliability of information from literature resources,Identify and locate sources of information needed to solve drug related problems,Utilize an evidence based approach to therapeutic management of the conditions of primary focus.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of primary focus.,Apply concepts and knowledge of pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of primary focus.,Identify applicable health system resources,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify ethical issues surrounding treatment of the conditions of primary focus.,"Describe the mechanisms, efficacy, side effect profiles and role of each of the following drugs or drug classes: i. Anticoagulants ii. Antiplatelets iii. Fibrinolytics iv. Antifibrinolytics v. Stimulating Factors vi. Iron products","Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,"Describe the pathophysiology of the conditions of primary focus, including clinical presentation and symptomatology and long term health consequences.","Discuss the physiology of the blood supply and lymphatic system including the composition and properties of blood, blood groups and selected functions of blood.",Explain the anatomy of blood supply and the lymphatic system of the human.,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",,,,,,,,,,,,,,,,,,,,,,,,,PHARM 347 (Fall 2018 LEC A1 SEM E1),PHARM 347 Fa18 - HEMATOLOGY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. Paul Jurasz,,Final ,Exam,Multiple choice,65,NA,18-12-10,,Accept responsibility for keeping abreast of emerging technologies and drugs,"Develop a caring, empathic attitude for patients experiencing anemia and thrombosis.",Utilize self-directed learning abilities,Critically evaluate the appropriateness and reliability of information from literature resources,Identify and locate sources of information needed to solve drug related problems,Utilize an evidence based approach to therapeutic management of the conditions of primary focus.,"Recognize the integration of knowledge of therapeutics with medicinal chemistry and pharmacology required to develop rational treatment decisions for therapy, evaluation and monitoring","Select appropriate treatment for special groups (pediatrics, elderly, pregnancy, lactation).",Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of primary focus.,Apply concepts and knowledge of pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of primary focus.,Identify applicable health system resources,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify ethical issues surrounding treatment of the conditions of primary focus.,"Describe the mechanisms, efficacy, side effect profiles and role of each of the following drugs or drug classes: i. Anticoagulants ii. Antiplatelets iii. Fibrinolytics iv. Antifibrinolytics v. Stimulating Factors vi. Iron products","Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters)",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus.,Explain the effects of drugs used in the management of the conditions of primary focus.,"Describe the pathophysiology of the conditions of primary focus, including clinical presentation and symptomatology and long term health consequences.","Discuss the physiology of the blood supply and lymphatic system including the composition and properties of blood, blood groups and selected functions of blood.",Explain the anatomy of blood supply and the lymphatic system of the human.,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",,,,,,,,,,,,,,,,,,,,,,,,,PHARM 327 (LEC B1 Wi18),PHARM 327 NUTRITION (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Hoon Sunwoo,,Final,Exam,Written and multiple choice,60,NA,18-02-17,,"By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",Search and report on a topic of relevance to nutrition and health.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).",Discuss dietary management for prophylactic and therapeutic approach of patient care.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Explain their learning and knowledge of nutrition to those who are disease state.,Explain how dietary agents (functional foods and nutraceuticals) may preventor delay the onset of some chronic diseases.,Explain the interaction of food and drug.,"Explain the interrelation of the biochemical, pharmacological and physiological functions of nutrients.","Understand the application of various tools for nutritional assessment, nutritional deficiencies and toxicities, components of healthy diets, and principles of non-prescription natural health products, functional food regulations, food safety and food processing technologies.","Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 327 (LEC B1 Wi18),PHARM 327 NUTRITION (LEC B1 Wi18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Hoon Sunwoo,,Midterm,Exam,Written and multiple choice,40,NA,18-01-24,,"By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",Search and report on a topic of relevance to nutrition and health.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).",Discuss dietary management for prophylactic and therapeutic approach of patient care.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Explain their learning and knowledge of nutrition to those who are disease state.,Explain how dietary agents (functional foods and nutraceuticals) may preventor delay the onset of some chronic diseases.,Explain the interaction of food and drug.,"Explain the interrelation of the biochemical, pharmacological and physiological functions of nutrients.","Understand the application of various tools for nutritional assessment, nutritional deficiencies and toxicities, components of healthy diets, and principles of non-prescription natural health products, functional food regulations, food safety and food processing technologies.","Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Online Exercises,Assignment,N/A,5,NA,18-08-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Midterm,Exam,Written and multiple choice,27,NA,18-10-10,,"Outline the basic, healthy anatomy and physiology of: the cell, and of tissues in the human body; neurons; the autonomic nervous system; pain; muscles; the central and peripheral nervous systems; the cardiovascular and lymphatic systems; the blood; the respiratory system.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Final ,Exam,Written and multiple choice,53,NA,18-12-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Post-seminar quiz,Quiz,Multiple choice,5,NA,18-11-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 204 (Fall 2018 LEC A1 SEM E1),PHARM 204 Fa18 - PHYSIOLOGY AND ANATOMY PHARM 1 Combined LEC SEM Fa18,Cross Listed Courses,,"Susan Patrick, Ph.D",,Online Discussion Participation,Participation,N/A,10,NA,18-08-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Hot Topic Assignment,Assignment,N/A,2,,16-10-16,,Be aware of recent trends in development of new drug delivery systems,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Lab reports,Assignment,N/A,12,,16-12-07,,Apply knowledge of sterility requirements,Explain how to maintain a clean work environment,Explain importance of quality of ingredients including bioburden,Identify risks of cross contamination in a laminar flow work bench,Explain importance of monitoring programs and training of personnel,Explain how Health Canada Guidelines (GMP and GLP) are related to the pharmacistâ€™s role in compounding.,"Gain and apply knowledge on the formulation needs and process involved for the manufacturing of solid dosage forms, controlled release products, transdermal delivery systems and aerosols in pharmaceutical industry",Perform compounding and packaging of drug products in small quantities according to legal and professional standards,"Develop skills and techniques that are important for the handling of drugs, excipients and pharmaceutical equipment and instruments.",Apply modern pharmacopeia standards and methods to assess the quality of dosage forms,"Interpret official compendia standards and specifications for pharmaceutical preparations including USP standards, International pharmacopoeias, and Professional standards.",Perform aseptic compounding techniques,Evaluate various sterilization methods,Develop standard operation procedures,Apply knowledge of a quality assurance program for sterile compounding,Evaluate risk levels,Set up an aseptic work environment and maintain the quality of the work environment,Conduct quality control of the final product,Apply appropriate parenteral technique in clinical situations.,Evaluate the stability and the shelf life of drugs under different storage conditions,Evaluate and interpret literature with respect to existing and new dosage forms as related to Pharmaceutics and Compounding procedures. ,Identify and locate sources of information needed to solve a problem related to Pharmaceutics,Critically evaluate the appropriateness and reliability of information from literature resources related to Pharmaceutics.,Synthesize information gained from various literature resources to solve problems or make recommendations related to Pharmaceutics,Demonstrate appropriate documentation practices in compounding.,Be aware of recent trends in development of new drug delivery systems,,,,,,,,,,,,,,,,,,,,,PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Final,Exam,Written and multiple choice,48,,16-11-04,,Apply knowledge of sterility requirements,Explain how to maintain a clean work environment,Explain importance of quality of ingredients including bioburden,Identify risks of cross contamination in a laminar flow work bench,Explain importance of monitoring programs and training of personnel,Explain how Health Canada Guidelines (GMP and GLP) are related to the pharmacistâ€™s role in compounding.,"Gain and apply knowledge on the formulation needs and process involved for the manufacturing of solid dosage forms, controlled release products, transdermal delivery systems and aerosols in pharmaceutical industry",Perform compounding and packaging of drug products in small quantities according to legal and professional standards,"Develop skills and techniques that are important for the handling of drugs, excipients and pharmaceutical equipment and instruments.",Apply modern pharmacopeia standards and methods to assess the quality of dosage forms,"Interpret official compendia standards and specifications for pharmaceutical preparations including USP standards, International pharmacopoeias, and Professional standards.",Perform aseptic compounding techniques,Evaluate various sterilization methods,Develop standard operation procedures,Apply knowledge of a quality assurance program for sterile compounding,Evaluate risk levels,Set up an aseptic work environment and maintain the quality of the work environment,Conduct quality control of the final product,Apply appropriate parenteral technique in clinical situations.,Evaluate the stability and the shelf life of drugs under different storage conditions,Evaluate and interpret literature with respect to existing and new dosage forms as related to Pharmaceutics and Compounding procedures. ,Identify and locate sources of information needed to solve a problem related to Pharmaceutics,Critically evaluate the appropriateness and reliability of information from literature resources related to Pharmaceutics.,Synthesize information gained from various literature resources to solve problems or make recommendations related to Pharmaceutics,Demonstrate appropriate documentation practices in compounding.,Be aware of recent trends in development of new drug delivery systems,,,,,,,,,,,,,,,,,,,,,PHARM 361 (Fall 2018 LAB D1 D2 D3 LEC A1 SEM E1),PHARM 361 Fa18 - PHARMACEUTICS 2 Combined LAB LEC SEM Fa18,Cross Listed Courses,"Pharmaceutical Sciences,, BSc in Pharmacy, 2nd year",Afsaneh Lavasanifar,,Midterm,Exam,Written and multiple choice,38,,16-09-28,,Apply knowledge of sterility requirements,Explain how to maintain a clean work environment,Explain importance of quality of ingredients including bioburden,Identify risks of cross contamination in a laminar flow work bench,Explain importance of monitoring programs and training of personnel,Explain how Health Canada Guidelines (GMP and GLP) are related to the pharmacistâ€™s role in compounding.,"Gain and apply knowledge on the formulation needs and process involved for the manufacturing of solid dosage forms, controlled release products, transdermal delivery systems and aerosols in pharmaceutical industry",Perform compounding and packaging of drug products in small quantities according to legal and professional standards,"Develop skills and techniques that are important for the handling of drugs, excipients and pharmaceutical equipment and instruments.",Apply modern pharmacopeia standards and methods to assess the quality of dosage forms,"Interpret official compendia standards and specifications for pharmaceutical preparations including USP standards, International pharmacopoeias, and Professional standards.",Perform aseptic compounding techniques,Evaluate various sterilization methods,Develop standard operation procedures,Apply knowledge of a quality assurance program for sterile compounding,Evaluate risk levels,Set up an aseptic work environment and maintain the quality of the work environment,Conduct quality control of the final product,Apply appropriate parenteral technique in clinical situations.,Evaluate the stability and the shelf life of drugs under different storage conditions,Evaluate and interpret literature with respect to existing and new dosage forms as related to Pharmaceutics and Compounding procedures. ,Identify and locate sources of information needed to solve a problem related to Pharmaceutics,Critically evaluate the appropriateness and reliability of information from literature resources related to Pharmaceutics.,Synthesize information gained from various literature resources to solve problems or make recommendations related to Pharmaceutics,Demonstrate appropriate documentation practices in compounding.,,,,,,,,,,,,,,,,,,,,,,PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Final Exam,Exam,Written and multiple choice,45,NA,18-12-13,,Develop an appreciation of the interdisciplinary nature of patient care.,Evaluate and apply information from literature and other resources to provide patient care.,Utilize an evidence based approach to therapeutic management of the psychiatric conditions covered.,Manage clinically significant drug interactions with drugs used to treat the psychiatric conditions covered.," Apply principles of therapeutic drug monitoring to deliver patient care, taking into consideration health system and economic factors.","Develop a therapeutic and monitoring plan, taking into consideration patient factors, efficacy, toxicity, cost, route of administration, etc.","Conduct a patient assessment using relevant data from the patient history, review of systems, laboratory tests, diagnostic imaging and medication history in order to provide patient care.",Identify ethical issues in the management of mental health conditions.,Outline the economic and health policy issues as they relate to mental health conditions.,Describe the role of therapeutic drug monitoring for selected medications in the provision of patient care.,"Describe the therapeutic approach to managing the conditions covered, including: guideline recommendations and clinical targets, pharmacological (dose, duration of therapy, monitoring parameters), non-pharmacological treatments, and CAM.","Explain the mechanism of action, pharmacokinetic principles, clinical effect(s), and adverse effects and drug interactions for the medication classes covered.","Describe the risk factors, clinical presentation, and assessment parameters (signs and symptoms, laboratory values/tests, physical findings and diagnostic measurements) of the conditions covered.","Outline the epidemiology, etiology and pathophysiology of the mental health conditions covered.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Midterm Exam,Exam,Written and multiple choice,40,NA,18-11-23,,Develop an appreciation of the interdisciplinary nature of patient care.,Evaluate and apply information from literature and other resources to provide patient care.,Utilize an evidence based approach to therapeutic management of the psychiatric conditions covered.,Manage clinically significant drug interactions with drugs used to treat the psychiatric conditions covered.," Apply principles of therapeutic drug monitoring to deliver patient care, taking into consideration health system and economic factors.","Develop a therapeutic and monitoring plan, taking into consideration patient factors, efficacy, toxicity, cost, route of administration, etc.","Conduct a patient assessment using relevant data from the patient history, review of systems, laboratory tests, diagnostic imaging and medication history in order to provide patient care.",Identify ethical issues in the management of mental health conditions.,Outline the economic and health policy issues as they relate to mental health conditions.,Describe the role of therapeutic drug monitoring for selected medications in the provision of patient care.,"Describe the therapeutic approach to managing the conditions covered, including: guideline recommendations and clinical targets, pharmacological (dose, duration of therapy, monitoring parameters), non-pharmacological treatments, and CAM.","Explain the mechanism of action, pharmacokinetic principles, clinical effect(s), and adverse effects and drug interactions for the medication classes covered.","Describe the risk factors, clinical presentation, and assessment parameters (signs and symptoms, laboratory values/tests, physical findings and diagnostic measurements) of the conditions covered.","Outline the epidemiology, etiology and pathophysiology of the mental health conditions covered.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 447 (Fall 2018 LEC A1 SEM E1),PHARM 447 Fa18 - PSYCHIATRY Combined LEC SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 3rd year",Candace Necyk,,Seminar Assessments/Activities,Other,N/A,15,NA,18-10-23,,Develop lifelong learning skills that will enable maintenance of competence through keeping abreast of emerging technologies and drugs.,Develop an appreciation of the interdisciplinary nature of patient care.,"Develop a caring, empathic attitude for patients experiencing the conditions covered.",Utilize independent and collaborative approaches to learning.,Evaluate and apply information from literature and other resources to provide patient care.,Utilize an evidence based approach to therapeutic management of the psychiatric conditions covered.,Manage clinically significant drug interactions with drugs used to treat the psychiatric conditions covered.," Apply principles of therapeutic drug monitoring to deliver patient care, taking into consideration health system and economic factors.","Develop a therapeutic and monitoring plan, taking into consideration patient factors, efficacy, toxicity, cost, route of administration, etc.",Identify and locate sources of information needed to provide patient care.,"Conduct a patient assessment using relevant data from the patient history, review of systems, laboratory tests, diagnostic imaging and medication history in order to provide patient care.",Identify ethical issues in the management of mental health conditions.,Outline the economic and health policy issues as they relate to mental health conditions.,Describe the role of therapeutic drug monitoring for selected medications in the provision of patient care.,"Describe the therapeutic approach to managing the conditions covered, including: guideline recommendations and clinical targets, pharmacological (dose, duration of therapy, monitoring parameters), non-pharmacological treatments, and CAM.","Explain the mechanism of action, pharmacokinetic principles, clinical effect(s), and adverse effects and drug interactions for the medication classes covered.","Describe the risk factors, clinical presentation, and assessment parameters (signs and symptoms, laboratory values/tests, physical findings and diagnostic measurements) of the conditions covered.","Outline the epidemiology, etiology and pathophysiology of the mental health conditions covered.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Lab Assignments,Assignment,N/A,20,,18-08-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Midterm,Exam,Other,25,,18-12-20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Final,Exam,Other,35,,19-04-26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Integrated cases ,Exam,Multiple choice,15,,18-08-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 330A (Fall 2018 LAB D3 LEC C1),PHARM 330A Fa18 - COMPREHENSIVE PATIENT ASSESS 1 Combined LAB LEC Fa18,Cross Listed Courses,"BSc in Pharmacy, 2nd year","Gillian Johnson, Renette Bertholet, Theresa Charrois",,Professionalism ,Participation,N/A,5,,18-08-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 427 (Winter 2018 LEC B1 SEM J1),PHARM 427 Wi18 - PAIN Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Midterm,Exam,Written and multiple choice,40,NA,18-02-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 427 (Winter 2018 LEC B1 SEM J1),PHARM 427 Wi18 - PAIN Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Class Participation,Participation,N/A,5,NA,18-01-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 427 (Winter 2018 LEC B1 SEM J1),PHARM 427 Wi18 - PAIN Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",John Ussher,,Final,Exam,Written and multiple choice,55,NA,18-04-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Midterm,Exam,Multiple choice,34,,18-10-22,,Become proactive in including and considering concepts of therapeutic drug monitoring in practice skills.,"Determine CL, Vd, and other dependent pharmacokinetic parameters (half-life, maximum concentration after dosing, area under the concentration vs. time curve) from plasma concentration vs. time data.",Grasp the concept of steady state and its dependency on half-life in relation to constant intravenous infusion and repeated dose administration.,"Identify the relationships between different pharmacokinetic parameters and blood fluid concentrations after drug administration by the intravenous, oral and injectable routes.","Understand the relationship between organ clearance and total body clearance, and detail the mechanisms involved in renal and hepatic drug clearance of a particular drug.",Recognize factors that can influence the relationship between plasma concentrations and pharmacodynamics potency of drugs,Comprehend concepts related to nonlinear elimination of drug.,"Use the knowledge obtained from determination of pharmacokinetic parameters to devise an individualized dosing regimen for a patient, tailored to achieve a therapeutic goal of concentration and/or effect.","Comprehend one and two compartmental models, including the underlying reasons for the appearance of more than one compartment in a plasma concentration vs. time profile.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Final,Exam,Multiple choice,44,,18-12-19,,Become proactive in including and considering concepts of therapeutic drug monitoring in practice skills.,"Use knowledge related to measures of organ clearance to predict changes in blood levels when physiological 3 factors or clinical conditions are present that may affect blood flows, intrinsic clearance and transporter function.","Explain the following pharmacokinetic concepts:a. First and zero order rate processes. b. Rates, rate constants, and intercepts. c. Total body clearance (CL). d. Volume of distribution (Vd).",Recognize the relationship between pharmacokinetics and therapeutic relevance in: a. Extremes of age b. Genetic differences in drug metabolism (polymorphism) c. Diminished renal function d. Concomitant administration of interacting drugs e. Drug disposition in maternal and infants (pregnancy and breastmilk,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Lecture Participation,Participation,N/A,2,,18-12-19,,Become proactive in including and considering concepts of therapeutic drug monitoring in practice skills.,"Use knowledge related to measures of organ clearance to predict changes in blood levels when physiological 3 factors or clinical conditions are present that may affect blood flows, intrinsic clearance and transporter function.","Determine CL, Vd, and other dependent pharmacokinetic parameters (half-life, maximum concentration after dosing, area under the concentration vs. time curve) from plasma concentration vs. time data.",Grasp the concept of steady state and its dependency on half-life in relation to constant intravenous infusion and repeated dose administration.,"Identify the relationships between different pharmacokinetic parameters and blood fluid concentrations after drug administration by the intravenous, oral and injectable routes.","Understand the relationship between organ clearance and total body clearance, and detail the mechanisms involved in renal and hepatic drug clearance of a particular drug.","Explain the following pharmacokinetic concepts:a. First and zero order rate processes. b. Rates, rate constants, and intercepts. c. Total body clearance (CL). d. Volume of distribution (Vd).",Recognize the relationship between pharmacokinetics and therapeutic relevance in: a. Extremes of age b. Genetic differences in drug metabolism (polymorphism) c. Diminished renal function d. Concomitant administration of interacting drugs e. Drug disposition in maternal and infants (pregnancy and breastmilk,Recognize factors that can influence the relationship between plasma concentrations and pharmacodynamics potency of drugs,Comprehend concepts related to nonlinear elimination of drug.,"Use the knowledge obtained from determination of pharmacokinetic parameters to devise an individualized dosing regimen for a patient, tailored to achieve a therapeutic goal of concentration and/or effect.","Comprehend one and two compartmental models, including the underlying reasons for the appearance of more than one compartment in a plasma concentration vs. time profile.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 351 (LEC A1 Fa18),PHARM 351 BIOPHARMACEUTICS&PHARMACOKINET (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Dion Brocks,,Pharmacokinetic web-based problem assignments (15 in total),Assignment,N/A,20,,18-07-06,,Become proactive in including and considering concepts of therapeutic drug monitoring in practice skills.,"Use knowledge related to measures of organ clearance to predict changes in blood levels when physiological 3 factors or clinical conditions are present that may affect blood flows, intrinsic clearance and transporter function.","Determine CL, Vd, and other dependent pharmacokinetic parameters (half-life, maximum concentration after dosing, area under the concentration vs. time curve) from plasma concentration vs. time data.",Grasp the concept of steady state and its dependency on half-life in relation to constant intravenous infusion and repeated dose administration.,"Identify the relationships between different pharmacokinetic parameters and blood fluid concentrations after drug administration by the intravenous, oral and injectable routes.","Understand the relationship between organ clearance and total body clearance, and detail the mechanisms involved in renal and hepatic drug clearance of a particular drug.","Explain the following pharmacokinetic concepts:a. First and zero order rate processes. b. Rates, rate constants, and intercepts. c. Total body clearance (CL). d. Volume of distribution (Vd).",Recognize the relationship between pharmacokinetics and therapeutic relevance in: a. Extremes of age b. Genetic differences in drug metabolism (polymorphism) c. Diminished renal function d. Concomitant administration of interacting drugs e. Drug disposition in maternal and infants (pregnancy and breastmilk,Recognize factors that can influence the relationship between plasma concentrations and pharmacodynamics potency of drugs,Comprehend concepts related to nonlinear elimination of drug.,"Use the knowledge obtained from determination of pharmacokinetic parameters to devise an individualized dosing regimen for a patient, tailored to achieve a therapeutic goal of concentration and/or effect.","Comprehend one and two compartmental models, including the underlying reasons for the appearance of more than one compartment in a plasma concentration vs. time profile.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Online Quiz #3,Quiz,Multiple choice,3,,18-11-29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Midterm,Exam,Written and multiple choice,40,,18-10-18,,Develop an appreciation of the interdisciplinary nature of patient care.,Work effectively within the healthcare team.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus. ",Accept responsibility for keeping abreast of emerging technologies and drugs,"Identify the presenting signs and symptoms of electrolyte disorders, acid-base disorders, acute kidney injury, chronic kidney disease, nephrolithiasis, and LUTS and describe criteria used to make the diagnosis.",Calculate creatinine clearance and adjust doses for medications that are renally eliminated.,"Assess fluid balance based on medical history as well as presenting signs and symptoms, and recommend appropriate management of the patient.","Describe the etiology, pathophysiology, clinical presentation, and compensatory mechanism of the four acid-base disorders.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Online Quiz #1,Quiz,Multiple choice,3,,18-10-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Online Quiz #2,Quiz,Multiple choice,3,,18-11-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 397 (Fall 2018 LEC A1 SEM E1),"PHARM 397 Fa18 - VALUES, UROLOGY & NEPHROLOGY Combined LEC SEM Fa18",Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Michael Doschak,,Final,Exam,Written and multiple choice,50,,18-12-17,,Work effectively within the healthcare team.,Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Examination 1 (Pediatrics),Exam,Written and multiple choice,40,,18-01-25,,Discuss presentation and treatment for common pulmonary pediatric illnesses; croup and bronchiolitis.,Identify and discuss appropriate management plans for common pediatric concerns such as teething and fevers.,Discuss basic neonatal care and challenges including premature birth.,"Describe the various forms of pediatric abuse and discuss the Child, Youth and Family Enhancement Act and the responsibilities that are associated with the Act",Review pediatric toxicology and discuss preventative interventions that pharmacists can promote to patients or utilize in their practice to minimize pediatric toxicological poisonings or incidences.,Explain how pharmacokinetic parameters are different in infants and children versus adults.,Describe the role of pharmacists in the care of pediatric and geriatric patients.,Identify and describe age-appropriate communication strategies.," Explain the significant differences in physiologic parameters between adolescents, children, toddlers and infants, including premature babies, and neonates",Discuss the importance of medication safety and identify measures used to ensure safe medication practices,"Identify and discuss appropriate management plans for common pediatric gastrointestinal illnesses (e.g. vomiting, diarrhea, dehydration, colic, and constipation).","Identify and discuss some of the challenges involved in treating the pediatric population, including communication strategies, presentation of illness and the management and administration of medications to infants and children.",Briefly describe the psychosocial aspects of aging and be able to explain the role of the pharmacist in dealing with these aspects.,"Describe the role that culture, religion, and ethnicity may play in health and decision-making.","Explain the demographics of the pediatric population in society, and explain how that may impact our role as pharmacists. (e.g. improvement of childhood illnesses, trend towards chronic disease management)",Identify sources of information needed to solve drug-related problems specific to the populations being studied.,"Empathize with children, older adults, and caregivers regarding challenging decision-making.",Be able to triage patients in a community setting and refer them to medical attention as appropriate.,Apply applicable pharmacokinetic parameters to monitor patients and assess appropriate use of medications.,Utilize when available an evidence-based approach to therapeutic management of pediatric and geriatric patients., Apply knowledge and skills to establish safe and effective drug use.,Appreciate the challenges related to decision-making and advocacy in grey areas of clinical practice and health.,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Examination 2 (Geriatrics),Exam,Written and multiple choice,40,,18-02-09,,Categorize the types of abuse commonly suffered by seniors.,Describe the challenges of providing care in a population with limited evidence.,"Describe the use and effect of drugs, pharmacoepidemiology, including prescription, non-prescription medication, and natural health products.","Describe risks for adverse drug events in pediatric and geriatric patients, and explain why they are more susceptible to adverse events.",List the common geriatric syndromes.,Discuss the role of the pharmacist in medication management of seniors.,Identify appropriate home care supports for a given patient.,Identify controversial health issues involving pediatric and geriatric populations,Describe the role of the pharmacist in reducing elder abuse," Explain the demographics of aging, and how that may impact society and the healthcare system.", List the most common chronic diseases and causes of death in seniors.,Describe the physiologic alterations associated with normal aging that modify drug response in the elderly patient.,"Describe the pharmacokinetic and pharmacodynamic changes associated with aging, and apply the principles to medications commonly used in geriatrics.",Contrast disease presentation between the young adult and the elderly adult.,Define polypharmacy and underutilization in terms of medications in seniors.,Contrast the presentation of adverse events in the elderly compared to the young adult.,Describe the impact of falls on the senior population.,Identify risk factors for falls in older individuals.,Describe appropriate interventions for falls.,Contrast how a geriatric syndrome is different than a disease state.,Identify methods of appropriately communicating with older adults who are hard of hearing.,Describe the role of the pharmacist in working with home care.,Describe the role of pharmacists in the care of pediatric and geriatric patients.,Identify and describe age-appropriate communication strategies.,Discuss the importance of medication safety and identify measures used to ensure safe medication practices,Identify medications that are considered inappropriate or high risk in older adults and explain why they are inappropriate or high risk.,Describe how criteria were developed to classify medications as appropriate or inappropriate in seniors.,Briefly describe the psychosocial aspects of aging and be able to explain the role of the pharmacist in dealing with these aspects.,"Describe the role that culture, religion, and ethnicity may play in health and decision-making.","Define and be able to use the following terms in a clinical context: geriatrics, gerontology, elderly, aging, frailty.",Describe common stereotypes and biases toward aging in our western society.,Use tools to assess medication appropriateness and medication management in seniors.,Identify sources of information needed to solve drug-related problems specific to the populations being studied.,Identify and be able to recommend aids to assist in medication management and administration.,Apply applicable pharmacokinetic parameters to monitor patients and assess appropriate use of medications.,Appreciate the challenges related to decision-making and advocacy in grey areas of clinical practice and health.,,,,,,,,,,,PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Assignment 1: Pediatrics: Reflection and personal â€œscriptâ€ù,Assignment,N/A,10,,18-01-23,,Describe the role of pharmacists in the care of pediatric and geriatric patients.,Take and defend a position on a controversy related to pediatrics and geriatrics using evidence-based arguments.,Prepare and present a personal script to address a controversial topic.,Communicate position through oral and written formats.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 387 (Winter 2018 LEC B1 SEM J1),PHARM 387 Wi18 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi18,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 3rd year",Cheryl Sadowski,,Assignment 2: Geriatrics: Perspectives on care of geriatric patients and future practice,Assignment,N/A,10,,18-02-07,,Describe the role of pharmacists in the care of pediatric and geriatric patients.,Communicate position through oral and written formats.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,"""Tools for Practice"" Evidence Summary ",Assignment,N/A,25,,17-11-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Weekly Tasks/ Appraisals,Assignment,N/A,10,,17-06-30,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,EBCP Literacy Assignment,Assignment,N/A,5,,17-10-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Midterm Exam,Exam,Written and multiple choice,30,,17-10-26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 501 (Fall 2018 LEC A1 SEM E1),PHARM 501 Fa18 - CRITICAL ANALYS EVIDENCE PRACT Combined LEC SEM Fa18,Cross Listed Courses,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),"Mark Makowsky, BSP, PharmD, ACPR",,Final Exam,Exam,Written and multiple choice,30,,17-12-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Reflection in Practice #2,Assignment,N/A,0,,18-12-17,,Envision oneâ€™s future role in pharmacy practice,Apply clinical judgment and critical thinking skills,Communicate effectively in writing,Demonstrate a process to develop and maintain professional competence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Prescribing Case Feedback,Assignment,N/A,0,,19-02-22,,Deliver effective feedback,Apply clinical judgment and critical thinking skills,Communicate effectively in writing,Demonstrate a process to develop and maintain professional competence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Reflection in Practice #3,Assignment,N/A,0,,19-03-04,,Envision oneâ€™s future role in pharmacy practice,Apply clinical judgment and critical thinking skills,Communicate effectively in writing,Demonstrate a process to develop and maintain professional competence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Preceptor Development,Assignment,N/A,0,,19-03-22,,Envision oneâ€™s future role in pharmacy practice,Communicate effectively in writing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Implementation Record Feedback,Assignment,N/A,0,,19-04-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Reflection in Practice #4,Assignment,N/A,0,,19-04-29,,Envision oneâ€™s future role in pharmacy practice,Apply clinical judgment and critical thinking skills,Communicate effectively in writing,Demonstrate a process to develop and maintain professional competence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Tools For Practice ,Assignment,N/A,0,,18-09-21,,Develop a tool for practice based consideration of a clinical question and review of literature,Communicate effectively in writing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Learning Plan Feedback ,Assignment,N/A,0,,18-10-12,,Deliver effective feedback,Communicate effectively in writing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Reflection in Clinical Practice #1,Assignment,N/A,0,,18-10-15,,Envision oneâ€™s future role in pharmacy practice,Apply clinical judgment and critical thinking skills,Communicate effectively in writing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Patient Centred Care,Assignment,N/A,0,,19-01-18,,Envision oneâ€™s future role in pharmacy practice,Apply clinical judgment and critical thinking skills,Communicate effectively in writing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Tools For Practice Presentation,Assignment,N/A,0,,18-11-09,,Deliver effective feedback,Develop a tool for practice based consideration of a clinical question and review of literature,Communicate effectively in writing,Demonstrate effective verbal and nonverbal communication skills ,Demonstrate a process to develop and maintain professional competence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Additional Prescribing Self Assessment Form,Assignment,N/A,0,,19-02-04,,Envision oneâ€™s future role in pharmacy practice,Communicate effectively in writing,Demonstrate a process to develop and maintain professional competence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Intetprofessional Practice,Assignment,N/A,0,,18-11-30,,Envision oneâ€™s future role in pharmacy practice,Communicate effectively in writing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (Fall 2017 SEM 800) PHARM 539 (Winter 2018 SEM 850),PHARM 538 PHARM 539 Fa17 Wi18 - Combined Section (SEM Fa17 Wi18),Cross Listed Courses,"Doctor of Pharmacy (PharmD), Doctor of Pharmacy (PharmD) for BScPharm Students","Sheila Walter, Ken Cor",,Plan for Success in Experiential Education,Assignment,N/A,0,,18-09-07,,Envision oneâ€™s future role in pharmacy practice,Communicate effectively in writing,Demonstrate a process to develop and maintain professional competence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Midterm ,Exam,Multiple choice,15,,18-10-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 203 (LEC A1 Fa18),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Dr. Paul Jurasz, Dr. John Ussher",,Final,Exam,Multiple choice,35,,18-12-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 1 Reflection with SMART Goal ,Assignment,N/A,10,,18-01-22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 6 SMART Goal Response,Assignment,N/A,5,,18-03-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab 5 Reflection ,Assignment,N/A,5,,18-02-26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Learning Opportunities (LOs),Quiz,Multiple choice,10,,18-03-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Lab Final,Exam,Other,40,,18-03-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 334 (Winter 2018 LEC B1 SEM J1 J2),PHARM 334 Wi18 - HLTH PROF COMM PART 2 Combined LEC SEM Wi18,Cross Listed Courses,"Pharmacy Practice,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy, 1st year",Lisa Guirguis,,Written Final,Exam,Written and multiple choice,30,,18-03-16,,Identify communication challenges associated with providing care to a patient whose first language is not English. ,"Compare and contrast concordance, compliance, and adherence frameworks ",Differentiate strategies to communicate with patients with vision and hearing loss. ,Identify core principles and key skills of motivational interviewing,Outline effective patient education skills,Describe the appropriate process for working with an interpreter in a healthcare setting. ,Define shared decision making and differentiate it from other decision making models.,Identify several strategies for effectively communicating risk,Select and integrate communication techniques to effectively communicate with other healthcare professionals.,Explain a process to manage emotional consults,Identify supportive communication techniques to assess patients medication to assess med taking behaviours and detect barriers,Describe the elements of a medication history,Apply communication techniques for monitoring medications ,Compare and contrast intentional and unintentional medication taking behaviours ,Explain the importance of stress management in professional life,Reflect on communication skills,"Listen, actively solicit and respond appropriately to ideas, opinions and feedback from others.", Detect and address barriers to patients medication taking behaviors using supportive probing techniques ," Provide timely, clear responses that are tailored to the context and audience.","Demonstrate appropriate techniques for dealing with anger, conflict, and lack of trust ","Communicate effectively with people with vision, hearing loss or who are using a translator",Apply the Three Talk model to make a shared decisions,Select and integrate communication techniques to effectively communicate risk to patients,"Engage in respectful, empathetic, compassionate, non-judgmental, culturally safe, tactful conversations with patients and health team members.",Engage in effective partnerships with their patients to support positive behaviour changes, Practice self-care activities to manage stress in professional life,Establish organization and flow while taking a full medication history,Accept responsibility for communicating professionally through both student and professional career ,Advocate for pharmacists role in monitoring medication therapy at the medication refill,Foster curiosity to understand and appreciate patients unique life experience,,,,,,,,,,,,,,,,,PHARM 496 (LEC A1 Sp18),PHARM 496 CLINICAL PHARMACOGENOMICS (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,,Patrick Mayo,,Final,Exam,Written and multiple choice,30,NA,18-05-22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 496 (LEC A1 Sp18),PHARM 496 CLINICAL PHARMACOGENOMICS (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,,Patrick Mayo,,Midterm,Exam,Written and multiple choice,30,NA,18-05-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 496 (LEC A1 Sp18),PHARM 496 CLINICAL PHARMACOGENOMICS (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,,Patrick Mayo,,Project: Nof1 Trial,Assignment,N/A,20,NA,18-05-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 496 (LEC A1 Sp18),PHARM 496 CLINICAL PHARMACOGENOMICS (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,,Patrick Mayo,,Class Participation: Case Discussions/Clinical DecisionMaking Discussion,Participation,N/A,5,NA,18-11-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 496 (LEC A1 Sp18),PHARM 496 CLINICAL PHARMACOGENOMICS (LEC A1 Sp18),Faculty of Pharmacy and Pharmaceutical Sciences,,Patrick Mayo,,Pre-class activity (quiz) ,Quiz,Multiple choice,15,NA,18-11-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 505 (Summer 2018 SEM 850) PHARM 545 (Summer 2018 SEM 850),PHARM 505 PHARM 545 Su18 - Combined Section (SEM Su18),Cross Listed Courses,,to be assigned,,Participation,Participation,N/A,10,NA,18-11-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 505 (Summer 2018 SEM 850) PHARM 545 (Summer 2018 SEM 850),PHARM 505 PHARM 545 Su18 - Combined Section (SEM Su18),Cross Listed Courses,,to be assigned,,Written Reflection or MyCred Reflection (e-class) ,Assignment,N/A,15,NA,18-06-22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 505 (Summer 2018 SEM 850) PHARM 545 (Summer 2018 SEM 850),PHARM 505 PHARM 545 Su18 - Combined Section (SEM Su18),Cross Listed Courses,,to be assigned,,Self-Assessment (google form) ,Assignment,N/A,10,NA,18-11-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 505 (Summer 2018 SEM 850) PHARM 545 (Summer 2018 SEM 850),PHARM 505 PHARM 545 Su18 - Combined Section (SEM Su18),Cross Listed Courses,,to be assigned,,Comprehensive Webinar ,Assignment,N/A,50,NA,18-11-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 505 (Summer 2018 SEM 850) PHARM 545 (Summer 2018 SEM 850),PHARM 505 PHARM 545 Su18 - Combined Section (SEM Su18),Cross Listed Courses,,to be assigned,,Brief Evidence-based Assessment of Research (BEAR)  (e-class) ,Assignment,N/A,15,NA,18-05-18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 531 (Spring 2018 LEC A1 SEM E1),PHARM 531 Sp18 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp18,Cross Listed Courses,,Morgan Basiuk,,EBCP Literacy Assignment,Assignment,N/A,5,,17-06-02,,Demonstrate the EBCP process for answering clinical questions in practice.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 531 (Spring 2018 LEC A1 SEM E1),PHARM 531 Sp18 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp18,Cross Listed Courses,,Morgan Basiuk,,Journal Club ,Research,N/A,20,,17-06-20,,Demonstrate the ability to search for and find the best evidence according to the type of question being asked.,Effectively provide a verbal study synopsis.,"Critically appraise the most common types of clinical studies pertinent to clinical pharmacist practice for validity, clinical relevance, and applicability. ",Calculate and interpret various estimates of treatment effect.,"Apply evidence, patient values, and clinical expertise and the principles of shared decision making to confidently & competently manage a patientâ€™s medication therapy.",Demonstrate skills in selfâ€“directed learning and self-reflection as required for continuous professional development.,Demonstrate professional attitude and behaviour consistently and work collaboratively with other group members to achieve an evidence-based clinical practice.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 531 (Spring 2018 LEC A1 SEM E1),PHARM 531 Sp18 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp18,Cross Listed Courses,,Morgan Basiuk,,Final Exam,Exam,Written and multiple choice,40,,17-07-11,,Demonstrate the EBCP process for answering clinical questions in practice.,Apply verbal and written communication skills important for collaboration in professional team environments.,Demonstrate the ability to search for and find the best evidence according to the type of question being asked.,Effectively provide a verbal study synopsis.,"Critically appraise the most common types of clinical studies pertinent to clinical pharmacist practice for validity, clinical relevance, and applicability. ",Calculate and interpret various estimates of treatment effect.,"Apply evidence, patient values, and clinical expertise and the principles of shared decision making to confidently & competently manage a patientâ€™s medication therapy.",Demonstrate skills in selfâ€“directed learning and self-reflection as required for continuous professional development.,Demonstrate professional attitude and behaviour consistently and work collaboratively with other group members to achieve an evidence-based clinical practice.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 531 (Spring 2018 LEC A1 SEM E1),PHARM 531 Sp18 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp18,Cross Listed Courses,,Morgan Basiuk,,Individual Critical Appraisal Assignments,Assignment,N/A,10,,17-01-30,,Demonstrate the ability to search for and find the best evidence according to the type of question being asked.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 531 (Spring 2018 LEC A1 SEM E1),PHARM 531 Sp18 - CRITICAL ANALYSIS OF EVIDENCE Combined LEC SEM Sp18,Cross Listed Courses,,Morgan Basiuk,,Group Critical Appraisal Assignments,Assignment,N/A,25,,17-01-30,,Demonstrate the ability to search for and find the best evidence according to the type of question being asked.,Effectively provide a verbal study synopsis.,"Critically appraise the most common types of clinical studies pertinent to clinical pharmacist practice for validity, clinical relevance, and applicability. ",Calculate and interpret various estimates of treatment effect.,"Apply evidence, patient values, and clinical expertise and the principles of shared decision making to confidently & competently manage a patientâ€™s medication therapy.",Demonstrate skills in selfâ€“directed learning and self-reflection as required for continuous professional development.,Demonstrate professional attitude and behaviour consistently and work collaboratively with other group members to achieve an evidence-based clinical practice.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Quiz #4,Quiz,Written and multiple choice,1,,18-09-24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Quiz #6,Quiz,Written and multiple choice,1,,18-10-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Quiz #9,Quiz,Written and multiple choice,1,,18-11-26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Quiz #10,Quiz,Written and multiple choice,1,,18-12-03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Final,Exam,Written and multiple choice,35,,18-12-11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Quiz #8,Quiz,Written and multiple choice,1,,18-11-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Quiz #2,Quiz,Written and multiple choice,1,,18-09-10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Quiz #3,Quiz,Written and multiple choice,1,,18-09-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Quiz #1,Quiz,Written and multiple choice,1,,18-09-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Quiz #5,Quiz,Written and multiple choice,1,,18-09-26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Business Plan Presentation â€“ Student Evaluation (Group Mark),Group,N/A,5,,18-10-29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Midterm,Exam,Written and multiple choice,30,,18-10-15,,"Anticipate, recognize and manage human, environmental and medication distribution situations that place patients at risk.",Adapt their practice to fulfill evolving professional roles.,"Set priorities and manage their time to balance patient care, workflow and practice requirements.","Contribute to planning, organizing and performing of work to be done, and integrating evidence while evaluating the results.",Help maintain a healthy work environment and assist with conflict management.,Utilize inventory control concepts to maintain an inventory control system.,Describe marketing principles in the context of supply and demand for professional services.,Describe strategic planning principles.,Critique the impact of funding and payment policies on the provision of professional services.,"Apply best practices in staff selection, training, development and evaluation.","Evaluate factors critical to safe and efficient medication distribution systems including pharmacy layout, workflow, technology and automation.",Apply regulatory and profession best practices to manage the distribution of medications in a variety of practice settings.,"Clarify roles, responsibilities and expertise of team members, identifying overlaps and gaps.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Quiz #7,Quiz,Written and multiple choice,1,,18-10-22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Business Plan Presentation â€“ Instructor / Guest Panel Evaluation (Group Mark),Group,N/A,10,,18-10-29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 372 (LEC A1 Fa18),PHARM 372 PHARMACY MANAGEMENT (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Business Plan Written Report (Group Mark),Assignment,N/A,10,,18-11-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 504 (LEC A1 Fa18),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Final Paper,Assignment,N/A,40,,18-12-04,,Demonstrate respect for diversity of views and experiences. ,Apply reflective and critical thinking skills. ,Present information and views effectively in written and oral presentation formats.,"Explore current issues on collaboration: teamwork, leadership, communication. ",Apply theoretical frameworks for collaboration and  groups. ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 504 (LEC A1 Fa18),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Contributions to eClass/Participation ,Participation,N/A,20,,18-08-09,,Facilitate student and professional learning.,Apply reflective and critical thinking skills. ,Present information and views effectively in written and oral presentation formats.,"Explore current issues on collaboration: teamwork, leadership, communication. ",Apply theoretical frameworks for collaboration and  groups. ,Examine the application of learning styles in the education of professionals. ,Discuss the role of feedback  related to preceptorship of pharmacy students.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 504 (LEC A1 Fa18),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Reflective Paper ,Assignment,N/A,20,,18-10-04,,Demonstrate appreciation for self-directed and life-long learning.,Present information and views effectively in written and oral presentation formats.,Examine the application of learning styles in the education of professionals. ,Discuss the role of feedback  related to preceptorship of pharmacy students.,Relate core beliefs about teaching and learning to educational experiences.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 504 (LEC A1 Fa18),"PHARM 504 FRAMEWORK TEAMS, COLLAB, EDUC (LEC A1 Fa18)",Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (full-time),Terri Schindel,,Education Plan - Group,Assignment,N/A,20,,18-08-09,,Facilitate student and professional learning.,Present information and views effectively in written and oral presentation formats.,"Explore current issues on collaboration: teamwork, leadership, communication. ",Examine the application of learning styles in the education of professionals. ,"Design, deliver, and evaluate education plans using theoretical frameworks ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,"Functional groups, acidic and basic groups, pH and pKa",Assignment,N/A,5,,18-10-03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Midterm Exam,Exam,Multiple choice,35,,18-10-03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,"Salts and solubility; drug binding interactions, stereochemistry",Assignment,N/A,5,,18-11-03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Drug metabolism,Assignment,N/A,5,,18-11-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,SAR and strategies in drug design,Assignment,N/A,5,,18-12-08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 201 (LEC A1 Fa18),PHARM 201 PRINCIPLES MEDICINAL CHEMISTRY (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD),"Khaled Barakat, Ph.D, Carlos A. VelÃ¡zquez, Ph.D, Ayman El-Kadi, Ph.D",,Final Exam,Exam,Multiple choice,65,,18-12-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Reflection in Practice #4,Assignment,N/A,0,,19-04-29,,Envision oneâ€™s future role in pharmacy practice,Apply clinical judgment and critical thinking skills,Communicate effectively in writing,Demonstrate a process to develop and maintain professional competence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Additional Prescribing Self Assessment Form,Assignment,N/A,0,,19-02-04,,Envision oneâ€™s future role in pharmacy practice,Communicate effectively in writing,Demonstrate a process to develop and maintain professional competence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Prescribing Case Feeback,Assignment,N/A,0,,19-02-22,,Deliver effective feedback,Apply clinical judgment and critical thinking skills,Communicate effectively in writing,Demonstrate a process to develop and maintain professional competence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Implementation Record Feedback,Assignment,N/A,0,,19-04-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Preceptor Development,Assignment,N/A,0,,19-03-22,,Envision oneâ€™s future role in pharmacy practice,Communicate effectively in writing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Plan for Success in Experiential Education,Assignment,N/A,0,,18-09-07,,Envision oneâ€™s future role in pharmacy practice,Communicate effectively in writing,Demonstrate a process to develop and maintain professional competence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Tools For Practice ,Assignment,N/A,0,,18-09-21,,Develop a tool for practice based consideration of a clinical question and review of literature,Communicate effectively in writing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Learning Plan Feedback ,Assignment,N/A,0,,18-10-12,,Deliver effective feedback,Communicate effectively in writing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Reflection in Clinical Practice #1,Assignment,N/A,0,,18-10-15,,Envision oneâ€™s future role in pharmacy practice,Apply clinical judgment and critical thinking skills,Communicate effectively in writing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Tools For Practice Presentation,Assignment,N/A,0,,18-11-09,,Deliver effective feedback,Develop a tool for practice based consideration of a clinical question and review of literature,Communicate effectively in writing,Demonstrate effective verbal and nonverbal communication skills ,Demonstrate a process to develop and maintain professional competence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Intetprofessional Practice,Assignment,N/A,0,,18-11-30,,Envision oneâ€™s future role in pharmacy practice,Communicate effectively in writing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Reflection in Practice #2,Assignment,N/A,0,,18-12-17,,Envision oneâ€™s future role in pharmacy practice,Apply clinical judgment and critical thinking skills,Communicate effectively in writing,Demonstrate a process to develop and maintain professional competence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Patient Centred Care,Assignment,N/A,0,,19-01-18,,Envision oneâ€™s future role in pharmacy practice,Apply clinical judgment and critical thinking skills,Communicate effectively in writing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 538 (SEM 800 Fa18),PHARM 538 PHARMD SEMINARS (SEM 800 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,,"Ken Cor, Sheila Walter",,Reflection in Practice #3,Assignment,N/A,0,,19-03-04,,Envision oneâ€™s future role in pharmacy practice,Apply clinical judgment and critical thinking skills,Communicate effectively in writing,Demonstrate a process to develop and maintain professional competence,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,7 Specified online exercises,Other,N/A,8,,18-08-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Assignment #1: Case Submission and question,Assignment,N/A,1,,18-09-06,,"Develop a caring, empathetic attitude for patients experiencing the conditions covered.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,7 Quizzes ,Quiz,Multiple choice,19,,18-08-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Midterm,Exam,Written and multiple choice,25,,18-09-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Assignment #2: Case reflection and learning application,Assignment,N/A,2,,18-10-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 487 (Fall 2018 LEC A1 SEM E1),PHARM 487 Fa18 - PULMONARY Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,, 2nd year",Renette Bertholet,,Final,Exam,Written and multiple choice,45,,18-10-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 533 (LEC 850 Wi19),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Tara Leslie,,Final Exam,Exam,Written and multiple choice,40,NA,19-04-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 533 (LEC 850 Wi19),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Tara Leslie,,Tutorial Evaluation - Summative Assessment,Participation,N/A,7,NA,19-04-20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 533 (LEC 850 Wi19),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Tara Leslie,,Quiz for Case Topic 7,Exam,Multiple choice,0,NA,19-04-08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 533 (LEC 850 Wi19),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Tara Leslie,,Quiz for Case Topic 6,Exam,Multiple choice,0,NA,19-03-25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 533 (LEC 850 Wi19),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Tara Leslie,,Quiz for Case Topic 5,Quiz,Multiple choice,0,NA,19-03-11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 533 (LEC 850 Wi19),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Tara Leslie,,Midterm ,Exam,Written and multiple choice,30,NA,19-03-02,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 533 (LEC 850 Wi19),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Tara Leslie,,Quiz for Case Topic 4,Quiz,Multiple choice,0,NA,19-02-25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 533 (LEC 850 Wi19),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Tara Leslie,,Tutorial Evaluation- Formative,Participation,N/A,7,NA,19-02-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 533 (LEC 850 Wi19),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Tara Leslie,,Quiz for Case Topic 3,Quiz,Multiple choice,0,NA,19-02-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 533 (LEC 850 Wi19),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Tara Leslie,,Quiz for Case Topic 2,Exam,Multiple choice,0,NA,19-01-21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 533 (LEC 850 Wi19),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Tara Leslie,,Pharmacogenomic/Drug Interaction Assignment,Assignment,N/A,10,NA,19-04-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 533 (LEC 850 Wi19),PHARM 533 ADVANCED PHARMACOTHERAPY PT 2 (LEC 850 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,Doctor of Pharmacy (PharmD) for Practicing Pharmacists (part-time),Tara Leslie,,Quiz for Case Topic 1,Quiz,Multiple choice,0,NA,19-01-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Final,Exam,Multiple choice,45,,18-04-20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Midterm,Exam,Written and multiple choice,25,,18-04-20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Reflection,Assignment,N/A,15,,18-04-20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 212 (Fall 2018 LEC A1 SEM E1),PHARM 212 Fa18 - BEHAV ADMIN SOC EVIDENCE PH 1 Combined LEC SEM Fa18,Cross Listed Courses,"Doctor of Pharmacy (PharmD), 1st year","Lisa Guirguis, Ravina Sanghera",,Quizzes,Quiz,Written and multiple choice,15,,18-04-20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Professionalism,Participation,N/A,10,NA,18-03-28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Final Exam,Exam,Other,35,NA,18-12-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Reflections (2),Assignment,N/A,10,NA,18-09-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Midterm Exam,Exam,Other,15,NA,18-10-25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 220 (Fall 2018 LAB A1 A2 SEM E1 E2),PHARM 220 Fa18 - PATIENT CARE SKILLS 1 Combined LAB SEM Fa18,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Jody Shkrobot,,Lab assignments,Assignment,N/A,30,NA,18-09-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 311 (LEC A1 Fa18),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Arno G. Siraki,,In Class Quiz #2,Quiz,Multiple choice,10,,18-09-26,,"To develop a basic understanding of the contemporary diagnostic imaging modalities, including nuclear medicine imaging, x-ray, CT, ultrasound, and MRI, and an understanding of the nature of the clinical information provided by each modality","This course will provide general knowledge regarding diagnostic imaging and radioactivity, and will allow the pharmacist to place a proper perspective on such common concerns in a community as: Radiation safety in general; Biological hazards of radioactive material and installations utilizing radioactivity (eg. xray units) in hospitals and in the community; Risk â€“ benefit concepts in diagnostic imaging; General familiarity with imaging techniques/underlying principles.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 311 (LEC A1 Fa18),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Arno G. Siraki,,In Class Quiz #1,Quiz,Multiple choice,10,,18-09-07,,"This module has been designed to familiarize pharmacy students with basic principles of diagnostic imaging, with emphasis on the use of radiation and radioactive drugs and contrast agents in medical diagnosis and therapy. The biological effects of radiation are presented from the viewpoint of a pharmacist's perspective as a health sciences team member.","This course will provide general knowledge regarding diagnostic imaging and radioactivity, and will allow the pharmacist to place a proper perspective on such common concerns in a community as: Radiation safety in general; Biological hazards of radioactive material and installations utilizing radioactivity (eg. xray units) in hospitals and in the community; Risk â€“ benefit concepts in diagnostic imaging; General familiarity with imaging techniques/underlying principles.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 311 (LEC A1 Fa18),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Arno G. Siraki,,Final Exam ,Exam,Multiple choice,40,,18-10-05,,"This module has been designed to familiarize pharmacy students with basic principles of diagnostic imaging, with emphasis on the use of radiation and radioactive drugs and contrast agents in medical diagnosis and therapy. The biological effects of radiation are presented from the viewpoint of a pharmacist's perspective as a health sciences team member.","Following this course, students should be able to interpret the labels on radiopharmaceuticals; perform simple calculations related to radioactive decay.",To consider the various types of radiation and their characteristics and interactions with matter from the viewpoint of how these factors: Influence the utility of different radiations for clinical diagnosis or for therapy; Can present a health hazard from improper use or handling; Determine the methods of radiation detection and measurement,To present the basic principles underlying the biological effects observed with exposure to various levels of radioactivity.,To illustrate the rationale for the use of radioactive drugs and contrast agents for diagnosis by discussing: the various agents presently available from commercial suppliers; the physiological basis of their utility and clinical applications; their formulation and manufacture; methods of quality control and dispensing and inventory control. The use of radioactive drugs for therapy will be examined.,"To illustrate ""radiopharmaceutical kits"", and radionuclide generators for daily preparation of short-lived radiopharmaceuticals in a hospital.",To indicate the levels of radiation dose received from common radiopharmaceutical diagnostic procedures and the inherent dangers with contrast materials and to place these into a benefit vs. risk concept.,"To develop a basic understanding of the contemporary diagnostic imaging modalities, including nuclear medicine imaging, x-ray, CT, ultrasound, and MRI, and an understanding of the nature of the clinical information provided by each modality","To acquaint students with basic physical fundamentals regarding concepts of radioactivity, rates and types of radioactive decay; units of radiation; biological effects of radiation â€“ toxicity and therapy; free radical formation and detoxification; diagnostic imaging techniques, instrumentation, and utilization of radiopharmaceuticals.","This course will provide pharmacists with fundamental knowledge of contemporary clinical imaging modalities, including the use of radiopharmaceuticals and contrast agents in clinical diagnosis and therapy. Such a basic understanding will enable pharmacists, as members of a Health Team, to communicate knowledgeably with physicians, nurses, technicians and patients regarding the use of various imaging techniques. Emphasis will be placed on radiopharmaceuticals and contrast agents used with these procedures. The use of radioactive materials for in vitro and in vivo tests, and for radiation therapy, will be addressed. An understanding of the general principles underlying the biologic effects of various levels of radiation will assist the pharmacist in allaying patients' fears and misapprehensions regarding radioactivity.","This course will provide general knowledge regarding diagnostic imaging and radioactivity, and will allow the pharmacist to place a proper perspective on such common concerns in a community as: Radiation safety in general; Biological hazards of radioactive material and installations utilizing radioactivity (eg. xray units) in hospitals and in the community; Risk â€“ benefit concepts in diagnostic imaging; General familiarity with imaging techniques/underlying principles.","This course will provide a basis for further training (either formally or on-the-job) which will provide the expertise for safe and effective handling, preparation and dispensing of radiopharmaceuticals and maintaining proper quality control and inventory.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 311 (LEC A1 Fa18),PHARM 311 RADIOPHARM/DIAGNOSTIC IMAGING (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Arno G. Siraki,,Midterm Exam ,Exam,Multiple choice,40,,18-09-14,,"This module has been designed to familiarize pharmacy students with basic principles of diagnostic imaging, with emphasis on the use of radiation and radioactive drugs and contrast agents in medical diagnosis and therapy. The biological effects of radiation are presented from the viewpoint of a pharmacist's perspective as a health sciences team member.",To consider the various types of radiation and their characteristics and interactions with matter from the viewpoint of how these factors: Influence the utility of different radiations for clinical diagnosis or for therapy; Can present a health hazard from improper use or handling; Determine the methods of radiation detection and measurement,To present the basic principles underlying the biological effects observed with exposure to various levels of radioactivity.,To indicate the levels of radiation dose received from common radiopharmaceutical diagnostic procedures and the inherent dangers with contrast materials and to place these into a benefit vs. risk concept.,"To acquaint students with basic physical fundamentals regarding concepts of radioactivity, rates and types of radioactive decay; units of radiation; biological effects of radiation â€“ toxicity and therapy; free radical formation and detoxification; diagnostic imaging techniques, instrumentation, and utilization of radiopharmaceuticals.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 362 (LEC A1 Fa18),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Group Writing Assignment,Assignment,N/A,30,,16-12-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 362 (LEC A1 Fa18),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Midterm,Exam,Multiple choice,30,,16-11-21,,Be sensitive to ethical/legal issues that arise in contemporary pharmacy practice.,"Accept possible differences between personal values, morals and rights versus professional obligations and ethics.",Demonstrate caring and respect for others.,Accept the professional responsibility to act for the benefit of the patient.,"Demonstrate awareness of the demands of professional, ethical and legal responsibility.",Participate in debating a legal/ethical issue with oneâ€™s peers,"Demonstrate ability to distinguish an ethical problem from a legal one, and to identify points of intersection, divergence or confrontation.",Apply actions that a pharmacist can take to avoid ethical breaches and professional discipline,"Utilize the problem-solving method (e.g. identify the problem, identify possible alternatives, evaluate the alternatives, choose the best course of action, and defend the action) to integrate ethical and legal principles, and professionalism into pharmacy practice.","Apply actions that a pharmacist can take in order to avoid legal liability (e.g. avoiding medication errors, proper documentation, etc.).","Analyze an ethical or legal issue by determining principles involved, clarifying facts, prioritizing principles, assessing alternatives, determining duty and justifying decisions.","Argue both sides of an ethical or legal issue using ethical and legal principles derived from statutes, case law, bioethics literature and the Alberta College of Pharmacists Code of Ethics",Apply legal and ethical principles to issues that may occur in practice.,Describe the course of action taken by the Alberta College of Pharmacists on the issue of substance abuse by pharmacists.,Explain the process of disciplinary action by the Alberta College of Pharmacists.,Describe the court system in the Province of Alberta.,Outline the pharmacists ethical obligations.,"Define and explain the following ethical concepts: beneficence, nonmaleficence, autonomy, and informed consent.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 362 (LEC A1 Fa18),PHARM 362 PHARMACY LAWS AND ETHICS (LEC A1 Fa18),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Dr. Ubaka Ogbogu,,Final,Exam,Multiple choice,40,,16-12-09,,Explain the elements of negligence.,Define and explain the meaning and relevance of law and legal institutions.,"Describe the types of legal actions: Criminal prosecution, civil actions and professional discipline",Explain the process of disciplinary action by the Alberta College of Pharmacists.,Describe notable events in the history of medical ethics as relates to the pharmacy profession.,Describe ways that a pharmacist can avoid being sued for negligence.,Explain the legal requirements for privacy and confidentiality of health information under the Alberta Health Information Act.,Explain the legal implications of a personal directives and enduring powers of attorney.,Describe the unique health care issues faced by the Aboriginal Peoples of Canada.,Describe the legal and professional rules governing medical aid in dying.,Describe the defenses to a negligence or malpractice lawsuit.,Explain how compensation for a negligence lawsuit is determined.,Describe the course of action taken by the Alberta College of Pharmacists on the issue of substance abuse by pharmacists.,Apply legal and ethical principles to issues that may occur in practice.,"Argue both sides of an ethical or legal issue using ethical and legal principles derived from statutes, case law, bioethics literature and the Alberta College of Pharmacists Code of Ethics","Analyze an ethical or legal issue by determining principles involved, clarifying facts, prioritizing principles, assessing alternatives, determining duty and justifying decisions.","Apply actions that a pharmacist can take in order to avoid legal liability (e.g. avoiding medication errors, proper documentation, etc.).","Utilize the problem-solving method (e.g. identify the problem, identify possible alternatives, evaluate the alternatives, choose the best course of action, and defend the action) to integrate ethical and legal principles, and professionalism into pharmacy practice.",Apply actions that a pharmacist can take to avoid ethical breaches and professional discipline,"Demonstrate ability to distinguish an ethical problem from a legal one, and to identify points of intersection, divergence or confrontation.",Participate in debating a legal/ethical issue with oneâ€™s peers,"Demonstrate awareness of the demands of professional, ethical and legal responsibility.",Accept the professional responsibility to act for the benefit of the patient.,Demonstrate caring and respect for others.,"Accept possible differences between personal values, morals and rights versus professional obligations and ethics.",Be sensitive to ethical/legal issues that arise in contemporary pharmacy practice.,,,,,,,,,,,,,,,,,,,,,PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Seminar 2 Quiz,Quiz,Written,5,,17-06-23,,"Describe the pathophysiology of the conditions of primary focus including clinical presentations, symptomatology, and complications. ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Midterm,Exam,Multiple choice,40,,17-11-22,,Describe the specific laboratory tests and other diagnostic tests used in the diagnosis and monitoring of the conditions of primary focus.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the conditions of primary focus.",Discuss the complementary and alternative medicine used in GI diseases.,"Describe the pathophysiology of the conditions of primary focus including clinical presentations, symptomatology, and complications. ",Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of primary focus,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.","Describe the mechanisms, efficacy, side effect profiles and role of each of the following drugs or drug classes: i. Antidiarrheals ii. Laxatives iii. Antinauseants iv. Antiemetics v. Antacids vi. Anti-gas vii. Antispasmodics viii. Drugs Stimulating Gastrointestinal Motility (Prokinetic Agents) ix. Proton-Pump Inhibitors x. H2 receptor antagonists xi. Mucosal protective agents Sucralfate, Prostaglandin analogs (ie misoprostil), Colloidal Bismuth Compounds xii. Antibiotics used for PUD xiii. Aminosalicylates xiv. Corticosteroids used in IBD xv. Immunosuppressants used in IBD (including azathioprine, 6-mercaptopurine, cyclosporine, methotrexate) xvi. Tumour necrosis factor â€“ alpha antagonists (infliximab, adalimumab, certolizumab, golimumab) xvii. Pharmacotherapy for complications of cirrhosis (ie diuretics, spironolactone, beta-blockers, octreotide, lactulose, and metronidazole)",Describe the societal and economic impact of the conditions of primary focus.,Identify ethical issues surrounding treatment of the conditions of primary focus,Discuss drugs that can be toxic to the liver,"Describe the treatment options for oral health such as canker sores, dry mouth, and mouth care.",Discuss the types of ostomy supplies used by patients with ostomies,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments to the conditions of primary focus, including use of specific target drugs for condition as well as complementary and alternative therapies",Discuss monitoring parameters for each of the disease of focus,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Select appropriate treatment for special groups (pediatrics, elderly, pregnancy)",Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Final,Exam,Written and multiple choice,50,,17-12-15,,Explain the anatomy of the gastrointestinal tract; describe the functions of the gastrointestinal tract.  ,Explain the anatomy of the liver; describe the functions of the liver . ,Identify applicable health system resources.,Appreciate the interdisciplinary approach to management of the condition,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Discuss monitoring parameters for each of the disease of focus,Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,"Select appropriate treatment for special groups (pediatrics, elderly, pregnancy)",Utilize self-directed learning abilities.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.",Develop an appreciation of the interdisciplinary nature of patient care.,Accept responsibility for keeping abreast of emerging technologies and drugs.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 357 (Fall 2018 LEC A1 SEM E1 E2),PHARM 357 Fa18 - GASTROINTESTINAL Combined LEC SEM Fa18,Cross Listed Courses,"Therapeutics,",to be assigned,,Seminar 1 Quiz,Quiz,Written,5,,17-06-23,,"Describe the pathophysiology of the conditions of primary focus including clinical presentations, symptomatology, and complications. ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Rare Neurologic Disorders Assignment,Assignment,N/A,10,,17-06-29,,Summarize the impact on and care for patients with rare neurologic disorders.,Synthesize information gained from various literature resources to solve problems or make recommendations,Utilize self-directed learning abilities.,Calculate and apply the applicable pharmacokinetic parameters to monitor patients using these medications.,Identify actual and potential drug-related problems relating to of the conditions of primary focus in patient case studies.,Identify clinically significant drug interactions with drugs used to treat the conditions of primary focus.,Identify presenting symptoms that would be integrated into a triage approach for patients.,"Select appropriate treatment for special groups (e.g. pediatrics, geriatrics, pregnancy, lactation)",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug-related problems,Identify when to inform caregivers and other members of the health care team if there are danger signs apparent in the assessment.,"For each of the conditions described the student should: review the presenting signs and symptoms of the conditions of primary focus, and describe criteria used to make the diagnosis and to be able to relate the severity of the disease; discuss the therapeutic options with peers, including risks and benefits, and medication and alternative therapy choices; recommend appropriate monitoring parameters; recommend appropriate changes to therapy based on patient outcomes and monitoring parameters","Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Accept responsibility for keeping abreast of emerging technologies and drugs.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Develop an appreciation for advocacy required for individuals with neurologic disorders.,Appreciate the roles of members of the healthcare team in caring for patients with neurologic conditions,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Midterm,Exam,Multiple choice,40,,17-10-20,,Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of primary focus.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify ethical issues surrounding treatment of the conditions of primary focus,"Explain the anatomy of the central, peripheral and autonomic nervous system, cranial nerves and sensory and motor system","Describe the physiology of the spinal reflexes, somatosensory system, motor control and higher nervous function.",Describe the pathophysiology of the conditions of primary focus.,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Describe the clinical presentation and symptomatology of the conditions of primary focus.,Describe the laboratory tests used in the diagnosis and monitoring of the conditions of primary focus.,"Apply concepts and knowledge of medicinal chemistry, pharmacology/toxicology, and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe the societal and economic impact of the conditions of primary focus.,Appreciate the interdisciplinary approach to management of the conditions of primary focus.,Describe the long term health consequences of the conditions of primary focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments for the conditions of primary focus, including use of specific target drugs for condition as well as alternative therapies (including dose, route of administration, duration of therapy, monitoring parameters)",Synthesize information gained from various literature resources to solve problems or make recommendations,Calculate and apply the applicable pharmacokinetic parameters to monitor patients using these medications.,Identify actual and potential drug-related problems relating to of the conditions of primary focus in patient case studies.,Identify clinically significant drug interactions with drugs used to treat the conditions of primary focus.,Identify presenting symptoms that would be integrated into a triage approach for patients.,"Select appropriate treatment for special groups (e.g. pediatrics, geriatrics, pregnancy, lactation)",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug-related problems,Identify when to inform caregivers and other members of the health care team if there are danger signs apparent in the assessment.,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.","Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",,,,,,,,,,,,,,,,,,,,,,PHARM 417 (Fall 2018 LEC A1 SEM E1),PHARM 417 - NEUROLOGY (Fall 2018) ,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Sherif Mahmoud,,Final,Exam,Written and multiple choice,50,,16-11-01,,Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of primary focus.,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify ethical issues surrounding treatment of the conditions of primary focus,"Explain the anatomy of the central, peripheral and autonomic nervous system, cranial nerves and sensory and motor system","Describe the physiology of the spinal reflexes, somatosensory system, motor control and higher nervous function.",Describe the pathophysiology of the conditions of primary focus.,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",Describe the clinical presentation and symptomatology of the conditions of primary focus.,Describe the laboratory tests used in the diagnosis and monitoring of the conditions of primary focus.,"Apply concepts and knowledge of medicinal chemistry, pharmacology/toxicology, and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of primary focus.",Describe the societal and economic impact of the conditions of primary focus.,Appreciate the interdisciplinary approach to management of the conditions of primary focus.,Describe the long term health consequences of the conditions of primary focus.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments for the conditions of primary focus, including use of specific target drugs for condition as well as alternative therapies (including dose, route of administration, duration of therapy, monitoring parameters)",Synthesize information gained from various literature resources to solve problems or make recommendations,Calculate and apply the applicable pharmacokinetic parameters to monitor patients using these medications.,Identify actual and potential drug-related problems relating to of the conditions of primary focus in patient case studies.,Identify clinically significant drug interactions with drugs used to treat the conditions of primary focus.,Identify presenting symptoms that would be integrated into a triage approach for patients.,"Select appropriate treatment for special groups (e.g. pediatrics, geriatrics, pregnancy, lactation)",Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,Identify and locate sources of information needed to solve drug-related problems,Identify when to inform caregivers and other members of the health care team if there are danger signs apparent in the assessment.,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral, reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.","Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",,,,,,,,,,,,,,,,,,,,,,PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Midterm Exam,Exam,Multiple choice,40,,18-09-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Final Exam,Exam,Multiple choice,50,,18-10-05,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Online Discussion (Seminar 3),Exam,Multiple choice,5,,18-07-11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 467 (Fall 2018 LEC A1 SEM E1),PHARM 467 Fa18 - ONCOLOGY Combined LEC SEM Fa18,Cross Listed Courses,,Tara Leslie,,Oncology Basics (Seminar 1),Other,N/A,5,,18-09-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Integrated cases - 1 case per semester,Assignment,N/A,15,,18-08-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Professionalism,Participation,N/A,5,,18-08-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Midterm ,Exam,Other,25,,18-12-17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Lab assignments ,Lab,N/A,20,,18-08-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 430A (Fall 2018 LAB D1 LEC C1),PHARM 430A Fa18 - COMPREHENSIVE PATIENT ASSESS 2 Combined LAB LEC Fa18,Cross Listed Courses,,"Gillian Johnson, Teri Charrois, Rene Breault, Candace Necyk",,Final ,Exam,Other,35,,19-04-25,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,,,N/A,0,,69-12-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,,,N/A,0,,69-12-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,,,N/A,0,,69-12-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,,,N/A,0,,69-12-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,,,N/A,0,,69-12-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,,,N/A,0,,69-12-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,,,N/A,0,,69-12-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,,,N/A,0,,69-12-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,,,N/A,0,,69-12-31,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Midterm Exam ,Exam,Written and multiple choice,40,,18-10-11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Quizzes ,Quiz,Multiple choice,5,,18-07-09,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 407 (Fall 2018 LEC A1 SEM E1),PHARM 407 Fa18 - INFECTIOUS DISEASES 1 Combined LEC SEM Fa18,Cross Listed Courses,,Dr. Nathan Beahm,,Final Exam ,Exam,Written and multiple choice,55,,18-12-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Community Education Session,Assignment,N/A,0,,18-05-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Midterm Exam,Exam,Written and multiple choice,25,,19-03-01,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Seminars 1-6,Other,N/A,25,,18-05-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,EBCP Literacy Assignment ,Assignment,N/A,10,,19-04-03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Quizzes,Quiz,Written and multiple choice,20,,18-05-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 213 (Winter 2019 LEC B1 SEM J1),PHARM 213 Wi19 - BEHAV ADMIN SOC EVIDENCE PH 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Ravina Sanghera, Terri Schindel, Lisa Guirguis, Mark Makowsky, Tatiana Makhinova",,Final Exam,Exam,Written and multiple choice,45,,19-04-23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Online Discussion Participation,Participation,N/A,10,,18-04-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Final,Exam,Multiple choice,0,,18-04-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Midterm,Exam,Multiple choice,30,,18-04-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Post-Seminar Quiz,Quiz,Multiple choice,5,,18-04-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Online exercises,Participation,N/A,5,,18-04-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 205 (Winter 2019 LEC B1 SEM J1),PHARM 205 Wi19 - PHYSIOLOGY AND ANATOMY PHARM 2 Combined LEC SEM Wi19,Cross Listed Courses,,"Susan Patrick, Ph.D",,Assignment: Bone and joint anatomy and physiology,Assignment,N/A,10,,18-04-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Midterm,Exam,Multiple choice,15,,19-02-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 203 (LEC B1 Wi19),PHARM 203 INTRODUCTION TO PHARMACOLOGY (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,,"Dr. Paul Jurasz , Dr. John Ussher",,Final,Exam,Multiple choice,35,,19-04-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi19),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Peer Assessment,Group,N/A,2,NA,18-10-08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi19),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Team Debate (Group) â€“ Instructor evaluation,Assignment,N/A,8,NA,18-10-08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi19),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Quiz #1,Quiz,Written and multiple choice,1,NA,19-01-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi19),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Quiz #2,Quiz,Written and multiple choice,1,NA,19-01-21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi19),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Quiz #3,Quiz,Written and multiple choice,1,NA,19-02-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi19),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Quiz #4,Quiz,Written and multiple choice,1,NA,19-03-04,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi19),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Quiz #5,Quiz,Written and multiple choice,1,NA,19-03-11,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi19),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Midterm Exam,Exam,Written and multiple choice,30,NA,19-02-25,,Develop an appreciation of the different pharmacy service delivery models in different provincial and relevant international jurisdictions.,"Develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Albertan health systems.",Develop and debate solutions to some of the challenges facing the Canadian healthcare system with emphasis on how pharmacists and pharmacies can be a part of those solutions.,Identify and debate key issues and challenges facing the Canadian healthcare system.,Describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,"List the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to the delivery of health care in Canada with particular emphasis on organizations that impact the profession of pharmacy.","Describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically, Alberta.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi19),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Final Exam,Exam,Written and multiple choice,50,Cumulative,19-04-12,,Develop an appreciation of the different pharmacy service delivery models in different provincial and relevant international jurisdictions.,"Develop an appreciation for the recommendations made by current (i.e. within the past 10 years) studies, reports and reviews of the Canadian and Albertan health systems.",Develop and debate solutions to some of the challenges facing the Canadian healthcare system with emphasis on how pharmacists and pharmacies can be a part of those solutions.,Identify and debate key issues and challenges facing the Canadian healthcare system.,Describe some of the strategies that pharmacists and pharmacy organizations use to influence others within the Canadian healthcare system.,"List the names and describe the function of relevant health professional associations, government agencies, advocacy groups, and private sector players as it pertains to the delivery of health care in Canada with particular emphasis on organizations that impact the profession of pharmacy.","Describe the components of the healthcare system and how they interrelate as it pertains to the delivery of healthcare services in Canada and more specifically, Alberta.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 382 (LEC B1 Wi19),PHARM 382 PROV/CDN HEALTHCARE (LEC B1 Wi19),Faculty of Pharmacy and Pharmaceutical Sciences,BSc in Pharmacy,Jody Shkrobot,,Team Debate (Group) â€“ Peer evaluation,Other,N/A,5,NA,18-10-08,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Seminars,Participation,N/A,20,NA,18-12-19,,Accept responsibility for keeping abreast of emerging technologies and drugs.,Develop an appreciation of the interdisciplinary nature of patient care.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Work effectively in a healthcare team.,Utilize self-directed learning abilities.,Develop and practice skills for measuring blood pressure and heart rate.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Critically evaluate the appropriateness and reliability of information from literature resources.,Identify and locate sources of information needed to solve drug related problems.,Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,Follow appropriate monitoring parameters,Apply and demonstrate appropriate counseling and communication with patients,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,Obtain a relevant history from a patient,Identify applicable health system resources,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify ethical issues surrounding treatment of the conditions of primary focus,Describe the societal and economic impact of the conditions of primary focus,Describe how to manage the toxicity of cardiac medications,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,"Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.","Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction",Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Discuss the physiology of the blood supply, lymphatic system and cardiovascular system of the human body.",Explain the anatomy of the heart and great blood vessels.,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",,,,,,,,,,,,PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,BP Clinic ,Assignment,N/A,0,NA,18-12-19,,Develop an appreciation of the interdisciplinary nature of patient care.,Obtain a relevant history from a patient,Describe the societal and economic impact of the conditions of primary focus,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Midterm,Exam,Written and multiple choice,35,NA,19-02-13,,Accept responsibility for keeping abreast of emerging technologies and drugs.,Develop an appreciation of the interdisciplinary nature of patient care.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Work effectively in a healthcare team.,Utilize self-directed learning abilities.,Develop and practice skills for measuring blood pressure and heart rate.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Critically evaluate the appropriateness and reliability of information from literature resources.,Identify and locate sources of information needed to solve drug related problems.,Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,Follow appropriate monitoring parameters,Apply and demonstrate appropriate counseling and communication with patients,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,Obtain a relevant history from a patient,Identify applicable health system resources,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify ethical issues surrounding treatment of the conditions of primary focus,Describe the societal and economic impact of the conditions of primary focus,Describe how to manage the toxicity of cardiac medications,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,"Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.","Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction",Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Discuss the physiology of the blood supply, lymphatic system and cardiovascular system of the human body.",Explain the anatomy of the heart and great blood vessels.,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",,,,,,,,,,,,PHARM 367 (Winter 2019 LEC B1 SEM J1),PHARM 367 Wi19 - CARDIOLOGY Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Dr. John M. Seubert,,Final,Exam,Written and multiple choice,45,NA,18-12-19,,Accept responsibility for keeping abreast of emerging technologies and drugs.,Develop an appreciation of the interdisciplinary nature of patient care.,"Develop a caring, empathic attitude for patients experiencing the conditions of primary focus.",Work effectively in a healthcare team.,Utilize self-directed learning abilities.,Develop and practice skills for measuring blood pressure and heart rate.,Synthesize information gained from various literature resources to solve problems or make recommendations.,Critically evaluate the appropriateness and reliability of information from literature resources.,Identify and locate sources of information needed to solve drug related problems.,Utilize an evidence-based approach to therapeutic management of the conditions of primary focus.,"Make rational, safe and effective drug treatment decisions for therapy, evaluation and monitoring based on an integrated knowledge of therapeutics, medicinal chemistry, and pharmacology.",Manage clinically significant drug interactions with drugs used to treat the conditions of primary focus.,Identify actual and potential drug related problems relating the conditions of primary focus and in various patient cases.,"Design pharmaceutical care plans including alternatives (drug, non-drug, referral,reassurance), recommendations, implementation, monitoring and follow up for patients with the conditions of primary focus.",Recommend appropriate changes to therapy based on patient outcomes and monitoring parameters,Follow appropriate monitoring parameters,Apply and demonstrate appropriate counseling and communication with patients,"Discuss the therapeutic options with patient, including risks and benefits, and medication and alternative therapy choices",Review the presenting signs and symptoms of the conditions of primary focus and describe criteria used to make the diagnosis and to be able to relate the severity of the disease,Obtain a relevant history from a patient,Identify applicable health system resources,Identify the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify ethical issues surrounding treatment of the conditions of primary focus,Describe the societal and economic impact of the conditions of primary focus,Describe how to manage the toxicity of cardiac medications,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of primary focus including use of specific target drugs forcondition as well as alternative therapies (dose, route of administration, length of therapy,monitoring parameters)",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of primary focus,Explain the effects of drugs used in the management of the conditions of primary focus.,Describe pharmacokinetic and pharmacodynamic principles applicable to the treatment of the conditions of primary focus.,"Describe medicinal chemistry, pharmacology and therapeutic principles applicable to selecting and monitoring drug therapy for the management of the conditions of primary focus.","Explain various basic cardiovascular measurements including: Heart sounds, Blood Pressure, Heart Rate, CXR, ECG, Ejection fraction",Describe the pathophysiology of the conditions of primary focus including clinical presentation and symptomatology and long term health consequences.,"Discuss the physiology of the blood supply, lymphatic system and cardiovascular system of the human body.",Explain the anatomy of the heart and great blood vessels.,"Describe the epidemiology, etiology, and risk factors of the conditions of primary focus.",,,,,,,,,,,,PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Group Homework Assignment,Assignment,N/A,15,NA,19-03-27,,"Demonstrate critical appraisal skills to assess validity, relevance, and applicability of the pharmacoepidemiologic literature.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,In-Class Quiz,Quiz,Multiple choice,5,NA,19-02-08,,Classify and describe common types of bias that threaten internal validity of pharmacoepidemiologic studies,List Sir Bradford-Hills considerations for inferring causation from observational data.,Define causal inference.,Define and interpret effect modification.,Interpret different measures of association reported in pharmacoepidemiologic studies.,Identify the advantages and limitations of each pharmacoepidemiologic study design. Examples of different studies will be used to illustrate these elements.,Describe the role of observational studies and randomized controlled trials to support evidence based clinical decisions about safety.,Define power and other factors that can influence sample size when trying to detect a difference in risk.,Recognize the difference between type I and type II errors.,Describe the inherent limitations of the drug approval process and pre-marketing clinical trials with regard to assessment of drug safety and effectiveness.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Midterm,Exam,Written and multiple choice,40,NA,19-03-06,,"Demonstrate critical appraisal skills to assess validity, relevance, and applicability of the pharmacoepidemiologic literature.",Explain how we can use pharmacoepidemiologic studies to assess the suspected causal relationship between a drug and an adverse reaction.,Describe the major elements of a systematic review and meta-analysis.,Explain the role of systematic reviews and meta-analyses.,Describe methods used to minimize the effects of confounding in pharmacoepidemiologic studies.,Define confounding and explain how it can affect the interpretation of an association.,Explain how specific biases may affect measures of association.,Classify and describe common types of bias that threaten internal validity of pharmacoepidemiologic studies,List Sir Bradford-Hills considerations for inferring causation from observational data.,Define causal inference.,Define and interpret effect modification.,Interpret different measures of association reported in pharmacoepidemiologic studies.,Identify the advantages and limitations of each pharmacoepidemiologic study design. Examples of different studies will be used to illustrate these elements.,Recognize the difference between type A and type B drug reactions and explain which drug reactions are the focus of pharmacoepidemiologic studies.,Explain why we need adverse drug reaction reporting systems and why pharmacists should contribute to this process.,Describe the role of observational studies and randomized controlled trials to support evidence based clinical decisions about safety.,Define power and other factors that can influence sample size when trying to detect a difference in risk.,Recognize the difference between type I and type II errors.,Describe the inherent limitations of the drug approval process and pre-marketing clinical trials with regard to assessment of drug safety and effectiveness.,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 392 (Winter 2019 LEC B2 SEM J2),PHARM 392 Wi19 - PHARMACOEPIDEMIOLOGY/PRACT RSC Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, BSc in Pharmacy, 2nd year","Tatiana Makhinova, BSP, PhD",,Final,Exam,Written and multiple choice,40,NA,19-04-04,,"Demonstrate critical appraisal skills to assess validity, relevance, and applicability of the pharmacoepidemiologic literature.",Describe the major elements of pharmacoeconomic evaluations.,Describe how validity of a survey is measured.,Describe the major elements of a survey.,Explain how the guiding ethical principles from the Tri-Council Policy Statement (TCPS) apply when conducting practice based research.,List common challenges and solutions when integrating research into practice settings.,Describe different study designs that are commonly used in pharmacy practice research. Examples will be used to illustrate the advantages and limitations of these different study designs.,Describe the knowledge-to-action cycle.,Define knowledge translation.,Define care gap.,Describe the structure-process-outcomes model for evaluating quality of health services.,Describe the major elements of a quality improvement framework.,Explain how we can use pharmacoepidemiologic studies to assess the suspected causal relationship between a drug and an adverse reaction.,Describe the major elements of a systematic review and meta-analysis.,Explain the role of systematic reviews and meta-analyses.,Describe methods used to minimize the effects of confounding in pharmacoepidemiologic studies.,Define confounding and explain how it can affect the interpretation of an association.,Explain how specific biases may affect measures of association.,Classify and describe common types of bias that threaten internal validity of pharmacoepidemiologic studies,List Sir Bradford-Hills considerations for inferring causation from observational data.,Define causal inference.,Define and interpret effect modification.,Interpret different measures of association reported in pharmacoepidemiologic studies.,Identify the advantages and limitations of each pharmacoepidemiologic study design. Examples of different studies will be used to illustrate these elements.,"Describe the major elements of cross-sectional, case-control and cohort studies.",Describe the common data sources used in pharmacoepidemiologic studies. Examples will be presented to highlight the advantages and limitations of each data source.,Define safety signal and explain how it may be generated.,Recognize the difference between type A and type B drug reactions and explain which drug reactions are the focus of pharmacoepidemiologic studies.,Explain why we need adverse drug reaction reporting systems and why pharmacists should contribute to this process.,Describe the role of observational studies and randomized controlled trials to support evidence based clinical decisions about safety.,Define power and other factors that can influence sample size when trying to detect a difference in risk.,Recognize the difference between type I and type II errors.,Describe the inherent limitations of the drug approval process and pre-marketing clinical trials with regard to assessment of drug safety and effectiveness.,,,,,,,,,,,,,,PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,Midterm,Exam,Written and multiple choice,40,NA,19-01-26,,"By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",Search and report on a topic of relevance to nutrition and health.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).",Discuss dietary management for prophylactic and therapeutic approach of patient care.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Explain their learning and knowledge of nutrition to those who are disease state.,Explain how dietary agents (functional foods and nutraceuticals) may preventor delay the onset of some chronic diseases.,Explain the interaction of food and drug.,"Explain the interrelation of the biochemical, pharmacological and physiological functions of nutrients.","Understand the application of various tools for nutritional assessment, nutritional deficiencies and toxicities, components of healthy diets, and principles of non-prescription natural health products, functional food regulations, food safety and food processing technologies.","Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 327 (Winter 2019 LEC B1 B2),PHARM 327 Wi19 - NUTRITION Combined LEC Wi19,Cross Listed Courses,,Hoon Sunwoo,,Final,Exam,Written and multiple choice,60,NA,19-02-16,,"By the end of this course, students will be able to develop an appreciation of the fundamental importance of nutrition.",Search and report on a topic of relevance to nutrition and health.,"Discuss the criteria of an adequate diet for healthy individuals at various lifecycles (preconception, pregnancy, lactation, infancy, toddler, adolescence, adult and elder).",Discuss dietary management for prophylactic and therapeutic approach of patient care.,Identify healthy diet for prevention and amelioration of chronic diseases inpatient cases.,Explain their learning and knowledge of nutrition to those who are disease state.,Explain how dietary agents (functional foods and nutraceuticals) may preventor delay the onset of some chronic diseases.,Explain the interaction of food and drug.,"Explain the interrelation of the biochemical, pharmacological and physiological functions of nutrients.","Understand the application of various tools for nutritional assessment, nutritional deficiencies and toxicities, components of healthy diets, and principles of non-prescription natural health products, functional food regulations, food safety and food processing technologies.","Understand nutritional terminology, dietary requirements, and the role of nutrients in health and disease states, including obesity, diabetes, cardiovascular, osteoporosis, celiac disease, non-celiac gluten sensitivity, cancer, and autoimmune-inflammatory diseases.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Health Aisle Assignment  ,Assignment,N/A,5,NA,19-03-15,,Develop an appreciation of the role of complementary and alternative medicine in patient care and the role of the pharmacist around CAM use by patients. ,Appreciate the need for lifelong learning skills that will enable maintenance of competence through keeping abreast of emerging technologies and drugs.,Develop an appreciation of the interdisciplinary nature of patient care.,Utilize independent and collaborative approaches to learning,Evaluate and apply information from literature and other resources to provide patient care.,"Utilize an evidence based approach to therapeutic management of the self-care, CAM and pulmonary conditions covered.",Identify and locate sources of information needed to provide patient care.,"Identify ethical issues in the management of self-care, CAM, and pulmonary conditions.","Outline the economic and health policy issues as they relate to self-care, CAM, and pulmonary conditions.",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,#2 Reflection,Assignment,N/A,4,NA,19-04-05,,Develop an appreciation of the role of complementary and alternative medicine in patient care and the role of the pharmacist around CAM use by patients. ,Appreciate the need for lifelong learning skills that will enable maintenance of competence through keeping abreast of emerging technologies and drugs.,Develop an appreciation of the interdisciplinary nature of patient care.,"Develop a caring, empathetic attitude for patients experiencing the conditions covered.",Utilize independent and collaborative approaches to learning,"Utilize an evidence based approach to therapeutic management of the self-care, CAM and pulmonary conditions covered.","Develop a therapeutic and monitoring plan, taking into consideration patient factors, efficacy, toxicity, cost, route of administration, etc.","Conduct a patient assessment using relevant data from the patient history, review of systems, laboratory tests, diagnostic imaging and medication history in order to provide patient care.","Describe the therapeutic approach to managing the conditions covered, including: Guideline recommendations and clinical targets; Pharmacological (dose, duration of therapy, monitoring parameters); Non-pharmacological treatments, and; CAM.","Describe the role of the patient, the pharmacist and other healthcare providers in the management of common self-care conditions, CAM  and pulmonary diseases of focus",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,#1 Reflection,Assignment,N/A,1,NA,19-01-11,,Develop an appreciation of the interdisciplinary nature of patient care.,"Develop a caring, empathetic attitude for patients experiencing the conditions covered.","Describe the role of the patient, the pharmacist and other healthcare providers in the management of common self-care conditions, CAM  and pulmonary diseases of focus",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Exercises,Assignment,N/A,10,NA,18-12-19,,Utilize independent and collaborative approaches to learning,Evaluate and apply information from literature and other resources to provide patient care.,"Utilize an evidence based approach to therapeutic management of the self-care, CAM and pulmonary conditions covered.",Manage clinically significant drug interactions with drugs used to treat the self-care and pulmonary conditions covered.,"Develop a therapeutic and monitoring plan, taking into consideration patient factors, efficacy, toxicity, cost, route of administration, etc.",Identify and locate sources of information needed to provide patient care.,"Conduct a patient assessment using relevant data from the patient history, review of systems, laboratory tests, diagnostic imaging and medication history in order to provide patient care.","Identify ethical issues in the management of self-care, CAM, and pulmonary conditions.","Outline the economic and health policy issues as they relate to self-care, CAM, and pulmonary conditions.","Describe the therapeutic approach to managing the conditions covered, including: Guideline recommendations and clinical targets; Pharmacological (dose, duration of therapy, monitoring parameters); Non-pharmacological treatments, and; CAM.","Explain the mechanism of action, pharmacokinetic principles, clinical effect(s), adverse effects & drug interactions for the medication classes covered.","Describe the risk factors, clinical presentation, and assessment parameters (signs and symptoms, laboratory values/tests, physical findings and diagnostic measurements) of the conditions covered. ","Outline the epidemiology, etiology and pathophysiology of the self-care and pulmonary conditions covered.","Describe the role of the patient, the pharmacist and other healthcare providers in the management of common self-care conditions, CAM  and pulmonary diseases of focus",Identify the different complementary and alternative medicine modalities and the reasons why patients may seek care from a CAM provider or product.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Final,Exam,Written and multiple choice,40,NA,18-04-25,,Develop an appreciation of the role of complementary and alternative medicine in patient care and the role of the pharmacist around CAM use by patients. ,Appreciate the need for lifelong learning skills that will enable maintenance of competence through keeping abreast of emerging technologies and drugs.,Develop an appreciation of the interdisciplinary nature of patient care.,"Develop a caring, empathetic attitude for patients experiencing the conditions covered.",Utilize independent and collaborative approaches to learning,Evaluate and apply information from literature and other resources to provide patient care.,"Utilize an evidence based approach to therapeutic management of the self-care, CAM and pulmonary conditions covered.",Manage clinically significant drug interactions with drugs used to treat the self-care and pulmonary conditions covered.,"Develop a therapeutic and monitoring plan, taking into consideration patient factors, efficacy, toxicity, cost, route of administration, etc.",Identify and locate sources of information needed to provide patient care.,"Conduct a patient assessment using relevant data from the patient history, review of systems, laboratory tests, diagnostic imaging and medication history in order to provide patient care.","Identify ethical issues in the management of self-care, CAM, and pulmonary conditions.","Outline the economic and health policy issues as they relate to self-care, CAM, and pulmonary conditions.","Describe the therapeutic approach to managing the conditions covered, including: Guideline recommendations and clinical targets; Pharmacological (dose, duration of therapy, monitoring parameters); Non-pharmacological treatments, and; CAM.","Explain the mechanism of action, pharmacokinetic principles, clinical effect(s), adverse effects & drug interactions for the medication classes covered.","Describe the risk factors, clinical presentation, and assessment parameters (signs and symptoms, laboratory values/tests, physical findings and diagnostic measurements) of the conditions covered. ","Outline the epidemiology, etiology and pathophysiology of the self-care and pulmonary conditions covered.","Describe the role of the patient, the pharmacist and other healthcare providers in the management of common self-care conditions, CAM  and pulmonary diseases of focus",Identify the different complementary and alternative medicine modalities and the reasons why patients may seek care from a CAM provider or product.,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Seminar Quizzes,Quiz,Multiple choice,15,NA,18-12-19,,Develop an appreciation of the role of complementary and alternative medicine in patient care and the role of the pharmacist around CAM use by patients. ,Appreciate the need for lifelong learning skills that will enable maintenance of competence through keeping abreast of emerging technologies and drugs.,Develop an appreciation of the interdisciplinary nature of patient care.,"Develop a caring, empathetic attitude for patients experiencing the conditions covered.",Utilize independent and collaborative approaches to learning,Evaluate and apply information from literature and other resources to provide patient care.,"Utilize an evidence based approach to therapeutic management of the self-care, CAM and pulmonary conditions covered.",Manage clinically significant drug interactions with drugs used to treat the self-care and pulmonary conditions covered.,"Develop a therapeutic and monitoring plan, taking into consideration patient factors, efficacy, toxicity, cost, route of administration, etc.",Identify and locate sources of information needed to provide patient care.,"Conduct a patient assessment using relevant data from the patient history, review of systems, laboratory tests, diagnostic imaging and medication history in order to provide patient care.","Identify ethical issues in the management of self-care, CAM, and pulmonary conditions.","Outline the economic and health policy issues as they relate to self-care, CAM, and pulmonary conditions.","Describe the therapeutic approach to managing the conditions covered, including: Guideline recommendations and clinical targets; Pharmacological (dose, duration of therapy, monitoring parameters); Non-pharmacological treatments, and; CAM.","Explain the mechanism of action, pharmacokinetic principles, clinical effect(s), adverse effects & drug interactions for the medication classes covered.","Describe the risk factors, clinical presentation, and assessment parameters (signs and symptoms, laboratory values/tests, physical findings and diagnostic measurements) of the conditions covered. ","Outline the epidemiology, etiology and pathophysiology of the self-care and pulmonary conditions covered.","Describe the role of the patient, the pharmacist and other healthcare providers in the management of common self-care conditions, CAM  and pulmonary diseases of focus",Identify the different complementary and alternative medicine modalities and the reasons why patients may seek care from a CAM provider or product.,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 243 (Winter 2019 LEC B1 SEM J1),PHARM 243 Wi19 - PHARMACOTHERAPY 1 Combined LEC SEM Wi19,Cross Listed Courses,Doctor of Pharmacy (PharmD),"Candace Necyk , Renette Bertholet, Ravina Sanghera-Grewal , Patrick Mayo, Alysha Hemraj",,Midterm,Exam,Written and multiple choice,25,NA,19-02-11,,Develop an appreciation of the role of complementary and alternative medicine in patient care and the role of the pharmacist around CAM use by patients. ,Appreciate the need for lifelong learning skills that will enable maintenance of competence through keeping abreast of emerging technologies and drugs.,Develop an appreciation of the interdisciplinary nature of patient care.,"Develop a caring, empathetic attitude for patients experiencing the conditions covered.",Utilize independent and collaborative approaches to learning,Evaluate and apply information from literature and other resources to provide patient care.,"Utilize an evidence based approach to therapeutic management of the self-care, CAM and pulmonary conditions covered.",Manage clinically significant drug interactions with drugs used to treat the self-care and pulmonary conditions covered.,"Develop a therapeutic and monitoring plan, taking into consideration patient factors, efficacy, toxicity, cost, route of administration, etc.",Identify and locate sources of information needed to provide patient care.,"Conduct a patient assessment using relevant data from the patient history, review of systems, laboratory tests, diagnostic imaging and medication history in order to provide patient care.","Identify ethical issues in the management of self-care, CAM, and pulmonary conditions.","Outline the economic and health policy issues as they relate to self-care, CAM, and pulmonary conditions.","Describe the therapeutic approach to managing the conditions covered, including: Guideline recommendations and clinical targets; Pharmacological (dose, duration of therapy, monitoring parameters); Non-pharmacological treatments, and; CAM.","Explain the mechanism of action, pharmacokinetic principles, clinical effect(s), adverse effects & drug interactions for the medication classes covered.","Describe the risk factors, clinical presentation, and assessment parameters (signs and symptoms, laboratory values/tests, physical findings and diagnostic measurements) of the conditions covered. ","Outline the epidemiology, etiology and pathophysiology of the self-care and pulmonary conditions covered.","Describe the role of the patient, the pharmacist and other healthcare providers in the management of common self-care conditions, CAM  and pulmonary diseases of focus",Identify the different complementary and alternative medicine modalities and the reasons why patients may seek care from a CAM provider or product.,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Midterm,Exam,Written and multiple choice,40,NA,19-03-27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Seminar Quiz,Quiz,Written and multiple choice,5,NA,19-02-06,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Seminar Quiz,Quiz,Written and multiple choice,5,NA,19-03-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 477 (Winter 2019 LEC B1 SEM J1),PHARM 477 Wi19 - INFECTIOUS DISEASES 2 Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,",Christine Hughes,,Final,Exam,Written and multiple choice,50,NA,19-04-23,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 427 (Winter 2019 LEC B1 SEM J1),PHARM 427 Wi19 - PAIN Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Patrick Mayo,,Class Participation,Participation,N/A,5,NA,19-01-15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 427 (Winter 2019 LEC B1 SEM J1),PHARM 427 Wi19 - PAIN Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Patrick Mayo,,Midterm,Exam,Written and multiple choice,40,NA,19-02-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 427 (Winter 2019 LEC B1 SEM J1),PHARM 427 Wi19 - PAIN Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 2nd year",Patrick Mayo,,Final,Exam,Written and multiple choice,55,NA,19-04-13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 377 (Winter 2019 LEC B1 SEM J1),PHARM 377 Wi19 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,, BSc in Pharmacy, Doctor of Pharmacy (PharmD), 2nd year",Tony KL Kiang,,Seminar participation and quizzes,Participation,N/A,10,NA,18-12-19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 377 (Winter 2019 LEC B1 SEM J1),PHARM 377 Wi19 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,, BSc in Pharmacy, Doctor of Pharmacy (PharmD), 2nd year",Tony KL Kiang,,Midterm,Exam,Multiple choice,40,Cumulative,19-03-14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 377 (Winter 2019 LEC B1 SEM J1),PHARM 377 Wi19 - IMMUNOTHERAPEUTIC & TRANSPLANT Combined LEC SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Pharmaceutical Sciences,, Therapeutics,, BSc in Pharmacy, Doctor of Pharmacy (PharmD), 2nd year",Tony KL Kiang,,Final Exam,Exam,Written and multiple choice,50,Cumulative,19-04-12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Seminar 1 Quiz,Quiz,Written,5,NA,19-03-20,,Accept responsibility for keeping abreast of emerging technologies and drugs.,Utilize self-directed learning abilities.,Discuss monitoring parameters for each of the condition of focus.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.","Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Discuss the methods of contraception available for men and women and describe the efficacy of each.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Seminar 3 Quiz,Quiz,Written,5,NA,19-04-03,,Accept responsibility for keeping abreast of emerging technologies and drugs.,Utilize self-directed learning abilities.,Discuss monitoring parameters for each of the condition of focus.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.","Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.","Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Midterm,Exam,Multiple choice,40,NA,19-03-27,,Accept responsibility for keeping abreast of emerging technologies and drugs.,Utilize self-directed learning abilities.,Discuss monitoring parameters for each of the condition of focus.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.","Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Identify applicable health system resources.,Describe the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the societal and economic impact of the conditions of focus.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,"Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.","Describe the epidemiology, etiology, and risk factors of the conditions of focus (see list above).",Describe the physiology of the female and male reproductive systems.,Explain the anatomy of the female and male reproductive systems.,,,,,,,,,,,,,,,,,,,,,,,,PHARM 499 (Winter 2019 LEC B1 SEM J1),PHARM 499 Wi19 - WOMEN'S & MEN'S HEALTH Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, BSc in Pharmacy, 3rd year",Nese Yuksel,,Final,Exam,Written and multiple choice,50,NA,19-04-15,,Accept responsibility for keeping abreast of emerging technologies and drugs.,Utilize self-directed learning abilities.,Discuss monitoring parameters for each of the condition of focus.,"Utilize an evidence-based approach to the therapeutic management of the conditions of primary focus, including use of drug, non-drug and complementary and alternative medicines.","Discuss alternatives (drug, non-drug), recommendations, implementation, monitoring and follow up for patients with the conditions of focus.",Identify actual and potential drug-related problems relating to the conditions of focus and in patient cases.,Apply pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,"Apply concepts and knowledge of medicinal chemistry, pharmacology and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.",Identify applicable health system resources.,Describe the role and the responsibility of the pharmacist within the course of the disease state and its therapy.,Identify ethical issues surrounding treatment of the conditions of focus.,Describe the societal and economic impact of the conditions of focus.,Discuss the methods of contraception available for men and women and describe the efficacy of each.,Discuss the role of Complementary and Alternative Medicines (CAM) for womens and mens health and describe the efficacy.,"Describe the therapeutic approach incorporating non-pharmacologic and pharmacologic treatments of the conditions of focus including use of specific target drugs for condition as well as alternative therapies (dose, route of administration, length of therapy, monitoring parameters).",Describe the specific laboratory tests used in the diagnosis and monitoring of the conditions of focus.,"Describe the pharmacology, including mechanisms, efficacy, toxicology, side effect profiles, and role of each for the drugs and drug classes associated with the conditions of focus.",Describe pharmacokinetic and pharmacodynamic principles to the treatment of the conditions of focus.,Describe the medicinal chemistry and therapeutic principles in selecting and monitoring drug therapy for the management of the conditions of focus.,"Describe the pathophysiology of the conditions of focus including clinical presentation, symptomatology and health consequences.",,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 354 (Spring 2019 CLN 800 801),PHARM 354 Sp19 - INTRO PHARM PRACT EXP PART 1 Combined CLN Sp19,Cross Listed Courses,"Experiential,, Doctor of Pharmacy (PharmD), 2nd year",Renette Bertholet,,Assignment #1:  PHARM 354 Learning Plan ,Assignment,N/A,0,NA,18-12-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 354 (Spring 2019 CLN 800 801),PHARM 354 Sp19 - INTRO PHARM PRACT EXP PART 1 Combined CLN Sp19,Cross Listed Courses,"Experiential,, Doctor of Pharmacy (PharmD), 2nd year",Renette Bertholet,,Assignment #2: Care Plan,Assignment,N/A,0,NA,18-12-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 354 (Spring 2019 CLN 800 801),PHARM 354 Sp19 - INTRO PHARM PRACT EXP PART 1 Combined CLN Sp19,Cross Listed Courses,"Experiential,, Doctor of Pharmacy (PharmD), 2nd year",Renette Bertholet,,Assignment #3: Medication Safety,Assignment,N/A,0,NA,18-12-07,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Integrated Care Plan,Assignment,N/A,10,,18-05-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Midterm Exam,Exam,Other,15,,19-02-28,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Final Exam ,Exam,Other,35,,19-04-26,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Lab Assignments,Assignment,N/A,30,,18-05-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 223 (Winter 2019 LAB B1 SEM J1),PHARM 223 Wi19 - PATIENT CARE SKILLS 2 Combined LAB SEM Wi19,Cross Listed Courses,"Pharmacy Practice,, Doctor of Pharmacy (PharmD), 1st year",Candace Necyk,,Professionalism ,Participation,N/A,10,,18-05-16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Examination 2 (Geriatrics),Exam,Written and multiple choice,40,,18-02-09,,Appreciate the challenges related to decision-making and advocacy in grey areas of clinical practice and health.,Apply applicable pharmacokinetic parameters to monitor patients and assess appropriate use of medications.,Identify and be able to recommend aids to assist in medication management and administration.,Identify sources of information needed to solve drug-related problems specific to the populations being studied.,Use tools to assess medication appropriateness and medication management in seniors.,Describe common stereotypes and biases toward aging in our western society.,"Define and be able to use the following terms in a clinical context: geriatrics, gerontology, elderly, aging, frailty.","Describe the role that culture, religion, and ethnicity may play in health and decision-making.",Briefly describe the psychosocial aspects of aging and be able to explain the role of the pharmacist in dealing with these aspects.,Describe how criteria were developed to classify medications as appropriate or inappropriate in seniors.,Identify medications that are considered inappropriate or high risk in older adults and explain why they are inappropriate or high risk.,Discuss the importance of medication safety and identify measures used to ensure safe medication practices,Identify and describe age-appropriate communication strategies.,Describe the role of pharmacists in the care of pediatric and geriatric patients.,Describe the role of the pharmacist in working with home care.,Identify methods of appropriately communicating with older adults who are hard of hearing.,Contrast how a geriatric syndrome is different than a disease state.,Describe appropriate interventions for falls.,Identify risk factors for falls in older individuals.,Describe the impact of falls on the senior population.,Contrast the presentation of adverse events in the elderly compared to the young adult.,Define polypharmacy and underutilization in terms of medications in seniors.,Contrast disease presentation between the young adult and the elderly adult.,"Describe the pharmacokinetic and pharmacodynamic changes associated with aging, and apply the principles to medications commonly used in geriatrics.",Describe the physiologic alterations associated with normal aging that modify drug response in the elderly patient., List the most common chronic diseases and causes of death in seniors.," Explain the demographics of aging, and how that may impact society and the healthcare system.",Describe the role of the pharmacist in reducing elder abuse,Identify controversial health issues involving pediatric and geriatric populations,Identify appropriate home care supports for a given patient.,Discuss the role of the pharmacist in medication management of seniors.,List the common geriatric syndromes.,"Describe risks for adverse drug events in pediatric and geriatric patients, and explain why they are more susceptible to adverse events.","Describe the use and effect of drugs, pharmacoepidemiology, including prescription, non-prescription medication, and natural health products.",Describe the challenges of providing care in a population with limited evidence.,Categorize the types of abuse commonly suffered by seniors.,,,,,,,,,,,PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Examination 1 (Pediatrics),Exam,Written and multiple choice,40,,18-01-25,,Appreciate the challenges related to decision-making and advocacy in grey areas of clinical practice and health., Apply knowledge and skills to establish safe and effective drug use.,Utilize when available an evidence-based approach to therapeutic management of pediatric and geriatric patients.,Apply applicable pharmacokinetic parameters to monitor patients and assess appropriate use of medications.,Be able to triage patients in a community setting and refer them to medical attention as appropriate.,"Empathize with children, older adults, and caregivers regarding challenging decision-making.",Identify sources of information needed to solve drug-related problems specific to the populations being studied.,"Explain the demographics of the pediatric population in society, and explain how that may impact our role as pharmacists. (e.g. improvement of childhood illnesses, trend towards chronic disease management)","Describe the role that culture, religion, and ethnicity may play in health and decision-making.",Briefly describe the psychosocial aspects of aging and be able to explain the role of the pharmacist in dealing with these aspects.,"Identify and discuss some of the challenges involved in treating the pediatric population, including communication strategies, presentation of illness and the management and administration of medications to infants and children.","Identify and discuss appropriate management plans for common pediatric gastrointestinal illnesses (e.g. vomiting, diarrhea, dehydration, colic, and constipation).",Discuss the importance of medication safety and identify measures used to ensure safe medication practices," Explain the significant differences in physiologic parameters between adolescents, children, toddlers and infants, including premature babies, and neonates",Identify and describe age-appropriate communication strategies.,Describe the role of pharmacists in the care of pediatric and geriatric patients.,Explain how pharmacokinetic parameters are different in infants and children versus adults.,Review pediatric toxicology and discuss preventative interventions that pharmacists can promote to patients or utilize in their practice to minimize pediatric toxicological poisonings or incidences.,"Describe the various forms of pediatric abuse and discuss the Child, Youth and Family Enhancement Act and the responsibilities that are associated with the Act",Discuss basic neonatal care and challenges including premature birth.,Identify and discuss appropriate management plans for common pediatric concerns such as teething and fevers.,Discuss presentation and treatment for common pulmonary pediatric illnesses; croup and bronchiolitis.,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Assignment 1: Pediatrics: Reflection and personal â€œscriptâ€ù,Assignment,N/A,10,,18-01-23,,Communicate position through oral and written formats.,Prepare and present a personal script to address a controversial topic.,Take and defend a position on a controversy related to pediatrics and geriatrics using evidence-based arguments.,Describe the role of pharmacists in the care of pediatric and geriatric patients.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,PHARM 387 (Winter 2019 LEC B1 SEM J1),PHARM 387 Wi19 - PEDIATRICS / GERIATRICS Combined LEC SEM Wi19,Cross Listed Courses,"Therapeutics,, Behavioural, Social and Administrative Sciences, BSc in Pharmacy",Cheryl A Sadowski,,Assignment 2: Geriatrics: Perspectives on care of geriatric patients and future practice,Assignment,N/A,10,,18-02-07,,Communicate position through oral and written formats.,Describe the role of pharmacists in the care of pediatric and geriatric patients.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,